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Understanding the genetics and function of complex human retinal
phenotypes
Hannah Currant
The human retina is the tissue at the back of the eye responsible for converting light stim-
ulus into neuronal signal that can be interpreted by the brain. To perform this integral
role within the central nervous system, the retina has a complex and layered structure,
with each layer performing a vital step in the signal transformation process.
Changes in themorphology of this structure are often a consequence of disease, which
can affect the function of the eye. Better understanding of the genetics influencing this
structure may teach us about the biological processes underlying these diseases as well
as general eye development.
The retina is imaged routinely in the clinic using optical coherence tomography
(OCT), providing a non-invasive imaging technique that produces high-resolution,
three-dimensional representations of the retina fromwhichmeasures describing retinal
morphology can be extracted.
This thesis summarises my research into the genetic variation underlying retinal mor-
phology.
Firstly, I explored the morphology of the inner retina, whose thickness is used as a
biomarker of glaucoma, using quantitative phenotypes extracted fromOCT. I conducted
genome-wide association studies (GWAS) of the thickness of the retinal nerve fibre layer
and the ganglion cell inner plexiform layer to understand the genetic variation driving
inner retinal morphology. I further explored the causal relationship between the inner
retina and glaucoma using Mendelian randomisation analysis.
I next performed GWAS of the thickness of the outer retinal layers, including both the
component photoreceptor cell layers (the outer nuclear layer, inner segment, and outer
segment), and the retinal pigment epithelium layer. I explored how genetic variation
was affecting the outer retinal morphology at a higher dimension by looking for genetic
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variants thatwere differentially affecting the outer retinal thickness at the centralmacula
compared to the peripheral macula.
To further explore the rich dimensionality of OCT data, I developed several image
analysis techniques to gain more granular information about the morphological vari-
ation being affected by the discovered genetic variants. In doing so I established a novel
population level trait and examined its effect on visual acuity.
In summary, this thesis provides a well-rounded and detailed look into the genetic
variation underlying morphological variation of the retinal layers. As the largest study
of retinal layer genetics of its kind, it offers insight into clinical ophthalmology and ret-
inal development, and furthermore opens new avenues for clinical research.
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1. Introduction
Academics and scholars have been studying the human eye and the mechanism of sight
for millennia. The eye is a key part of the central nervous system, and its dysfunc-
tion leads to notable changes in quality of life [Moschos, 2014]. The eye has a complex
structure and the anatomy of the eye has therefore been of great scientific interest, with
disruption to the normal morphology often leading to pathology. In particular, the ret-
ina, the ocular tissue responsible for conversion of light stimuli into neurological signal
that is interpreted by the brain, has an intricate structure that is acutely specialised to
its function and disruptions can lead to a diverse catalogue of diseases. Advances in
imaging technologies have enabled non-invasive imaging of live retinal tissue. This has
allowed for a deeper understanding of retinal structure and pathology as well as aiding
diagnosis and disease management. This advancement of imaging and its use in the
clinical field, coupled with the increased use of genomics, has helped elucidate the un-
derlying genetic cause of ocular diseases and their link to morphology. New large scale
databases that contain optical imaging and genetic data are also allowing for study of
normal variation in retinal morphology and their consequences on health and disease.
There is great potential for the further integration of genomics into ophthalmic care
[Black & al., 2020], and an understanding of the genetic variation underlying normal
morphological variation may aid this.
In this thesis I used the data-rich, large-scale UK Biobank database, which contains
both retinal imaging and genotype data, to study the genetic variation underlying mor-
phological variation of the retina. Throughout this thesis the term morphology is used
to encompass a measure of thickness and topography of retinal layers. I performed the
first large-scale genome-wide association studies (GWAS) of morphology of individual
retinal layers. I looked at the relationship between the genetic drivers of retinal morpho-
logy and a number of retinal diseases. I also developed image processingmethodologies
in order to study the spatial variation in retinalmorphology across the field of the retina.
For the remainder of this chapter, I will describe some of the key aspects of ocular
and retinal morphology. I will briefly describe the history of the study of the eye. I will
further explain some of themethods for imaging the retina and some of the diseases that
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can affect the retina. In the second part of the introduction, I will describe the journey to
our current understanding and utility of genetics that has enabled the study of human
variation using quantitative genetics.
1.1. The Eye
Human curiosity with the eye, both its function and dysfunction, can be documented
back to ancient history. The eye has long held a place in mythology and religion along-
side medicine and biology. Consider the Egyptian eye of Horus, a symbol of wealth
and prosperity; the third eye, a symbol seen in both Buddhism and Hinduism associ-
ated with spiritual insight and awareness; or the evil eye in Greek legend, a curse cast
by an evil stare that can be protected against using the iconic blue eye-shaped talisman
[Potts, 1982; Abbasi, 2017]. Through history, the eyes were seen to have great power,
providing spiritual insight and knowledge as well as the less philosophical power of
physical sight. As academics began to study the anatomy, function and dysfunction of
the eye further, it became clear that this organ could provide scientific insight into many
aspects of biology, development and health.
1.2. History of Ocular Study
Study and speculation of themechanism of sight and the biology of the eye can be dated
back to ancient Egyptian times. Both the ancient Egyptians and Babylonians recorded
descriptions of eye diseases, most of which were thought to be caused by demons and
thus cured by spiritual practises and application of various ointments [Finger, 1994]. In
∼1500BC, Suśruta, an Indian physician, provided further descriptions of eye anatomy
and diseases including glaucoma. He is also one of the earliest known physicians to
have performed a form of cataract surgery known as couching, in which he physically
pushed the cataract out of the field of vision [Dutt, 1938], a technique copied by many
visiting Greek scholars.
Various contributions weremade by the Ancient Greeks to both eye anatomy and the-
ories of visual mechanism. In terms of anatomical advancements, Alcmaeon is thought
to be the first to identify the optic nerves via dissection in the 5th century BC. Hippo-
crates and his disciples split the eye into three areas, the sclera, the uveal tunic and the
retina, a model furthered by Herophilus through the inclusion of the vitreous humor
and the optic nerves. Proposed theories of visualmechanism included that of Alcmaeon
who hypothesised that beams of visual fire emanated from the eye and captured the im-
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age of objects. This concept, of the eye emitting something that allowed for sight, was
reiterated by many and given the name extramission [Finger, 1994].
The Roman scholar Galen was also a supporter of extramission believing that
pneuma, a spirit, was released from the eye through hollow optic nerves to capture
images. Despite his incorrect beliefs on the mechanism of vision, Galen did provide
detailed descriptions of eye anatomy, outlining the cornea, iris, lens, choroid, sclera and
humors [Ajita, 2015]. Galen and the majority of his contemporaries believed the lens
to be the structure within the eye responsible for vision, with the retina providing only
nutrition to the eye. He also noted that whilst the optic nerves of the two eyes appeared
to meet at the chiasma, he believed they did not cross but merely communicated with
one another to aid binocular vision.
Arabic academics and physicians are often creditedwithmany important ophthalmo-
logical advancements. Hunayn ibn Is-Hâq, a physician born in 809AD in Iraq, is thought
to have written the earliest Middle Eastern text about the eye, and went on to be a pro-
lific writer on ophthalmology. Most famously he wrote The Book of Hunayn ibn Is-Hâq
on the Structures of the Eye, Its Diseases, and Their Treatment, According to the Teachings of
Hippocrates and Galen, in Ten Treatises [1928], in which the earliest anatomical diagrams
of the eye can be found.
One of the most famous Arab scholars was Hasan Ibn al-Haytham, born in Iraq in the
early 11th century. Ibn al-Haytham is one of the first scholars to show understanding of
the inversion of images within the optic pathway. He also was clear in his opposition to
the theory of extramission and instead proposed light and colour travelled in straight
lines froman object andwas converged at the eye [Al-Khalili, 2015]. His theorywas seen
to disprove extramission. Amajor advancewas the suggestion by Ibn Sina andAbūBakr
Muhammad ibn Zakariyyā al-Rāzī that the optic nerves crossed at the chiasma [Finger,
1994].
Moving to mid-16th century Europe, Andreas Vesalius was the first to depict the op-
tic nerves as non-hollow, a fact later confirmed in the late 17th century by Antony van
Leeuwenhoek using microscopy. Vesalius is also credited with suggesting the retina,
not the lens, is the receptive tissue within the eye, although his originality is disputed
by those who claim the Arab scholar Averroes suggested this in the early 12th century.
The importance of the retina was further supported by Felix Platter, who in the late
17th and early 18th century performed experimental procedures to evidence his theory
[Lindberg, 1981].
Other notable advances include the discovery of the blind spot in 1668 by l’Abbé Edme
Mariotte [Mariotte & Pecquet, 1668], the identification of the macula and the fovea by
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Samuel Thomas von Sömmerring in 1791 [Finger, 1994], and the description of the cross-
ing over of nerve fibres at the optic chiasma by Isaac Newton in 1704 [Newton, 1704].
Johannes Müller was the first to identify rods and cones, a series of cells that he de-
scribed as rod like and cylindrical in shape, although he and several others incorrectly
described them as facing inwards to the eye [Müller, 1837]. Heinrich Müller correc-
ted this, describing the receptors as facing outwards from the eye. He also identified
a number of the other key retinal layers. Max Schultze would later describe a distinc-
tion between rod and cone cells, as well as theorise about their unique roles based on
observations of their ratios within animals of different chronotypic tendencies [Finger,
1994].
Advances in our understanding of retinal structure were enabled by the development
of new fixation and staining techniques in the late 19th and early 20th century. Santiago
Ramón y Cajal employed these techniques to identify the separation of the retinal nerve
fibres and the optic nerve, the independent photoreceptors, bipolar cells, horizontal cells
and amacrine cells [Ramón y Cajal, 1893].
The study of the eye has developed through history to a point of detailed understand-
ing. We now possess an in-depth knowledge of the eye, both anatomically and mech-
anically. This has been enabled in part by novel imaging techniques discussed later.
1.3. Anatomy of the Eye
The eye has a complex structure, acutely tuned to its function, somuch so that its design
caused Charles Darwin to doubt his theory of natural selection [Darwin, 1859]. The eye
is an organ made of numerous layers, each with a unique function (figure 1.1A). The
outermost layer of the eye consists of the sclera and the cornea. The sclera makes up the
majority of the outer layer and is a tough protective layer with a white colouring. The
cornea constitutes the outermost layer at the anterior portion of the eye. It is a clear, pain
sensitive connective tissue that allows light into the eye. The next layer is the choroid,
the vascular layer that provides blood supply to all layers of the eye. The inner most
layer of the eye is the retina, which absorbs light energy and converts it to neural signal
that can be interpreted by the brain [James & al., 2003].
The journey of light to the retina starts at the cornea, which acts as a window for light
into the eye. The cornea’s curvature is responsible for the first stage of light refraction
and focusing. It then passes through the pupil, an opening at the front of the eye whose
size is controlled by the iris. The area between the cornea and the iris is the anterior
chamber. The iris is the colouredmuscle tissue in the eyewhose contraction and dilation
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control the amount of light allowed into the eye. The light then passes through the
biconvex crystalline lens which provides further refraction. The space between the iris
and the lens is known as the posterior chamber. Collectively the anterior and posterior
chambers of the eye are called the anterior segment and are filled with aqueous humor.
The lens is held in place in part by the ciliary bodies, which regulate the shape of the
lens and are also responsible for production of aqueous humor which flows from the
posterior chamber, into the anterior chamber [Fautsch & al., 2006]. The lens focuses
the light onto the retina, which is the flat surface at the back of the eye that captures
light and converts it to neural signal. The large cavernous space between the lens and
the retina is known as the posterior segment and is filled with vitreous humor [Freddo,
2018].
1.3.1. Optics of the Eye
The human eye is required to detect light at a broad range of intensities and distances
whilst maintaining high visual acuity and colour vision. Both the cornea and the lens
contribute to focusing light onto the retina to maintain this visual acuity. The difference
in the index of refraction between the air (1.0) and the cornea (1.38), and the subsequent
change in the speed of light as it passes through the cornea, means that the cornea is
accountable for about two-thirds of the refractive power of the eye. The lens performs
the remaining focusing of the light onto the retina, aided by its convex shape. Due to this
shape, the image is projected onto the retina inverted, and the brain is responsible for
flipping it to the correct orientation (figure 1.1B). As the distance between the cornea to
the retina is fixed, variation in the focal length is controlled by altering the shape of the
lens. This allows focusing of light from objects at varying distances. The ciliary bodies
control thickening and thinning of the lens to focus light onto the retina. Individuals
with uncalibrated distance between the cornea and the retina, for example those who
are myopic or hypermetropic, may require glasses that alter the focal length [Urone,
1998].
1.4. The Retina
The retina itself is a highly structured layered tissue (figure 1.2A). As previously stated,
it is responsible for conversion of light energy into neurological signal. It can be broadly
separated into the inner retina - the neural section nearest the front of the eye - and the




















Figure 1.1: Anatomy and optics of the eye. A) A cross-section of the human eye highlighting
different tissues and substructures. B) A diagram of the optics of vision, demonstrating the focal
length and projection of an inverted image onto the retina.
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travels through the layers of the retina until it is absorbed in the posterior of the retina
by the photoreceptors in the photoreceptor layer (PRL).
Photoreceptors take light energy as an input and convert it to chemical energy in the
form of neurotransmitters. Two types of photoreceptors can be found in the human ret-
ina: rods and cones. Rods aremore populous in the peripheral areas of the retina, but are
in the minority in the central regions - the macula and fovea (figure 1.2B). They are re-
sponsible for vision in dim light but lack colour definition, and cannot provide detailed
vision. Conversely, cones are present mainly in the central retina and are responsible
for high clarity and colour vision, but only function in higher light levels. Cones come
in three forms: one that absorbs red light, one absorbing green light and one blue. By
the activation of multiple cone types at one time, humans are able to see a spectrum
of colour. The layer of photoreceptor cells is backed by the retinal pigment epithelium
(RPE) and Bruch’s Membrane (BM), the outer most layers of the retina. Both absorb
any scattered light which increases definition in vision. They also both supply the other
layers with nutrients and a blood supply, and remove waste from all the layers [James
& al., 2003].
The component layers of the photoreceptor cells (PRC) are the outer segment (OS),
inner segment (IS) and outer nuclear layer (ONL). The OS stores the photopigments
within stacked membranes. The IS contains mitochondria and ribosomes that aid the
assembly of the photopigments. The ONL contains both the cell body of the PRC, in-
cluding the nucleus and other organelles, and the synaptic terminal [Purves& al., 2001].
Signal from the photoreceptors is integrated by horizontal cells in the Outer Plexiform
Layer (OPL), which helps increase contrast in vision [Masland, 2012]. Signal from the
photoreceptors and horizontal cells is passed to the ganglion cells in the Ganglion Cell
Layer (GCL) by the bipolar cells in the Inner Nuclear Layer (INL). Once again, inform-
ation from multiple bipolar cells is combined in the Inner Plexiform Layer (IPL), this
time by amacrine cells. The ganglion cells, present in the GCL, then transfer signal to
the nerve cells in the Retinal Nerve Fibre Layer (RNFL) and exit along the optic nerve to
the brain via the optic disc. The optic disc contains no photoreceptors and is therefore a
blindspot, an area in each eye’s visual field that cannot see [Freddo, 2018].
Retinal layer structure differs slightly at themacula. Themacula is an area at the centre
of the retina responsible for high acuity vision. It has a characteristic valley-shaped
morphology (figure 1.2B). At the base of the macula dip is the fovea. The macula has
a much higher ratio of cones to rods than the rest of the retina. At the fovea only cones
are present, hence this area being responsible for highest acuity vision. At the macula,







Figure 1.2: Anatomy of the retina and macula. A) A schematic of the layers of the retina. The
light enters via the inner retina and is absorbed by the photorecpetors in the outer retina. The
direction of travel of both light and neuronal signal is labelled. The light energy is converted into
chemical signal which is then propagated back towards the inner retina before exiting the eye via
the optic nerve. The layers of the retina are labelled: retinal nerve fibre layer (RNFL), ganglion
cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer
(OPL), outer nuclear layer (ONL), inner segment/outer segment (ISOS) and retinal pigment
epithelium (RPE). Additionally the Bruch’s membrane (BM) and choroid are labelled. B) A
cross-section of the human macula, the central area of the retina, imaged with optical coherence
tomography (OCT) and labelled with substructures. This shows a characteristic valley-shaped
morphology that is responsible for highest acuity vision.
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for light to the photoreceptors.
In many ways the direction of travel of both light and signal within the human eye
seems counter-intuitive or back to front. The light must traverse all layers of the retina
before it is absorbed, and the signal must then travel back from whence the light came.
This is in contrast to other organisms such as cephalopods, whose photoreceptors are
found inverted compared to humans, with the photoreceptor cells in the inner retina dir-
ected towards the light [Hanke & Kelber, 2020]. Indeed, there is much variation in eye
structure across vertebrates which originally led to the initial conclusion that eyes had
independently evolved more than 40 times [Lamb & al., 2009]. However, the discovery
of the PAX6 gene, which is highly conserved across the animal kingdom, supported a
shared evolutionary history of eye development [Wawersik & Maas, 2000; Treisman,
2004; Bhatia & al., 2014] and further comparison of common structures suggest there
are more shared aspects than originally thought [Lamb & al., 2009].
A structure that has developed differently in different species is the fovea. Fish, such
as the teleosts, and reptiles all possess a fovea of differing depths with convex walls
[Bringmann & al., 2018]. Comparatively the majority of mammals lack a fovea, al-
though some maintain an area of increased photoreceptor density such as the visual
streak in rabbits [Levick, 1967], or the area centralis in cats [Beltran & al., 2014]. The
fovea appears to have ”re-emerged” in higher primates, where it is present as a valley
with concave sides that sees thinning of inner retinal layers at the centre, as in humans
[Bringmann & al., 2018].
1.5. Imaging the Retina
Our current understanding of the retina has been largely informed by our ability to
visualise it [Li & al., 2018]. There are multiple forms of ocular imaging that allow for
visualisation of the tissue at different resolutions in a non-invasive manner. Here I will
describe two of these methods in greater detail.
1.5.1. Fundus Photography
Fundus photography is a technique for obtaining a two dimensional view of the ret-
inal surface using normal optical wavelengths [Abramoff & al., 2010]. It is non-invasive
and allows ophthalmologists to observe the optic disc, macula and retinal vasculature
[Bernardes & al., 2011]. It is a standard technique used in ophthalmological examin-
ations [Yannuzzi & al., 2004] and a primary tool in the diagnosis pathway of several
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diseases including age-related macular degeneration (AMD) [Fleckenstein & al., 2018]
and diabetic retinopathy [Goh & al., 2016].
1.5.2. Optical CoherenceTomography
Optical coherence tomography (OCT) is a non-invasive imaging method used med-
ically in dermatology, cardiology and ophthalmology [Kume & Uemura, 2018; Ulrich
& al., 2016; Tsang & Sharma, 2018]. It is able to image optically scattering biological
tissues, building three dimensional representations of the tissue by repeatedly imaging
their cross-section [Gabriele & al., 2010]. The technique takes advantage of the coher-
ent nature of light produced by a light amplification by stimulated emission of radiation
(laser). Coherent light has a constant phase difference [Ng & al., 2016] and thus inter-
ference, the combination of two light waves, can be calculated. In OCT light is emitted
by a coherent light source, a laser, and split by a mirror. One of the split beams is sent to
a fixedmirror, and the other is sent to the tissue sample. Light is reflected by both the re-
flectingmirror and the tissue, and combined again at the splittingmirror. This combined
signal is thenmeasured by a detector or spectrometer (figure 1.3A). The return distance
from the beam splitter to the reflecting mirror is l1 and the return distance between the
beam splitter and the sample is l2. During OCT, l1 remains fixed. The detector uses the
interference of the beams coming from the reflecting mirror and the tissue to select the
single scattered photons and calculate the relative location of the sample (figure 1.3B).
The location of the reference mirror can be altered (axial scanning) to obtain informa-
tion on different axial locations. To limit the area in which scanning is conducted, the
light source contains a mix of different but very similar wavelength lights. The differ-
ence in wavelengths is proportional to the coherence length, the distance in which inter-
ference can be calculated, thus limiting the scanning field (figure 1.3C) [Huang & al.,
1991]. OCT is performed routinely in hospitals and by primary care opticians [Fujimoto
& Swanson, 2016], and assists in diagnosis and monitoring of a broad range of ocular
diseases due to its visualisation of all retinal layers [Jaffe & Caprioli, 2004].
1.6. Dysfunction of the Retina
There are a wide range of retinal pathologies, each with different symptoms and under-
lying biology. Due to the interconnectivity of the different retinal layers, and the specific
role each cell type has in the transmission of signal, disruption to any of these layers can




Figure 1.3: Optical Coherence Tomography (OCT).A)A simplistic representation of themech-
anism underlying OCT. A low coherence light source, often a laser, is emitted and split by a
mirror. The split beams are sent to a a reference mirror, a distance of l1/2 away, and the sample,
a distance of l2/2 away. The light is reflected by the reference mirror and sample and com-
bined at the beam splitter where it is reflected to a spectrometer. B) The difference between l1
and l2 affects the interference. C) If a light source contains a mix of light with slightly differ-
ent wavelength, the length for which the wavelength is similar enough that interference can be
calculated is known as the coherence length lc.
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1.6.1. Glaucoma
Glaucoma is the leading cause of irreversible blindness globally [King & al., 2013].
Broadly, it is a disease that causes damage of the optic nerve (figure 1.4) leading to a
characteristic cupped optic disc [Chan & al., 2017]. There are four main types of glauc-
oma [Kwom&al., 2009]. Firstly, developmental glaucoma, which presents in infancy or
childhood and is largely genetic [Taylor & al., 1999], or results from corrective surgery
for other ocular diseases [Gothwal & al., 2020]. Secondly, secondary glaucoma refers
to forms of glaucoma that are caused by other diseases, trauma or medication [Wein-
reb & al., 2014]. Thirdly, primary angle closure glaucoma is caused by a rapid increase
in intraocular pressure (IOP) due to the passage way for the drainage of aqueous hu-
mor being too narrow [Sun & al., 2017]. And the fourth, primary open angle glaucoma









Figure 1.4: Aqueous humor production and drainage The anterior segment of the eye is filled
with aqueous humor which is produced by the ciliary bodies. The humor then passes through
the passage between the iris and lens to reach the anterior chamber (shown by the blue arrow).
Aqueous humor is drained from the anterior chamber via the trabecular meshwork and canal of
Schlemm, into the aqueous vein. Narrowing of the passage between the iris and cornea causes
primary angle closure glaucoma (PACG). The gradual blockage of the trabecular meshwork
leads to primary open angle glaucoma (POAG).
Primary Open Angle Glaucoma
POAG is the most common form of glaucoma. It is a complex disease with multiple
causes that leads to degradation of retinal ganglion cells. POAG first presents as loss of
peripheral vision due to damage of the outer layers of the optic nerve [Weinreb & al.,
2014]. POAG can in extreme cases lead to blindness as optic nerve damage continues
to the central field [King & al., 2013]. Glaucoma commonly co-exists with raised IOP.
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One cause of this is the gradual blockage of the canal of Schlemm and trabecular mesh-
work (Fig1.4) [Andrés-Guerrero & al., 2017]. This leads to disruption in the drainage of
aqueous humor from the anterior segment and often subsequent increased IOP and cu-
mulative damage to the retinal ganglion cells and optic nerve [Hood & al., 2013]. Main
treatment methods of POAG involve decreasing IOP [Beidoe & Mousa, 2012] whether
that be through medication or surgical intervention [Weinreb & al., 2014]. However,
some individuals who are diagnosed with POAG present with low IOP. There are sev-
eral risk factors associated with POAG, mainly age and familial history of the disease
[Quigley, 2011].
There have also been extensive studies on the genetic predisposition of individuals to
develop POAG [Bailey & al., 2016]. The most recent meta GWAS by the International
GlaucomaGenetics Consortium (IGGC) identified 127 independent loci associatedwith
POAG [Gharahkhani & al., 2020]. There are a number of well characterised genes that
are associated with POAG. SIX6 has been found associated with POAG and is involved
in regulating early retinal progenitor cell proliferation [Li & al., 2002]. This is also sup-
ported by SIX6 affecting the thickness of the retinal nerve fibre layer [Cheng & al., 2014;
Ulmer Carnes & al., 2014]. CAV1 has been associated with POAG and encodes a pro-
tein which has been shown to act by protecting the canal of Schlemm from elevated
IOP [Elliott & al., 2016]. CDKN2B-AS has also been shown to be associated with POAG
and acts synergistically with CAV1, and TMCO1, which has been linked to apoptosis
[Burdon & al., 2011].
1.6.2. Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is a condition that affects the centre of the
retina, the macula, and causes progressive loss of vision [van Lookeren Campagne
& al., 2014]. It is generally categorised into early-stage and late-stage AMD [Ferris & al.,
2013]. Late stage AMD can be further categorised into non-neovascular, or dry AMD,
and neovascular, or wet AMD [Jager & al., 2008]. The early stages of AMD are char-
acterised by the build up of lipid deposits known as drusen below the RPE. Late stage
non-neovascular AMD is characterised by the accumulation of these drusen in both size
and number [Mitchell & al., 2018]. This leads to degradation of the RPE [Al-Zamil &
Yassin, 2017], the retinal layer that provides nutrients and blood supply to the photore-
ceptors. This will present as increasing loss of vision as the photoreceptors are progress-
ively damaged [Cunningham, 2017]. Late stage neovascular AMD is characterised by
the additional abnormal growth of blood vessels in the choroid. If left untreated these
blood vessels may burst, and the resulting scar tissue leads to irreversible loss of sight
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[Lim & al., 2012]. Age, smoking and ethnicity have been identified as risk factors for
AMD [Cunningham, 2017]. The very first GWAS conducted was of AMD [Klein & al.,
2005] and since then further work has led to well established genetics underlying the
disease. A recent GWAS identified 52 variants associatedwith AMD including rare cod-
ing variants in CFH, CFI and TIMP3 [Fritsche & al., 2016].
1.6.3. Retinal Dystrophy
Retinal Dystrophy refers to a group of conditions, mostly rare genetic conditions, that
cause deterioration of vision associated with the retina [Ziccardi & al., 2019]. These
conditions are all incurable [Sahel & Dalkara, 2019] but have a wide range of manage-
ment therapies [Dias & al., 2018; Gill & al., 2019; Sahel & Léveillard, 2018]. A recent
study suggests that, worldwide, approximately 5.5 million individuals are affected by
an autosomal recessive inherited retinal disease or dystrophy [Hanany& al., 2020]. Ret-
inal dystrophies are broadly categorised into those that are isolated to just the eye, isol-
ated retinal dystrophies, and those that affect the retina in addition to other areas of the
body, syndromic retinal dystrophies [Verbakel & al., 2018; Hamel, 2006]. The isolated
retinal dystrophies can be further categorised into: early onset retinal dystrophies; rod-
cone dystrophies - in which rods are affected prior to cones [Hamel, 2007]; cone-rod
dystrophies - in which cones are affected prior to rods [Gill & al., 2019]; and macular
dystrophies, which affect central vision [Rahman & al., 2020].
Macular dystrophies include retinitis pigmentosa [Mrejen & al., 2017], the most com-
mon form of retinal dystrophy [Hanany & al., 2020] which affects 1 in 3000-7000 indi-
viduals and causes progressive loss of peripheral vision [Ratnapriya & Swaroop, 2013].
More than 40 genes have been found associated with one of the forms of retinitis pi-
gemtosa [Parmeggiani & al., 2011]. Genes of particular importance in the disease in-
clude RHO, USH2A and RPGR, which when considered together account for ∼30%
of retinitis pigmentosa cases [Hartong & al., 2006]. Another example is fundus albi-
punctatus, characterised by impaired night vision and lesions across the retina exclud-
ing the fovea [Skorczyk-Werner & al., 2015]. This condition is known to be caused by
a mutation in RDH5, the gene encoding the 11-cis retinol dehydrogenase 5 [Yamamoto
& al., 1999].
1.6.4. Oculocutaneous Albinism
Oculocutaneous albinism (OCA) is a rare genetic condition that affects levels of pig-
mentation in the skin, hair and eyes [Kamaraj & Purohit, 2014]. A key clinical feature
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of OCA is foveal hypoplasia, the flattening of the foveal dip due to lack of excavation
of central inner retinal layers [McAllister & al., 2010; McCafferty & al., 2015]. Both lack
of retinal pigment and foveal hypoplasia leads to reduced visual acuity. Affected indi-
viduals also sometimes experience nystagmus, rapid repetitive movements of the eye
[Grønskov & al., 2007].
Mutations in several genes have been previously identified as underlying causes of
OCA. Such genes include TYR, OCA2, TYRP1, SLC45A2 and SLC24A5 [Montoliu & al.,
2014; Simeonov& al., 2013]. Defects in the different genes lead to distinct sub-categories
of the disease, with different types of the disease having higher frequency in different
populations and causing slightly different symptoms [Norman & al., 2017; Kirkwood,
2009].
1.7. Understanding Retinal Morphology
As has been outlined, changes in retinal morphology are a key feature of retinal disease.
Due to the nature of the eye, the structure is integral to its function, and even slight
changes to its anatomy can cause changes in its capacity for accurate vision. Therefore
there is a body of research into the morphology of the retina, its links to pathology,
and its underlying genetic drivers. This has been enhanced by the advances in retinal
imaging technologies. Studies have shown changes in retinal layer thickness in diseases
including glaucoma [Khawaja & al., 2020; Kim & Park, 2018], AMD [Wood & al., 2011;
Nivison-Smith & al., 2018] and, more recently several neurodegenerative diseases in-
cluding Alzheimer’s disease [Kim & Kang, 2019; Chan & al., 2019; Mutlu & al., 2018]
and Parkinson’s disease [Ma & al., 2018]. Studies have been conducted to look at the ef-
fect of lifestyle variables such as smoking [Duman & al., 2017], and biological variables
such as ethnicity [Kashani & al., 2010] on retinal thickness. Most recently, work has
been conducted looking for genetic variation affecting the overall thickness of the ret-
ina, finding several novel loci, and some loci previously associated with ocular diseases
[Gao & al., 2019].
Work is still needed to understand the genetic contribution to the morphology of the
individual retinal layers. This is of value because, as previously described, the differ-
ent retinal layers are responsible for different biological processes and steps in visual
signal processing. For this reason, each of the layers is also affected by different patho-
logies. Therefore, insight on the common genetic variation underlying the individual
layers may help understand visual mechanism and pathology at a more detailed layer,
providing clinical value. The creation of large datasets containing both retinal imaging
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data and genetic data, as well as the development of methods for analysing such data,
has allowed for my further exploration of this topic.
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2. Genetics
Genetics, the study of heredity and its molecular basis, has a long and rich history. To
reach our current understanding it was necessary to elucidate the fundamental theories
underlying inheritance, the mechanisms by which it occurs, and the molecular reagents
that enable it.
Scientists and philosophers began theorising about the transmission of traits between
generations over 2000 years ago [Mukherjee, 2016]. Farmers have been utilising mech-
anisms of inheritance for even longer [Burian & Zallen, 2009]. However, our under-
standing of the underlying biological mechanisms behind inheritance are relatively re-
cent. Technological advances now allow for rich and detailed studies that help us un-
derstand the fine-grain effect of genetics on human biology.
Scientists have long been interested in recording the variation in human traits. The
creation of databases containing large scale phenotypic data has enabled novel studies
of human variation. More recently the ever-falling costs of genetic sequencing have led
to increasing masses of genetic data. This genetic data has been aggregated with phen-
otypic data into ’biobanks’. These vaults of data allow large-scale analysis of genetic
variation underlying a broad array of traits.
The access to this coupled phenotypic and genotypic data is important for clinically-
relevant research. Not only is the boom indata accumulation being found in the research
arena, it is massing in the clinical space. The Global Alliance for Genomic Healthcare
(GA4GH) predicts that by 2025, 60 million patients will have had their genome se-
quenced within the healthcare system [Birney & al., 2017] . More and more, healthcare
systems are turning to coupled genetic and phenotypic data for patients as an aid to tar-
geted clinical diagnosis and treatment. This translation of basic research on phenotype-
genotype relationships into the clinical space is increasingly important, and requires
large-scale datasets and novel techniques that utilise clinically interpretable phenotypes.
Here I provide a brief history of genetics, highlighting the discoveries that made the
research within this thesis possible, and detailing some of the particular methods used
in my analysis.
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2.1. Early Theories of Inheritance
2.1.1. Ancient Ideas of Inheritance
For millennia, people have noted that the offspring of plants, animals and humans bear
resemblance to their parents, and have utilised this in the way they selectively breed
crops [Burian & Zallen, 2009]. Although they recognised these patterns, they had yet
to understand them. Early theories of inheritance can be dated back to Pythagoras, who
suggested that semen traversed the body collecting information about various traits that
was then nurtured in the womb into an offspring [Mukherjee, 2016]. Aristotle rejected
this, noting that traits fromboth parents are present in the offspring, andmost obviously,
how could male sperm learn information to produce female genitalia? Consequently
he postulated that whilst the father provided the instructions to build an offspring, the
mother provided the materials for construction [Harper, 2008]. Various other mechan-
isms were suggested in the following centuries, including the idea of the homunculus,
a miniature fully formed human that resides in the sperm and is nurtured to full size in
the womb [Mukherjee, 2016].
Hippocrates put forward another theory of inheritance which was supported bymul-
tiple other philosophers including Galen, previously discussed for his contributions to
eye anatomy (section 1.2). This theory proposed that all parts of both parents were
involved in the process of trait inheritance [Zirkle, 1935]. Charles Darwin later cham-
pioned and formalised this theory, christening it Pangenesis. His interpretation stated
that each part of the body secreted a molecule, known as a gemmule, that possessed
information about the production of that cell. This information passes to offspring
through the gametes, activated during fertilisation to create a fully formed human [Dar-
win, 1868]. An advantage of this theory was that it allowed for traits acquired through-
out one’s lifetime to be passed on to offspring.
2.1.2. Evolution and Inheritance
Charles Darwin’s more famous theory is that of natural selection, originally published
in tandem papers at the Linnean Society with Alfred Wallace, titled On the Tendency of
Species to form Varieties; and on the Perpetuation of Varieties and Species by Natural Means of
Selection [1858], and later in his book On the Origin of Species [1859]. During his travels
around Central and South America, Darwin made observational studies of trait vari-
ation between species and concluded that speciation occurs when random advantage-
ous specialisations to niche environments are sexually selected for, and persist in, sub-
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sequent offspring. This theory revolutionised the field of natural history, suggesting
gradual change similar to that proposed by Charles Lyell [1832] in relation to forma-
tion of geological formations. This directly contradicted the religiously-underpinned
notions of both Lyell and Darwin’s time.
Darwin also realised that his theory required some integral assumptions about the
nature of hereditary. Firstly, that variation amongst a species can exist in order for ad-
vantageousmutants to arise. Secondly, that this variationmust be fixed in somemanner
for the newly acquired traits to be passed on to new generations and selected for. The
two assumptions seemed at odds: there needed to be both rigidity of the system to en-
able transfer between generations, but flexibility to allow for creation of new traits. In
The Variation of Animals and Plants under Domestication [1868], Darwin adopted Hippo-
crates’ theory of Pangenesis in an attempt to meld and satisfy these two assumptions,
however it was widely criticised.
2.2. Mendelian Laws of Inheritance
In parallel with Darwin’s famous work, Gregor Mendel was conducting research on the
mechanisms of inheritance that would also revolutionise the understanding of genetics.
Mendel was a monk at St Thomas’ Abbey in Brno, now the Czech Republic, where
he dedicated his time to understanding patterns of inheritance in the monastic gardens
[Mukherjee, 2016]. Using pea plants as his experimental reagent, Mendel identified
a number of true-breeding traits including pea texture, height and flower colour. By
systematically cross-breeding both pure-bred plants, and subsequently their offspring
at a large scale, Mendel noted distinct patterns in which traits were inherited.
His main observations were that each trait had two distinct forms, which others later
would term alleles, and that these traits did not blend but were inherited in distinct pat-
terns. He condensed these patterns andhis subsequent inferences about inheritance into
three laws, presented in Versuche uber Pflanzen-Hybriden (Experiments on Plant Hybridiz-
ation) [1866]. Firstly, the law of dominance: of the two forms of a trait, one is recessive
and one is dominant. The dominant form will be expressed as an observable trait, over-
ruling andmasking the recessive form. Secondly, the law of segregation: the two alleles
are separated in gamete formation with a single allele present in each gamete. Finally,
the law of independent assortment: this segregation process is random, with different
traits non-reliant on one another.
These three laws bind together to form a solution to the problem that Darwin aimed
to solve with Pangenesis. Considering the centrality of his findings to modern genetics,
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Mendel’s work remained unrecognised for an astonishingly long period.
2.3. Biometrics
Meanwhile an alternative theory of inheritance was being cultivated, that of the bio-
metricians. Francis Galton, Darwin’s half cousin, was born in the same year as Mendel.
Galton latched on to many of Darwin’s proposed theories of evolution and began to
draw parallels and apply the theories to human beings. Inspired by Adolphe Quetelet’s
extensive work measuring various traits in a cohort of soldiers [Quetelet, 1835], Galton
set out to perform a similar study of his own.
Using sometimes unscientific methodology, Galton collected large-scale data on mul-
tiple facets of human variation including height, intelligence and beauty. Similar to the
findings of Quetelet, Galton noticed that the distributions of continuous traits were bell-
shaped: the majority of data points sit around the mean, with a minority of data points
at the extreme values. Galton consequently constructed the concept of regression to-
wards the mean, presented in Regression towards mediocrity in heredity stature [Galton,
1886]. Karl Pearson further developed these initial concepts into statistical analyses that
remain commonly used in modern genetics. These include correlation, the chi-square
(𝜒2) test and the use of p-values, and principal component analysis (PCA) [Pearson,
1900; Pearson, 1901]. The joint school of study advocated by Galton, Pearson, and Wal-
terWeldon, who appliedGalton’s statistical technique in his zoological studies [Weldon,
1890; Weldon, 1892], was termed Biometrics.
Having made several inferences about human variation, Galton wished to expand his
work and understand how such variationwas inherited. To do so, Galton studied family
pedigree and concluded that an ephemeral mix of social class, intelligence and success,
a concept he coined as ”eminence”, was a biologically heritable trait [Galton, 1869].
However, his theories about normal distribution of anthropometric traits did not easily
mesh with his concepts of ”eminence”. Whereas height tended towards an average,
with only exceptional cases being strongly influenced by parents, eminence (a concept
we might now know as nepotism) appeared to be much more strongly influenced by
family structures.
As a recipient of a powerfully nepotistic upbringing, and in an age of industrial and
social revolution, Galton felt existentially threatened by the rise of the working masses
and the ”undesirable” qualities they possessed. These traitswere grounded in his know-
ledge of class, yet piqued with underlying racism and sexism: the upper-class white
manwas the ideal. Misinterpreting his own results, and fuelled by this social backdrop,
42
Galton advocated for selective breeding of those with desirable traits. He termed this
practise eugenics, meaning ”well born” [Galton, 1883], and thus birthed a movement
that would cast a shadow over modern genetics. In spite of both the long-term negative
impacts of eugenics and biometrics ultimately being eclipsed byMendelian theories, the
statistical techniques developed by the founders of biometrics are still central to current
statistical genetics.
2.4. Marrying Evolution and Mendelian Laws of Inheritance
2.4.1. Rediscovering Mendel
Mendel’s work was simultaneously rediscovered by multiple scientists in 1900, follow-
ing many years of being overlooked. Hugo de Vries replicated many of Mendel’s stud-
ies in pea-plants. He supported Mendel’s concept of discontinuous variation which he
proposed worked through sudden mutations causing large shifts in offspring traits as
compared to their parents. He summarised that traits have distinct particles that carry
this hereditary information, which he called pangenes [De Vries, 1889]. The botanist Carl
Correns also reiterated Mendel’s findings [Correns, 1900], as did Erich von Tschermak
[von Tschermak, 1900].
One of Mendel’s largest champions was William Bateson who dedicated a portion
of his career to spreading the Mendelian perspective of inheritance and translated his
works into English [Bateson, 1902]. Bateson is credited for coining the word genetics to
describe the study of inheritance, aswell as the term allelomorph, now shortened to allele,
to describe the two variants of a trait [Wilks, 1907]. His colleague Reginald Punnett
was also important in bridging the gap between Mendelian concepts of inheritance and
statistics, establishing the Punnett square to illustrate the combinations of alleles that can
arise [Punnett, 1907]. Alongside Punnett andBateson’s independent research successes,
they collaborated with Edith Rebecca Saunders to recreate Mendel’s experiments.
It is interesting to note that many with a broad knowledge of the history of genetics
may be unfamiliar with Saunders. Prior to her collaborative work with Bateson, she
had independently studied inheritance in Biscutella laevigata, observing that the texture
of the plant’s leaves was inherited discontinuously and not blended [Saunders, 1897].
In her time, she was a reputable and successful scientist. She published many papers as
an individual, was elected the first female member of the Linnean society, and served as
the president of the British Genetical Society in 1938 [Bronstein & Bolnick, 2018]. Des-
pite her ordainment by J B SHaldane as the ”mother of British plant genetics” [Haldane,
1945], Saunders contributions to the field have been largely minimised by scientific his-
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torians. This speaks to awider culture of reducing the role ofwomen and otherminority
groups in the field of genetics and wider science. One of her many important contribu-
tions, which is often attributed to only Bateson and Punnett, is the first account of gene
linkage deduced from proportions of flower colour and pollen grain shape [Bateson
& al., 1905].
With this increased prominence, Mendelian patterns of inheritance became a power-
ful rubric for the explanation of human disease in the early 20th century. Archibald
Garrod, a physician working in the 1920s, recognised Mendelian patterns of recessive
inheritance in alkaptonuria, a disorder affecting urine. He later published this and his
similar observations in cystinuria, pentosuria and albinism in Inborn Errors ofMetabolism
[1923].
Having established the use of the term genetics, more necessary vocabulary was cre-
ated by various scientists to help describe the mechanisms of inheritance explained by
Mendelian theories. Wilhelm Johannsen defined a number of integral genetics terms
including gene, used to refer to a unit of inheritance. He also established the terms phen-
otype, the external trait expressed by an individual, and genotype, the underlying genetic
trait of an individual [Johannsen, 1909]. Other important lexicographical inventions
of the time include polygenetic (or polygenic), referring to a trait that is influenced by
multiple genes [East, 1910], and pleiotropic referring to genes that influence multiple,
seemingly unrelated traits [Stearns, 2010].
2.4.2. The Birth of Quantitative Genetics
With the re-emergence of Mendelian theory, and its undeniably astute observations
about inheritance, there was a gap to be bridged between these laws and the theories of
evolution posed by Darwin. In 1918, Ronald A Fisher published The Correlation Between
Relatives on the Supposition of Mendelian Inheritance [1919]. In this paper, he established
that through polygenicity, the effect of multiple genes on a single trait, continuous vari-
ation can occur as a result of Mendelian inheritance. This paper also features the first
use of the term variance, defined as the square of the standard deviation.
Throughout his career, Fisher established a number of additional statistical concepts
that are integral to modern quantitative genetics. He initially studied experimental
design [Fisher, 1935], with other landmark contributions including his work on max-
imum likelihood, establishing a number of statistical distributions, and development of
a number of statistical tests. These included Analysis of Variance (ANOVA) [Fisher,
1925] and Fisher’s exact test [Fisher, 1922]. Later in his book The Genetical Theory of Nat-
ural Selection [Fisher, 1930], he outlined a number of concepts that further linked theor-
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ies of evolution with statistical interpretations of genetics, now known as quantitative
genetics [Fisher, 1919].
Unfortunately, Fisher extrapolated his work on natural selection to human fitness,
claiming that societal influence was enabling the survival of ”less well adapted” indi-
viduals, as detailed in the latter portion of The Genetical Theory of Natural Selection [1930].
This speaks to a growing popularity of eugenics at the time, and a further shift frompos-
itive eugenics, in which individuals with reportedly desirable traits were encouraged to
breed, towards negative eugenics, in which individuals with supposedly undesirable
traits were forcibly prevented from breeding [Mukherjee, 2016].
In eugenics, Fisher and others abused Darwin and Mendel’s works to fit pre-existing
racism and classism. Fisher was a British advocate for sterilisation [Blacker, 1931], work-
ing in close parallel to eugenics researchers in Nazi Germany who provided the cloak
of science to a brutal programme of genocide.
Eugenics has since beenwidely discredited. Morally, its use in justifying the atrocities
perpetrated in Nazi Germany exposed eugenics as a profoundly reprehensible practice.
In parallel, the field of science has come to recognise the large flaws in the scientific jus-
tification for eugenics. The importance of genetic diversity, exemplified by the negative
effects of persistent selective breeding in agriculture and domestic animals, is diamet-
rically opposed to the goals of eugenics. In spite of being discredited, Fisher remained
unfaltering in his support of the eugenics movement until his death [Weiss, 2010].
In the modern field of genetics, and throughout this thesis, statistical methods de-
veloped by Fisher and his contemporaries who supported eugenics are utilised and
considered central. Meanwhile, a growing minority of society still holds moral senti-
ment for the eugenics movement. It is a nuanced line to walk in which we must admit
the importance of Fisher’s work to quantitative genetics, whilst not providing a tacit
endorsement for the re-emerging support of his beliefs. More broadly it is vital that sci-
entists remain aware that increased knowledge of the scientific mechanisms of life is not
sufficient justification for actions and policy. Self-criticism, scientific rigour and regula-
tion by outside authorities must all contribute to ensure science remains both advancing
and ethical.
2.5. Deciphering the Medium of Inheritance
As the mechanism of inheritance was gradually deciphered, work was concurrently be-
ing conducted into the underlying molecular medium. In 1871, Friedrich Miescher first
published his work identifying nuclein, an acidic molecule that is located in the cells
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nuclei [Miescher, 1871]. Over a decade later, Walter Flemming published Zell-substanz,
Kern und Zelltheilung (Cytoplasm, Nucleus and Cell Division) [1882] in which he presen-
ted his discovery of chromatin, the thread-like structures in the nucleus that stained
using basophilic dyes. Flemming further described the chromatin’s movements during
mitosis, the term he coined for the division of cells.
Later, both Walter Sutton and Theodor Boveri advanced the research with a descrip-
tion of meiosis, the formation of gametes. Sutton, in his initial paper on the subject, On
the morphology of the chromosome group in Brachystola magna [1902], established that chro-
mosomes occur in pairs when studying grasshoppers. This led to his hypothesis that
chromosomes are the medium of inheritance, and that division of chromosomes during
meiosis is in-keeping with Mendel’s laws. His later paper The Chromosomes in Hered-
ity [Sutton, 1903] reinforced the connection between Mendel’s Laws of Inheritance and
chromosomes as the medium of this process. Boveri’s investigation into the reproduc-
tion of sea urchins established that all chromosomes were essential to normal embryo
development [Laubichler &Davidson, 2008]. Sutton and Boveri’s combinedwork is the
foundation of the Boveri-Sutton chromosome theory [Wilson, 1925]. This theory stated
that chromosomes occur in pairs, with each parent contributing one chromosome to
each pair. Further, it proposed that all chromosomes are needed for an organism’s nor-
mal development. Therefore each chromosomemust be performing its own role. Nettie
Maria Stevens contextualised the Boveri-Sutton theory when she proposed sex determ-
ination was controlled by chromosomes based on her observations of mealworm repro-
duction [Stevens, 1905b; Stevens, 1905a].
In 1904, Thomas Hunt Morgan joined Colombia University where he was interested
in studying inheritance and species variation. He choseDrosophila melanogaster, the fruit
fly, as his animal model which he studied in his famous fly room [Allen, 1968]. There
he worked on identifying inheritable artificial mutations. This took some time, but
eventually he identified a white-eyed mutant amongst red-eyed wild-type flies. Cross-
breeding of mutants andwild-types produced only red-eyed flies. However interbreed-
ing of these red-eyed offspringproduced amixture of red-eyedflies andwhite-eyedflies,
with all the white-eyed mutants being male. Although linkage had been previously ob-
served, Morgan synthesised this observation with the knowledge of sex-determination
being chromosome bound. Therefore Morgan concluded that eye colour was likely car-
ried on the sex-chromosome as the traits of sex and eye colour are linked [Morgan, 1910].
He extrapolated this conclusion to hypothesise that other genes may reside on particu-
lar chromosomes [Morgan, 1911]. Linkage was further noted in both maize by Guy N
Collins [Collins, 1912] and later in mice by John B S Haldane [Haldane & al., 1915].
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ThomasHuntMorgan continued to introducemutations in his flies that caused phen-
otypic variants. By doing so he identified variants that were inherited as four distinct
”linkage groups”, equivalent to the number of Drosophila chromosomes. This provided
additional support for chromosome theory. One of the identified trait variants produced
miniature wings. Although the gene responsible for this trait also appeared to be loc-
ated on the sex chromosome it was not always inherited alongside eye colour. Morgan
suggested that he was observing a phenomena of chiasmatypie previously described by
Frans Alfons Janssens in 1909 [Koszul & al., 2012]. Thomas renamed the phenomena
chromosomal crossover, andupdated the concept to suggest that the different genesmay
cross over with differing frequencies, representative of their physical distance in rela-
tion to one another. Barbara McClintock and Harriet Creighton observed chromosomal
crossover in maize, and described the physical process by which it occurred, having
observed it using microscopy [Creighton & McClintock, 1931].
The specification of hereditary material was further narrowed by Oswald Avery. He
disproved the more common hypothesis that protein was the genetic material and es-
tablished Deoxyribonucleic Acid (DNA) as the genetic material instead [Avery & al.,
1944]. This led to a cascade of discovery. Firstly Erwin Chargraff established that DNA
is composed of four bases - adenine, cytosine, guanine and thymine - and determined
the ratios inwhich these bases occur [Chargaff, 1950]. This knowledge aided JamesWat-
son, Francis Crick, Rosalind Franklin andMauriceWilkins in the determination of DNA
structure: two complementary chains of nucleic acids arranged in a double helix [Wat-
son & Crick, 1953]. Resolution of the structure allowed inference of mechanisms of rep-
lication. Subsequently Crick proposed the central dogma, the idea that DNA sequence
encodes protein sequence, but this flow of information is one-way andmay bemediated
by an intermediate molecule [Crick, 1958]. Mahlon Hoagland and Paul Zamecnik iden-
tified transfer ribonucleic acid (tRNA) as this intermediate molecule [Hoagland & al.,
1958]. This was confirmed by Sydnney Brenner and Francois Jacob, whilst studying
Escherichia coli [Brenner & al., 1961]. Subsequently Brenner, Crick and Leslie Barnett es-
tablished that the genetic code that translates into protein is read in triplets [Crick & al.,
1961] and by 1966 work by Marshall Nirenberg, Heinrich Matthei [Nirenberg & Mat-
thaei, 1961], and Har Gobind Khorana [Khorana & al., 1966] had ”cracked” this genetic
code.
The research into both the mechanism and reagents of inheritance is broad, rich and
deserving of more detailed exploration. However for the purposes of this chapter, I will




2.6.1. Creating the First Genetic Maps
Alfred Sturtevant extended his supervisor Thomas Hunt Morgan’s concept of crossing
over to theorise that the frequency by which traits were jointly inherited was inversely
proportional to the distance of their corresponding genes along chromosomes. Using
this logic, he was able to construct maps about the relative locations of genes. He pub-
lished the first genetic map in 1913, detailing the relative location of genes along the X
chromosome of D. melanogaster [Sturtevant, 1913].
In 1921, the first example of chromosome crossing-over in vertebrates was observed
between Aplocheilus latipes (Japanese Medaka fish) sex chromosomes [Aida, 1921]. In
1937, Haldane and Julia Bell published the first example of linkage in humans, identi-
fying linkage between haemophilia and colour blindness when studying family pedi-
grees [Bell & Haldane, 1937]. The potential for human gene maps was furthered by
James Renwick and Sylvia Lawler, who utilised the novel concept of Logarithm of Odds
(LOD) to analyse large scale family pedigrees and identify linked conditions, including
the ABO blood group and nail-patella syndrome [Renwick & Lawler, 1955]. Renwick
and Jane Schulze later computerised this process [Renwick & Schulze, 1961].
In 1970 Hamilton Smith discovered restriction enzymes that could break and recom-
bine DNA in a targeted manner. This finding enabled the creation of restriction maps
[Smith & Welcox, 1970]. These restriction maps could identify genetic variation as dif-
ferences in the characteristic sizes of DNA fragments, known as restriction fragment
length polymorphisms (RFLPs). David Botstein proposed taking advantage of this by
identifying RFLPs throughout the genome that would act as landmarks when studying
linkage [Botstein & al., 1980]. This was initially applied in a number of model organ-
isms before allowing the mapping of the Huntington’s gene in 1983 by Nancy Wexler
[Gusella & al., 1983]. One of the genetic variants causing retinitis pigmentosa, the ret-
inal dystrophy, was also mapped using this method [Bhattacharya & al., 1984].
2.6.2. Reading DNA Sequence
These initial genetic maps still lacked fine grain nucleotide-by-nucleotide information,
and reading direct genetic code remained an elusive challenge. The first sequence de-
ciphered was a twelve nucleotide section of bacteriophage lambda DNA by RayWu and
Ellen Taylor [1971] using primer extension.
In the early 1970s, two groups were competing to establish a novel method of sequen-
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cing: Walter Gilbert and Allan Maxam at Harvard, and Fredrick Sanger in Cambridge.
Sanger’s methodology recruited DNA polymerase, the enzyme that copies DNA. By
stalling the replication process via the incorporation of modified nucleotides he could
map out the sequence of DNA bases [Sanger & al., 1973; Sanger & Coulson, 1975]. This
method eclipsed that of Gilbert and Maxwell [Maxam & Gilbert, 1977], and in 1977
Sanger published the 5,386 nucleotide sequence of 𝜙X174 virus [Sanger & al., 1977].
He would later go on to sequence human DNA for the first time, in the form of mi-
tochondrial DNA, using shotgun sequencing [Anderson & al., 1981], an expansion of
his previous method [Messing & al., 1981]. In this method, the DNA is broken up into
random fragments, cloned and separately sequenced. These fragments are later recon-
structed into a single sequence by utilising the overlapping nature of the fragments. This
allowed for sequencing of longer sections of DNA.
Following the establishment of this technique, the 1990s saw a rapid succession
of organismal genomes being sequenced: firstly the bacteria Haemophilus influenzae
[Fleischmann& al., 1995]; followed by the first eukaryotic organism, yeast Saccharomyces
cerevisiae [Goffeau & al., 1996]; then Caenorhabditis elegans [The C. elegans Sequencing
Consortium, 1998]; and D. melanogaster [Adams & al., 2000]. In 2000 the first draft of
the human genome was announced [Lander & al., 2001; Craig Venter & al., 2001]. The
sequence was complete in 2003 [Abdellah & al., 2004] and consisted of 3 billion base
pairs.
Since then, huge advancements have been made in the speed and volume in which
sequencing can be performed. Next-generation (or second-generation) techniques al-
low for parallelisation of the process [Shendure & al., 2017]. The advent of genotyping
using microarray chips allowed for the simultaneous identification of genetic variants
at a large scale [Wang & al., 1998]. We have now moved into what is known as the
third-generation of DNA sequencing marked by the development of technologies such
as Oxford Nanopore Technologies (ONT) sequencing [Heather & Chain, 2016].
2.7. Genotype-Phenotype Association Analysis
The study of the relationship between genotypes and phenotypes in humans was en-
abled by the various methods of genome mapping. The relationship was initially ex-
plored using genetic linkage studies. The advent of second-generation sequencing and
subsequent increase in genetic datasets brought with it the use of association studies.
Both of these methods are detailed in brief below.
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2.7.1. Genetic Linkage
Linkage studies have been used to explore the relationship between human genotypes
and phenotypes since the 1930s. They utilised the concepts articulated by Morgan and
Sturevant and applied them to humans to identify the location of genes of interest, often
those involved in disease. By studying the transmission of disease or other traits within
family structures, and the joint inheritance of parallel traits, the relative location of a
gene can be described. This allowed for the discovery of a number of disease loci in-
cluding that of Huntington’s disease [Gusella & al., 1983] and cystic fibrosis [Tsui & al.,
1986]. Despite its utility in the early study of genetic disease, it is limited to use in rare
and monogenic disease.
2.7.2. The ”Common Disease-CommonVariant” Hypothesis
As previously described, linkage analysis had great success in mapping the location
of rare and monogenic diseases. This was possible as the genetic variation underlying
such diseases has a near binary effect on the presence of phenotype. The variation is
rare, but the size of effect of the variant on the phenotype is large. Conversely, it was
observed that many common diseases, such as coronary heart disease, did not follow
the same pattern. These diseases were termed polygenic, meaning they were affected
by a number of genetic variants. Each variant would contribute a small effect to the
outcome phenotype, but their occurrence in the population was much more frequent.
The cumulative effect of these genetic variants produces the disease phenotype. This is
the underlying principle of the ”common disease-common variant” hypothesis, stating
that genetic variants involved in complex disease are likely to be common, but affect
disease risk in smaller increments. For these diseases, linkage is less likely to be an
effective method for studying the genetic-phenotypic relationship, as people with the
same phenotype are not always representative of the same locus variant. Therefore new
methods were needed that could take account of variant effects at the population level.
2.7.3. Association Studies
Association studies move away from the study of family structures, and instead look at
the effect of genetic variants at the population level. Conducted in a case-control man-
ner, a chi-squared test, originally outlined by Pearson in the 1900s, is commonly used
to test if there is a significant difference in the frequency of a genetic variant between
those who possess a trait, and those who don’t. This technique was popular through-
out the 1990s and allowed for the identification of variants affecting Alzheimer’s disease
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[Strittmatter & Roses, 1996] amongst others. Noting the success of these studies when
applied in a targeted manner, alongside the growth of genetic sequencing capabilities,
a clear need emerged for linked genotypic-phenotypic databases.
2.7.4. Databases of Genetic and PhenotypicVariation
Scientists have understood the benefits of collecting information on human phenotypic
variation at scale for a long time, evidenced by Galton’s records as above. Sequencing
technologies now enable the collection of genetic variation information at the genome-
wide level as well. A number of databases have been constructed since the turn of the
21st century, some genetic, some phenotypic, and some with coupled data.
In 2002, the international HapMap Project was launched with the goal of mapping
variation in individuals from distinct ethnic lineages. It aimed to study inter-human
variation at the base pair level by measuring frequencies of single nucleotide poly-
morphisms (SNP), with the long-term goal of better understanding disease. Taking
advantage of haplotypes, groups of SNPs inherited together, allowed for genotyping of
relatively few SNPs whilst retaining a rich data resource [Frazer & al., 2007].
Multiple databases were established for studying disease. The Wellcome Trust Case
Control Consortium was a collaborative project established in 2005 to study seven core
diseases: type 1 diabetes, type 2 diabetes, coronary heart disease, hypertension, bipolar
disorder, rheumatoid arthritis and Crohn’s disease. For each of these seven diseases,
2,000 individuals were genotyped in addition to a 3,000-participant control group, and
the subsequent data used in GWAS to find disease associated variants [Burton & al.,
2007]. Closely paralleled, the Cancer Genome Atlas was designed as a database of ge-
netic sequences of 20,000 cancer samples coupled to control samples. The project began
in 2006 and looked to discover novel genetic variants influencing cancer [McLendon
& al., 2008]. The UK10K was launched in 2010 and aimed to sequence the genomes
of 10,000 individuals with rare diseases to provide a resource for studying the genetic
impact on these disorders [Walter & al., 2015].
The UK Biobank was developed to combine broad phenotypic and genotypic data
allowing for the study of general and pathological biology. It is a database containing
data collected from 2006 onwards from ∼500,000 participants. The project aimed to col-
lect broad data at a national scale covering lifestyle, anthropometrics, and basic clinical
measures. For each of the participants, biological samples were taken and genotyping
was conducted, with exome and whole genome sequencing to be completed in the near
future [Sudlow & al., 2015]. For more information see section 3.1.
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2.7.5. Genome-wide Association Studies
The growth of these databases documenting commonhumanvariation allowed for asso-
ciations between common variation and complex disease. The statistical framework be-
hind GWAS is relatively simple, with many GWAS relying on an additive linear model.
Statistical significance is evaluatedwith a chi-square test. The first GWASwas published
in 2005 [Klein & al., 2005] and identified two loci associated with AMD using a cohort
of 146 individuals.
Since the first GWAS, the technique has been central to the discovery of genetic loci
involved in a large number of common and complex diseases, including type 2 diabetes
[Xue & al., 2018], schizophrenia [Ripke & al., 2014] and Crohn’s disease [Franke & al.,
2010]. The use of GWAS has also shown great success in eye pathology, with discovery
of SNPs associatedwith diabetic retinopathy [Huang& al., 2011; Sheu& al., 2013; Awata
& al., 2014; Burdon & al., 2015; Liu & al., 2019], and glaucoma [Choquet & al., 2018].
GWAS is also used to look for genetic variation underlying general biological vari-
ation. The Genetic Investigation of Anthropometric Traits (GIANT) consortium invest-
igated the genetic loci that affect human anthropometrics including height, body mass
index (BMI) and body shape [Speliotes & al., 2010; Allen & al., 2010; Heid & al., 2010].
The combined success in pathology and general biology means that GWAS remains
one of the key tools used to progress the study of genetics.
2.7.6. Population Structure in Genome-wide Association Studies
Variation in phenotypes is affected by a number of confounders in addition to genetic
variation. Increased use of association studies in human populations identified new
confounders that had to be controlled for. One of the the largest confounders is pop-
ulation structure, which represents shared common-ancestry as well as shared envir-
onment and culture. Whereas in association studies in animals, such as those in agri-
culture, where you can leverage population structure to fit complex models with the
knowledge that the environment has been randomised, the same assumptions can not
be made in human studies.
Therefore when conducting GWAS of a trait, if population structure is not controlled
for it will confound the results. Whereas other confounders can be controlled for
through inclusion in the GWAS model as covariates, population structure is complex
to disentangle. Several methods are used to regulate this confounder, including con-
ducting GWAS on distinct well-mixed populations (see section 3.5.1), where it can be
assumed that individuals share common ancestry and environment, or linear mixed
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models can be used that account for this complex confounder.
Even with these precautions, it remains important to test that this population bias
has been removed. Commonly, a quantile-quantile (qq)-plot is generated that plots the
negative log of ranked p-values from the GWAS against the expected distribution. Tra-
ditionally, qq-plots are deemed ”healthy” if the GWAS p-values largely correlate with
the expected values, aside from a small proportion that have a higher than average neg-
ative log p-value. These present as an upward tick in the latter quartile of the data.
However, this analysis is not calibrated to study complex polygenic traits at increasingly
large-scales, for example using the UK Biobank. Here inflation in the observed negat-
ive log p-values may be caused by increased numbers of SNPs with low frequency in
the population (Minor Allele Frequency (MAF)), as well as confounding population
structure. Given this, it is necessary to be able to distinguish the underlying cause.
Linkage Disequilibrium Score (LDSC) regression aims to partition the traditional
measure of inflation due to population stratification, genomic control [Devlin & Roeder,
1999]. The termLinkage disequilibrium (LD)was first described in Lewontin&Kojima,
1960 and is defined as a nonrandom association of alleles at two or more loci [Slatkin,
2008]. LDSC regression partitions genomic control into two parts: that caused by poly-
genicity and that caused by residual confounding population structure [Bulik-Sullivan
& al., 2015]. To complete this, it utilises the concept of shared LD within population
factions. Statistics commonly reported from LDSC regression include the LDSC inter-
cept, which subtracted from 1 represents the confounding bias scaled to the cohort size.
This means an intercept close to 1 is representative of limited residual population struc-
ture. Additionally the ratio is also reported, which represents the proportion of inflation
caused by factors other than polygeneicity.
2.8. Mendelian Randomisation
Observational studies are used in many fields, from econometrics to epidemiology, to
try and discover relationships between different variables. In order to identify such rela-
tionships, many variables are measured. However, inference of a relationship between
variables is not simple. As well as knowing if a relationship exists, we want to know
why it is so: correlation does not imply causation. Variables exist in complex and in-
terconnected systems. Because of this complexity, variables can be confounded by one
another. The confounding measures are not always easily identifiable, and even when
identifiable, not always measurable. Therefore techniques have been developed to try
and deal with this problem.
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Instrumental variable analysis has been developed to try and mediate the issue of con-
founders. This technique aims to identify a causal relationship between two variables,
known as the exposure variable and outcome variable. The exposure variable is that which
we predict will be the cause of an outcome. The outcome variable is the observed variable
we wish to explain.
In order to identify this causal relationship, instrumental variable analysis utilises an
external variable believed to be unconfounded. Here unconfounded refers to a variable
that is directly associatedwith the exposure variable, and singularly associatedwith the
outcome variable through the exposure variable. This external variable is known as the
instrumental variable.
This method has been applied in multiple fields including econometrics. An example
of this is the use of the Vietnamwar draft as an instrumental variable in analysing the ef-
fect of military service on lifetime earnings. In many circumstances, membership of the
military is voluntary and thus confounded bymany variables including geographic loc-
ation and socioeconomic status. However, the draft lottery acts a instrumental variable
as it randomised recruitment thus randomising these confounders [Angrist, 1990].
In the biomedical field, researchers often wish to identify causative relationships
between exposure and outcome variables that relate to disease. Evidence of causality
is necessary before pursuing further avenues of disease treatment or prevention. One
way to do this is to use randomised controlled trials in place of observational studies.
Here an exposure variable is randomly assigned to different cohorts, thus randomising
their environment and minimising the effect of confounders. In most clinical trails, a
drug and placebo is randomly assigned to trial participants. Thus, the confounders are
randomised with respect to the treatment.
However the use of randomised controlled trials is not always feasible or ethical, and
observational studies must be utilised instead. Mendelian Randomisation (MR) bor-
rows from instrumental variable analysis to look for evidence of a causal relationship
between an exposure variable and an outcome variable in epidemiological observational
studies. First proposed in 1986 [Katan, 1986; Gray & Wheatley, 1991], this method util-
ises instrumental variable analysis to look for the relationship between two variables,
often with one being disease. It utilises genotypes as the instrumental variables. It is
named for its grounding in the concept developed by Mendel that germline genetics do
not alter from conception and thus cannot be influenced during the disease process or
by other environmental factors.
MR can be analogised through clinical trials. Whereas in clinical trials, the expos-
ure variable is randomised between participants, MR uses genotypes as a proxy meas-
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ure for the exposure variable. Due to the random distribution of genotypes across the
population, groups with the same genotype should be randomised with respect to con-
founders. Therefore genetic instruments, genetic variants associated with the exposure
variable, can be used to test for a causal relationship. It should be noted that despite the
naming of the variables, MR is inherently non-directional, and a positive MR analysis
with specified exposure and outcome variables does not denote a directional effect. This
can be further tested for with the Steiger test [Hemani & al., 2017].
A classic example of the utility of MR is its use to verify the causative relationship
between low density lipoprotein cholesterol (LDL-C) and the risk of coronary heart dis-
ease. Evidence for a causative relationship between elevated LDL-C and increased risk
of coronary heart disease has been shown numerous times usingMR [Burgess &Harsh-
field, 2016]. The genetic effect of SNPs associated with levels of LDL-C correlate with
the genetic effect of the same SNPs on coronary heart disease. UsingMR bypassesmany
confounders of the variables including lifestyle. The use ofMR has been further applied
to help interrogate potential therapeutic targets of coronary heart disease through the
LDL-C pathway. Randomised controlled trials are expensive and timely and so using
MR to establish support for a relationship prior to testing it in a clinical trial is incredibly
useful.
In Ference & al., 2019, this technique was employed to look at the relationship
between a proposed therapeutic intervention and LDL-C levels. The therapeutic in-
tervention involved the inhibition using bempedoic acid of an enzyme within the cho-
lesterol biosynthesis pathway, ATP citrate lyase. Genetic variants that mimic the inhib-
ition of the enzyme were used as genetic instruments to find evidence supporting its
causal relationship with LDL-C levels. This was compared to the effect of 3-hydroxy-
3-methylglutaryl–coenzyme A reductase (HMGCR) inhibition using statins on LDL-C.
Statins are widely used to reduce the risk of coronary heart disease by lowering LDL-C
levels. Again genetic variants were identified that mimic the inhibition of HMGCR and
used as genetic instruments in MR. This study concluded that MR showed similar size
of effect of ATP citrate lyase inhibition and HMGCR inhibition on reduction of LDL-C
levels and subsequent coronary events. This affirms the enzyme’s potential as a thera-
peutic target and gives support to pursuit of bempedoic acid as a therapeutic agent. This




This thesis aims to explore the effects of genetics on the morphology of the human ret-
ina. The retina, as previously described, is an integral instrument in sight, and also a key
part of the central nervous system (CNS). In understandingmore about the genetics un-
derlying its structure, I aim to further our understanding of its function and, conversely,
dysfunction.
In chapter 3 I describe the data used for the analysis within this thesis. I detail both
the genotypic and phenotypic data, including OCT images, available within the UK
Biobank and the measures derived from these OCT images. I further outline the quality
control metrics applied to this data, and describe the resulting dataset. The quality
control methods described in this chapter are also presented in [Currant & al., 2020].
These methods were developed and implemented with input from Anthony Khawaja,
a clinical colleague. I am an author on an epidemiology paper with clinical colleagues
that further describes some of this data [Khawaja & al., 2020].
In chapter 4 I present the largest GWAS of inner retinal thickness to date. I explain the
choice of phenotype used to describe inner retinal morphology and the choice of model.
I then present the loci discovered to be significantly associated with inner retinal mor-
phology. I further perform Mendelian randomisation analysis to explore the causative
relationship between inner retinal disease and glaucoma. A manuscript detailing these
results is currently under review and available as a pre-print [Currant & al., 2020].
Chapter 5 presents the largest GWAS of outer retinal morphology to date and the dis-
covered genetic loci associated with the outer retinal layers. Here, I extend the analysis
from the clinically-used phenotype of mean retinal layer thickness across the macula,
to retinal thickness in the peripheral, intermediate and foveal fields of the macula. I
further analyse the causal relationship between outer retinal thickness and age-related
macular degeneration. I intend to compile the work in this chapter into another first
author paper with my clinical colleagues upon submission of this thesis.
Finally, in chapter 6 I expand the dimensionality of the phenotype used to describe
retinal morphology. I first explore morphological variation of the macula, and the ge-
netic variation underlying it, at a higher dimensionality using the novel visualisation
technique, maculagrams. I then capitalise on the rich pixel-wise data available in the
raw OCT images, developing image analysis techniques that are able to extract retinal
morphologymeasures at a finer grain. I then look at the effect of genetic variants on this
granular representation of retinal morphology. The image analysis techniques presen-
ted in this chapter were developed in collaboration with Tomas Fitzgerald, and the ana-
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The ever decreasing cost of genetic sequencing has allowed the use of genomics within
medical practice to increase across recent years. This growth, alongside increased di-
gitisation of health records, means the benefits of personalised medicine have already
shown to enhance clinical treatment with remaining unexplored potential [Abul-Husn
& Kenny, 2019; Vogenberg & al., 2010].
As this clinical usage grows, further research on common genetic variation in pop-
ulations and complex modelling of genetic variation underlying disease is required to
maximise applicability in a clinical setting. Furthermore, to ensure that newly available
clinical technologies are benefiting all facets of the population, research must be done
on a representative sample of the population.
In order to facilitate such research, several databases have been, or are being, de-
veloped that provide rich, large-scale genetic and phenotypic data on cross-sections of
the population (See section 2.7.4). These datasets can largely be divided into either
clinical cohorts, where participants are selected for disease, or population cohorts that
aim to be representative of the cross-section of the general population. The category of
population cohorts can be further split into birth cohorts and adult recruitment cohorts.
Birth cohorts recruit individuals from birth, thus removing some of the bias of self se-
lected inclusion, however there is a long time period between initiation of the study
and the time at which some of the data can be utilised. There may also be difficulty
in follow-up measures with participant drop-out and logistical challenges of remain-
ing in contact over long time periods. A number of birth cohorts, including the two
Lothian birth-cohort studies started in 1921 and 1936 respectively [Deary & al., 2011],
and the Avon Longitudinal Study of Parents and Children (ALSPAC) study created in
the 1990s [Boyd & al., 2013; Northstone & al., 2019], have been utilised in many bio-
medical research projects. On the other hand, adult recruitment population cohorts
have the advantage of a much shorter turn around time. However due to the nature of
self-selection for inclusion, bias is introduced into the population. Furthermore, a por-
tion of data collection is often retrospective, relying upon accuracy of self-reporting or
the completeness of records. Examples of this include the Danish effort to genotype and
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phenotype a large portion of their population [Thygesen & al., 2011] and the FinnGen
study (https://www.finngen.fi/en) that combines multiple Finnish biobanks. The birth
cohort and adult recruitment cohort approach can be considered complementary to one
another in many ways, with both providing huge utility in academic research. Another
approach is that seen in the INTERVAL study [Moore & al., 2014], in which a cohort
initially recruited for a randomised control trial, is utilised to study broader variation.
The INTERVAL study originally aimed to assess the safety of different blood donation
intervals. Since then, the cohort has been genotyped, and the dataset used to study
common variation affecting human blood cell traits [Astle & al., 2016]. Additionally
exome sequencing of the cohort has allowed for its use as a control dataset in studies of
the genetics of schizophrenia [Singh & al., 2016]. The expanded use of the INTERVAL
dataset following collection of genetic data, exemplifies an efficient method to collect a
population cohort.
The UK Biobank is an adult recruitment population cohort of unprecedented size.
Initiated in 2006, it provides coupled phenotypic and genotypic data for a large-scale
cohort that enables novel research into human variation and clinical traits [UK Biobank,
2007]. Its design goal was to study late onset disease by collecting longitudinal data
on a middle-late aged population. The enormous size of the UK Biobank provides huge
statistical powerwhen performing analysis of the epidemiological and genetic data, and
the richness of the phenotypic data opens up new avenues of research and allows for
complex modelling.
In this chapter, I will give an overview of the UK Biobank, the cohort it comprises,
and the different data types that are available within it. I will give a more detailed
description of the data used within my analysis and how said data was generated. I will
then describe the sources of variation in this data and which quality control methods
are applied to create a dataset that is used throughout this thesis.
3.1. The UK Biobank
The UK Biobank is a database of genotypic and phenotypic information for ∼500,000
individuals from across the United Kingdom (UK). Participants were between 40 and
69 years of age at enrolment and were recruited via the National Health Service (NHS)
registry. The database contains genetic, biological, medical, demographic and lifestyle
data for each of the individuals, as well as imaging data for a subset of the cohort. Data
were collected at one of 20 assessment centres across the UK, with some participants
making repeat visits. The participants within the UK Biobank were not selected on the
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basis of having disease [UK Biobank, 2007].
3.1.1. Baseline Data
Upon their first visit to the assessment centre, participants had a number of baseline
measurements taken. This included anthropometric measures, for example height,
weight and hip and waist measurements. Other indicators of general health and bio-
logy were taken, such as bio-impedance measurement and hand-grip strength. A heel
bone ultrasound was performed to record density, spirometry was conducted to meas-
ure lung capacity and blood pressure was measured. All participants also completed
a questionnaire and several cognitive function tests. Finally several biological samples,
including blood and urine, were taken [UK Biobank, 2007].
3.1.2. Lifestyle Data
All UKBiobank participantswere required to complete an extensive questionnaire. This
included information on exercise, alcohol consumption, smoking and diet. Additionally
the database contains information on socio-economic status including income, educa-
tion, vocation and identity. Participants were given the option to skip questions that
they did not wish to answer.
3.1.3. Medical Data
In addition to providing self-reported medical history within the questionnaire, parti-
cipants within the UK Biobank consented to the linkage of their medical records with
the database. This enables access to the cancer and death registries, as well as medic-
ation history and disease diagnoses using the International Classification of Diseases
(ICD)10 codes. There are future plans to link more extensive medical records with the
database including primary care records.
3.1.4. Caveats
Due to the method of recruitment, it must be acknowledged that there is bias within the
cohort. Several studies have shown that participants in the UK Biobank are on average
of better overall baseline health than those who have not participated [Fry & al., 2017;
Batty & al., 2020]. As with any study performed on the UK Biobank cohort, this must
be considered when trying to generalise to a general population.
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3.1.5. Ocular Examination
As part of the final round of UK Biobank participant recruitment, a subset of 132,041
participants also underwent a number of ocular examinations at one of six study centres
around the UK (Sheffield, Liverpool, Birmingham, Croydon, Hounslow and Swansea).
Three differentmeasureswere taken: best corrected visual acuity, using logarithm of the
minimum angle of resolution (logMAR); refractive error, using a Tomey RC-5000 auto
refkeratometer [Cumberland&Rahi, 2016]; and IOP using an Reichert Ocular Response
Analyzer [Keane & al., 2016], fromwhich corneal compensated IOPwas calculated that
accounts for rigidity of the cornea [Khawaja & al., 2018]. The three measurements, as
well as OCT and retinal fundus photography, were completed within an ∼11 minute
time span [Keane & al., 2016] so were performed on undilated eyes as not all tests are
compatible with dilation [Khawaja & al., 2018].
3.2. Optical CoherenceTomography
A further subset of the UK Biobank cohort, consisting of 67,321 individuals, underwent
Spectral Domain Optical Coherence Tomography (SDOCT) imaging. The imaging was
conducted using the Topcon 3DOCT1000Mark IImachine using the 3-dimensional 6x6-
mm2 macular volume scan mode (512 A scans per B scan; 128 horizontal B scans). The
imaging was conducted in a dark room, following other optical measurements, on un-
dilated eyes. The right eyewas consistently imaged first, and themajority of individuals
had imaging repeated in their left eye. The images are stored in the common medical
image format, dicom as well as .fda and .png files [Patel & al., 2016].
3.2.1. Topcon Image Processing
Themanufacturers of the OCT device, Topcon, provide an industry standard segmenta-
tion software, Topcon Advanced Boundary Segmentation (TABS). TABS automatically
segments either five or eight retinal layers, dependent on confidence requirements. It
can segment RNFL, Ganglion Cell Inner Plexiform Layer (GCIPL) (GCL and IPL in
combination), ONL, OS and RPE at a high confidence (figure 3.1A), and RNFL, GCL,
IPL, INL, ONL, IS, OS and RPE with a less high confidence level. From this segment-
ation, the thickness of the different retinal layers is calculated, either as a mean taken
across the entire macular field, or per segment of one of two segmentation grids. The
two grids are known as the Early Treatment Diabetic Retinopathy Study (ETDRS) grid
and theMacula 6 grid. The ETDRS grid is widely used when analysing the outer retina,
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and consists of a bullseye shaped grid with 9 sub-segments (figure 3.1B) [Ooto & al.,
2015]. The Macula 6 grid is conversely used to analyse the inner retina. It is made up
of six equally sized segments arranged radially around the fovea, with the centre of the
grid excluded (figure 3.1C) [Chaglasian & al., 2018]. Glaucoma is the main disease that
affects the inner retina, and for this, the line segregating the superior (upper) segment
from the inferior (lower) segment of the retina is important. This is because visual de-
fects symptomatic of glaucoma usually affect the superior and inferior field of the retina
differentially [Gupta & Asrani, 2016].
A
CB
Figure 3.1: Optical coherence tomography images and Topcon advanced boundary segmenta-
tion processing. Topcon’s propriety software, TABS, segments the different retinal layers. These
segmentations are used to calculate the thickness of each layer as a mean across the whole mac-
ular field, or as means of sub-fields defined by one of two segmentation grids. A) An example
of an OCT cross-section with segmented boundaries (higher confidence level) shown in blue.
B and C show a fundus image, with the Early Treatment Diabetic Retinopathy Study (B) and
Macula 6 (C) grids superimposed, showing the boundaries of each segmentation scheme.
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3.3. Image Quality Control
There are several sources of potential variation and error in segmented thickness val-
ues derived from the OCT images. Some of these sources of error can be attributed to
technical and operator-related error occurring during image acquisition or processing.
Other artefacts can be attributed to biological factors such as disease.
Examples of potential sources of technical artefacts include poor centration of the eye
within the segmentation grid, especially important when looking at the separate seg-
ments of the ETDRS orMacula 6 grids. Movement of the eye or blinking may also intro-
duce artefact into the image leading to blurred images or missing portions of the scan.
Occasionally, the image is clipped at the edge, or shadows may be present in the im-
age causing low signal. All of these technical issues may interfere with the automated
segmentation of the image, leading to incorrect thickness values [Liu & al., 2015].
Equally, there are a number of biological factors that may affect the quality of the
scan. Presence of fluid, drusen (associated with AMD, see section 1.6.2), or significant
disruption to the retinal morphology may cause disruption to the scan or issues with
automated segmentation again causing inaccurate retinal thickness values. Dry or catar-
act eyes may cause low signal due to disruption of the OCT beam reaching the nerve
tissue. Equally, blood vessels can sometimes present as artefacts as they traverse the
choroid.
For these reasons, a quality control scheme is applied to the image data. The quality
control method is adapted from the methods used in [Patel & al., 2016]. The quality
control protocol is based on a number of parameters outputted from the OCT device
during the scan, as well as the segmented layer thickness’s themselves. Initially, all im-
ages which received an overall image quality score lower than 45 were removed. Fol-
lowing that the poorest 20% of images in several image segmentation indicators were
removed from the dataset. Those image segmentation indicators were: valid count, in-
ner limiting membrane (ILM) indicator, minimum motion correlation, maximum mo-
tion delta and maximum motion factor. Valid count identifies scans with a substantial
degree of clipping in the OCT scan’s z-axis. ILM indicator is a measure of the minimum
localised edge strength around the ILM boundary across all B scans. Minimum motion
correlation, maximum motion delta and maximum motion factor are a group of motion
indicators. Minimummotion correlation is the minimum value of Pearson’s r when cor-
relation is performed between the RNFL thickness and the the full retinal thickness of
consecutive B-scans. Max motion delta is the maximum absolute difference in RNFL
thickness and overall retinal thickness between consecutive B-scans. Both the ILM in-
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dicator and the motion indicators are indicative of blinks, motion in the scan, severe
signal fading and segmentation errors. Participants with outlier values of refractive er-
ror, defined as outside ±1.5 ×the Interquartile Range (IQR) from themedian of the data,
were removed from the dataset. The demographics of those that pass and fail the image
quality control are comparable and are detailed in table 3.1. To assess the image quality
control methods, I examined the principal component (PC)s of the component ETDRS
retinal thickness measurements for the cohort before and after quality control was ap-
plied (figure 3.2). As can be seen in figure 3.2A, prior to quality control filtering there
is some structure to the data, with a distinct group seen on the right-hand side of the
plot that is removed by the quality control process. These participants could be repres-
entative of a group with image artefacts, a group in which the image segmentation had
error, or a group with a certain pathology causing extreme values. It was decided that
for the analysis presented in this thesis in which I wanted to explore general biology
and variation in a healthy population, that this group should be removed via the image
quality control. Following image quality control, the data largely groups into a single
blob as seen in figure 3.2B, however a few outliers remain, with several in the upper
right section showing subtle signs of structure. It was decided that for now, the removal
of structure by the image quality metrics described was sufficient, and that any outliers
identified in the PC analysis could warrant further exploration in the future.
Table 3.1: Demographics of quality control subsets Comparison of biological, particularly op-
tical, characteristics between all UK Biobank participants with optical coherence tomography
data, the group that passes quality control and the group that fails. Results are presented as
mean ±standard deviation.
Total Topcon Population Pass Filter Fail Filter
N 67,310 31,434 35,876
Height (m) 168.68 ±9.25 169.43 ±9.15 168.03 ±9.29
Age (years) 57 ±8 57 ±8 57 ±8
Weight 78.12 ±16.02 78.48 ±15.83 77.81 ±16.18
Sex (m/f) 29,713/34,929 14,837/16,597 14,876/18,332
Refractive error left -0.32 ±2.73 0.23 ±1.49 -0.81 ±3.42
Refractive error right -0.38 ±2.73 0.19 ±1.48 -0.88 ±3.41
logMAR left 0.02 ±0.21 -0.00 ±0.18 0.05 ±0.23
logMAR right 0.03 ±0.21 0.00 ±0.18 0.05 ±0.22
IOP left 15.87 ±4.30 15.84 ±4.14 15.90 ±4.44








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.2: Principal component analysis of retinal thickness in filtered and unfiltered pop-
ulations. The first two principal components from a principal component analysis (PCA) of
the ETDRS grid, high confidence segmentation layer thickness performed on A) The full cohort
with optical coherence tomography segmentation data, coloured bywhether an individuals scan
passes or fail our quality control. B) Only individuals that pass our quality control.
3.4. Genetic Data
There are three types of genetic data currently available, or soon to be available, within
the UK Biobank: genome-wide genotyping data, the first genetic data type to be re-
leased; whole exome sequencing (WES), the second release; andwhole genome sequen-
cing (WGS), the final phase of genetic sequencing. Here I will describe the genotype
data which is used within the analysis presented in this thesis.
3.4.1. Genotyping Data
Genotyping of the UK Biobank was conducted over a period of 18 months using genetic
material extracted from blood samples provided at the initial assessment centre visit.
The genotype data within the UK Biobank were generated using two closely-related
custom arrays. The first array, the Applied BiosystemsTM UK BiLEVE AxiomTM Array
byAffymetrix, included 807,411markers andwas used to genotype a subset of 49,950 in-
dividuals who were part of the UK Biobank Lung Exome Variant Evaluation (BiLEVE).
The remaining 438,427 participants were genotyped for 825,927 markers using the Ap-
plied BiosystemsTM UK Biobank AxiomTM Array. In total, 95% of markers were shared
across the two subset arrays and included both SNPs and indels, some of which had
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been selected for their known associations with particular diseases or phenotypes. Af-
fymetrix performed various quality control methods resulting in the return of geno-
typing data for 489,212 samples across 812,428 markers. Further quality control and
imputation were performed as described in detail in Bycroft & al., 2018, and resulting in
genotype information for ∼ 96 million genetic variants which were returned to the UK
Biobank.
3.5. Preparing Genotype Data
3.5.1. Identifying aWell-Mixed Population
Population structure based on mixing of population groups, which often falls along
similar boundaries to ethnic background, can confound genetic analyses. One method
to control for this is to perform the genetic analysis on a single, well-mixed population.
Within the UK Biobank, due to the fact that 94% of the cohort self-reports a white ethnic
background [Bycroft & al., 2018], this dense well-mixed sub-population is largely rep-
resentative of those that self report as white. We select for said well-mixed population
based on PCs of the genotype data, comparing them to the PCs of the HapMap dataset
whose participants have known ethnic backgrounds.
Methods
The original genotype files, provided in the bgen format by UK Biobank, were conver-
ted to PLINK format (bim, bed and fam files) using PLINK [Chang & al., 2015], and
the subset (n=48,711) which have quality controlled processed OCT data available se-
lected. The genotypes for this subset were then filtered to select for markers with a
MAF > 0.001. The genotypes are further pruned based on LD (window size = 50kb,
step size = 1 variant count, r2 threshold = 0.8). Duplicate SNPs based on either rsid
or position were removed and the resulting pruned chromosome files merged into a
single genome-wide genotype file. This genotype file was further pruned to MAF > 0.1.
The cross-section of SNPs available in our pruned UK Biobank genotype dataset, and
the HapMap dataset was identified and selected for in each dataset. Duplicate markers
were removed, and the two datasetsmerged. A PCAwas performed on themerged gen-
otype dataset. The HapMap data contains individual level data of ethnic background,
dividing the cohort into sub populations representing: African ancestry from the South
West United States of America (USA) (ASW); Luhya in Webuye, Kenya(LWK); Yoruba
in Ibadan, Nigeria (YRI); Maasai in Kinyawa, Kenya (MKK); Caucasians from North
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and western Europe (CEU); Toscani in Italy (TSI); Gujarati Indians in Houston, USA
(GIH); Mexican ancestry in Los Angeles, USA (MXL); Han Chinese in Beijing, China
(CHB); Chinese in metropolitan Denver, USA (CHD); and Japanese in Tokyo, Japan
(JPT). These populations are further grouped to represent four broader groups of eth-
nic background. The four groups are: ASW, LWK, YRI and MKK (African ancestry);
GIH andMXL (Mexican/Native American ancestry); CHB, CHD and JPT (Asian ances-
try); and CEU and TSI (European ancestry). CEU and TSI jointly are representative of a
European ancestry. Themean value of PC1 and PC2 for the combined TSI andCEUpop-
ulations within the Hapmap data were calculated. The Euclidean distance of each TSI
or CEU individual within the Hapmap data to the mean in PC space was calculated and
the maximum value identified. The Euclidean distance of each of the UK Biobank parti-
cipants in PC space to the mean of the HapMap European population is calculated. UK
Biobank participants are selected for inclusion if their Euclidean distance to the mean
PC1/PC2 point is < 1.5 ×themaximumEuclidean distance of HapMap Europeans to the
mean (figure 3.3).
3.5.2. Identifying an Unrelated Population
Another source of confounding within the genetic data is family structure. As both
genetic variation and environmental variation are often inherited within families, it is
important that only single members from genetically related family units are included
in the study. Within the UK Biobank there are several family structures present that it
is necessary to remove.
Methods
Pairwise relatedness estimates for all individuals within the UK Biobank are available
for download from the UK Biobank database, generated by Bycroft & al., 2018. The res-
ulting table contains: an IBS0 score, for paired genotypes the proportion of SNPs where
one sample is homozygous for the reference allele, and the other sample is homozygous
for the alternative allele; the kinship coefficient for each pair of samples; and the HetHet
value, the proportion of markers which are heterozygous in both samples of the pair. A
filter adapted from Meyer, 2020 was used to remove individuals related to third-degree











Population UK Biobank CHB, CHD & JPT ASW, LWK, YRI & MKK GIH & MXL CEU & TSI
Figure 3.3: Population selection using principal component analysis. PC1 and PC2 of a PCA
performed on the UK Biobank and HapMap genotype data. HapMap participants are coloured
by the population to which they belong. An ellipse encloses the well-mixed population selected
for inclusion in my study. This ellipse has a radius of 1.5 ×the maximum Euclidean distance of
HapMap Europeans to the mean of the European population in PC space (shown in yellow).
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3.5.3. Final Dataset
Following both phenotypic and genotypic quality control, we are left with an unrelated,
genetically well-mixed population, with which I feel confident in proceeding to further
analyses. There may still be some regional population structure, which I aim to address
using covariates within the model.
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4. Genome-wide Association Study of Inner
Retinal Morphology
The inner retina is made up of ganglion cells and is responsible for the final stages of
transmission before the neuronal signal exits the eye towards the brain via the optic
nerve [Purves & al., 2001]. As previously mentioned, the distinction of the inner retina
from the outer retina is common in the clinic. Each of the layers is affected by different
diseases, as well as being differentially affected by a set of common diseases, with some
pathologies affecting the two retinal areas similarly [Müller & al., 2019]. Here I analyse
the genetic variation underlying inner retina morphology.
The inner retina is located closest to the front of the eye (figure 4.1A). It is comprised
of the RNFL and the GCIPL. In combination these layers are known as the Ganglion
Cell Complex (GCC). One well-characterised aspect of inner retinal morphology is that
both inner retinal layers taper to non-existence at the fovea, the centre of the macula
(figure 4.1B) [Khurana, 2007]. This tapered structure reduces interference of these lay-
ers, leading to reduced light scattering. This morphological characteristic, alongside the
increased density of cone cells, leads to the fovea being the area of highest visual acuity
[James & al., 2003].
It is well established that glaucoma causes damage to the inner retina. This is
commonly seen as thinning of the inner retinal layers in clinical settings [Tatham &
Medeiros, 2017; Bhagat & al., 2014]. Monitoring changes in the thickness of the inner
retina is a key part of glaucoma diagnosis andmanagement. More recently, inner retinal
thickness has been recognised as a biomarker for glaucoma, particularly POAG [Hood,
2017; Shin & al., 2017]. The genetic variation underlying inner retinal morphology has
not been studied at large-scale previously, owing to a lack of data availability, especially
in non-disease based cohorts.
In this chapter, utilising measures derived from the OCT images now available in the
UK Biobank, I present the first large-scale GWAS of quantitative inner retinal thickness.
Before this, I will present an outline of the analysis performed to choose both the model





Figure 4.1: Inner retinal morphology and extracted measures. A) A diagram of the retinal lay-
ers. The inner retina is comprised of the retinal nerve fibre layer (RNFL) and ganglion cell inner
plexiform layer (GCIPL).This is the first layer that light passes through before being absorbed by
the outer retina, but is the final layer of cells involved in neural signal transmission before signal
exits towards the brain via the optic nerve. B) An optical coherence tomography (OCT) image
that has been segmented by the Topcon Advanced Boundary Segmentation (TABS). On the left
half of the image the RNFL is shaded pink, and the GCIPL is shaded yellow. Taken together
these retinal layers are known as the ganglion cell complex (GCC).
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4.1. Inner Retina Data
The UK Biobank contains OCT images fromwhichmeasures of RNFL and GCIPL thick-
ness have been extracted using the industry standard software TABS.Measurements are
provided for right and left eyes separately. As well as the mean thickness of the inner
retinal layers across the macular field, thickness of subfields, as defined by the ETDRS
[Ooto & al., 2015] and Macula 6 grids [Chaglasian & al., 2018], are available. Of the
two, the Macula 6 grid is the one more commonly used to study the inner retina (fig-
ure 4.2A). It is particularly used when studying glaucoma. It differs from the ETDRS
grid in that it excludes the central area over the fovea, as the inner retina does not extend
into this area, and also divides the macular field across the horizontal midline. This is
important as it is well established that glaucoma affects the superior and inferior seg-
ments of the retina differentially, and this feature is used in diagnosis [Gupta & Asrani,
2016]. Due to its clinical utility when studying the inner retina, measures derived from
theMacula 6 grid are used throughout this chapter. Using the Macula 6 grid there are a
total of 28 available measures to describe inner retinal morphology (figure 4.2B). These
are the thicknesses of the RNFL and GCIPL at each of the six Macula 6 grid segments
for both eyes, alongside the mean thickness of each layer for each eye.
4.1.1. Quality Control
To select the cohort of individuals for use in the inner retinal analysis, the quality con-
trol methods, both genetic and phenotypic, described in chapter 3 are applied. When
applied specifically to the inner retinal data, this produces a final cohort of 31,434 parti-
cipants that are used in the inner retinal GWAS (figure 4.2C). As previously mentioned
in section 3.3, the quality control methodology removes structured groups as identified
using PCA of the retinal thickness measures. To reassure ourselves that a group of par-
ticipants had not been removed in the quality control process that were representative
of notable biological variation, I performed a GWAS on the status of whether a parti-
cipant passed or failed the quality control criteria. The GWAS was implemented using
SNPTEST [Marchini & Howie, 2010] and used both biological and technical covariates
as described below (section 4.2). This GWAS yielded no significantly associated loci (P
<5 ×10-8, figure 4.3). This reassured us that variation seen in future GWAS were not an
artefact of the quality control process. A structured group with shared common vari-
ation and biological importance had not been removed. Therefore, the genomic studies








Figure 4.2: Inner retinal data dimensions and quality control. A)An example fundus image of
a retina, with the Macula 6 grid, a commonly used partition matrix, superimposed atop in pink.
The matrix is comprised of six sections, with the central field being excluded from analysis.
B) A schematic of the 28 available measures that describe the inner retinal morphology. This
includes the thickness of the RNFL and GCIPL at each of the six segments of the Macula 6 grid,
as well as the thickness averaged across the Macula 6 grid, for left and right eyes separately.
C) A schematic of quality control stages in selecting a cohort of individuals to include in inner
retinal analysis based on criteria detailed in chapter 3.
4.2. Covariates
Before performing any GWAS, it was important to thoroughly consider necessary cov-
ariates to include in the models of genetic variation. These were likely a combination of
both biological and technical variables. A number of technical variables are outputted
from the OCT machine, described in detail in chapter 3. The OCT machine ID was also
considered as this would account for any batch-like effect caused by different machines,
examination set-ups and regional differences.
In terms of biological covariates, there are several phenotypeswith known association
to inner retinal thickness. Both sex and age [Song & al., 2010; Demirkaya & al., 2013;
Nieves-Moreno & al., 2018] have been previously linked to inner retinal thickness, with
increased age being amajor risk factor for thinning of the inner retina, and development
of POAG [Leske & al., 2003; Choquet & al., 2018]. The size of the eye was not directly
measured as part of UK Biobank phenotype acquisition, so height was considered as
a proxy measure. Weight was also considered given its correlation with health and
lifestyle variables. Finally, differences in refractive error may alter the magnification of
the OCT images, and somay affect the thickness measures of the inner retina [Hirasawa
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Figure 4.3: Quality control pass-fail status genome-wide association study. Manhattan plot
for a genome-wide association study on the status of whether an individual passes or fails our
quality control metrics. Variants were considered significant if they reached genome-wide sig-
nificance (P <5 ×10-8).
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&al., 2014]. Refractive error comprises several conditions, themost common ofwhich is
myopia (near-sightedness) [Hysi & al., 2020]. Although not directly measured within
the UK Biobank, it can be calculated from spherical and cylindrical power which were
recorded [Taylor & al., 2011].
𝑟𝑒𝑓𝑟𝑎𝑐𝑡𝑖𝑣𝑒 𝑒𝑟𝑟𝑜𝑟 = 𝑠𝑝ℎ𝑒𝑟𝑖𝑐𝑎𝑙 𝑒𝑟𝑟𝑜𝑟 + (0.5 × 𝑐𝑦𝑙𝑖𝑛𝑑𝑒𝑟𝑖𝑐𝑎𝑙 𝑒𝑟𝑟𝑜𝑟)
The inner retinal phenotypes, and their derivative PCs, were used in correlations
with the technical and biological factors mentioned (figure 4.4). Correlation was seen
between both the raw and dimensionality transformed phenotypes and many of the co-
variates. In particular, several PCs appear to be correlated with some of the covariates
(figure 4.4B). This suggests these covariates are considerably affecting variation in the
inner retinal thickness measurements. Notably, PC4 has a strong correlation with mac-
ula center frame, the measure of how central the macula is within the image frame. PC2
is also associated to a milder extent with macula center frame, whilst PC3 has some
correlation with mean refractive error and PC4 is additionally correlated with macula
center aline. This is in-keeping with the expected effect of these cofactors, and as such,
all of the described variables are used as covariates in future models of genetic variation
on inner retinal morphology.
4.3. Eye-Specific Analysis
As previously stated, there are a number of different variables available to describe the
morphology of the inner retina (figure 4.2B). Therefore we initially explored some of
these phenotypes, aiming for a final phenotype that balanced genetic power and in-
terpretability. A complexity of studying eye biology is that humans possess two eyes
which, although often sharing in considerable biological symmetry, should not be as-
sumed to be identical. This can be evidenced by the two eyes often having different
visual acuity, and the occurrence of ocular dominance, the preference of visual input
from one eye over the other [Carey & Hutchinson, 2013]. Equally, while glaucoma gen-
erally affects both eyes, it often presents asymmetrically [Gupta &Asrani, 2016]. There-
fore, I have initially explored the left and right eyes separately.
4.3.1. Methods
GWAS were performed for the mean thickness across the Macula 6 grid of the RNFL














































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.4: Correlation plots of inner retinal phenotypes with covariates. Correlation plots
of inner retinal phenotypes with a number of technical and biological factors. A) Correlation
between the thickness of both inner retinal layers at the Macula 6 subfields in the left and right
eye, and covariates. B) Correlation between PCs derived from the phenotypes in A and covari-
ates. The strength of correlation is represented by saturation of colour.
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BGENIE [Bycroft & al., 2018] using an additive linear model. The covariates described
above were included in the model. Loci were considered significantly associated if they
reached genome-wide significance (P <5 ×10-8).
4.3.2. Results
The fourGWAS, one for the thickness of each of the two retinal layers in each eye, yielded
a number of significantly associated genetic variants (figure 4.5). GWAS of the RNFL
thickness in the left and right eyes discovered 1,927 and 1,715 significantly associated
genetic variants respectively. GWAS of the GCIPL thickness in the left and right eyes
discovered 1,024 and 1,090 significantly associated genetic variants respectively. In both
cases, filtering of SNPs based on LD to identify lead variants in loci was not performed
because at this stage the goal is still phenotype exploration. In both layers, many of the
significant loci were shared across left and right eyes.
Upon observation that many of the significantly associated loci were common to both
eyes, I examined the correlation of their effect sizes between the left and right eye (fig-
ure 4.6). The effect size of SNPs significantly associated with the mean thickness of
the GCIPL across the Macula 6 grid was highly correlated between left and right eyes
(Pearson’s r = 0.956, P <2.2 ×10-16). The effect size of SNPs significantly associated with
RNFL thickness is correlated between left and right eyes, but to a milder extent (Pear-
son’s r = 0.743, P <2.2 ×10-16). It is apparent in the RNFL (figure 4.6A) that there is
a group of SNPs that are less correlated between left and right eyes. As mentioned in
section 3.2, the scan order of left and right eyes was not randomised, with the right eye
consistently imaged first. It is therefore difficult to decipher if the discrepancy in genetic
effect between the two eyes is representative of underlying biology specific to the RNFL,
or if it can be accounted for by the lack of randomisation in the data acquisition protocol.
This discrepancy warrants further investigation, and can hopefully inform future pro-
tocol design. However, for the purposes of the analysis within this thesis, a mean across
the two eyes was taken to generate the final selected phenotype.
4.4. Dimensionality Reduction Analysis
The data available that describes inner retinal morphology using the clinical segmenta-
tion grids is relatively high dimensional. In total 28 measurements are available to de-
scribe the morphology of the inner retinal layers (figure 4.2B). Analysing the genetics
underlying retinal morphology using the variation in each of these individual measure-




Figure 4.5: Genome-wide association study of inner retinal thickness phenotypes in left and
right eyes. Manhattan plots of the GWAS results of mean macular inner retinal thickness phen-
otypes: A) retinal nerve fibre layer (RNFL) thickness in the right eye. B) RNFL thickness in the
left eye. C) ganglion cell inner plexiform layer (GCIPL) thickness in the right eye. D) GCIPL
thickness in the left eye. Variants were considered significant if they reached genome-wide sig-


































































































































































































































































































































































































































































































































































































































































































































































Figure 4.6: Comparison of effect size from GWAS of inner retinal thickness in left and right
eyes separately A correlation plot of effect size of SNPs found significantly associated with
the inner retinal thickness in either the left or right eye for either: A) Retinal nerve fibre layer
(RNFL), Pearson’s r = 0.743, P <2.2 ×10-16. B) Ganglion cell complex (GCIPL), Pearson’s r =
0.956, P <2.2 ×10-16.
the continuousmorphological variation occurring within the retina. However, I wanted
to explore the high dimensional data in order to take advantage of all data available. To
do this I performed PCA on the high dimensional data available within the clinical seg-
mentation grids. These data comprises of the thickness of the RNFL and GCIPL at each
of the segments of the Macula 6 grid, considering the left and right eye separately (fig-
ure 4.2B). This resulted in 24 PCs, as the mean values across the Macula 6 grid were
excluded, with the first 10 PCs explaining 90% of variation (figure 4.7).
4.4.1. Principal Component GWAS
Observing the variance explained by the PCs, a GWAS was performed for each of the
first 10 PCs. An additive linearmodel was used, implemented in BGENIE [Bycroft & al.,
2018]. The same biological and technical covariates as detailed above (section 4.2) were
used in the model. The resulting summary statistics were meta-analysed using Multi-
Trait Analysis of GWAS (MTAG) [Turley & al., 2018] to create a single discovery list.
Variants were considered significant if they reached genome-wide significance (P <5
×10-8).
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Figure 4.7: Scree plot from principal component analysis of inner retinal thickness meas-
ures. A scree plot showing the variance explained by each of the PCs resulting from PCA of the
24 thickness phenotypes describing the inner retinal morphology. These phenotypes describe
the thickness of the two inner retinal layers, in left and right eyes separately, at each of the six
segments of the Macula 6 grid.
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4.4.2. Results
In total, 3,533 variants were found to be significantly associated with one of the first
ten PCs (figure 4.8). In comparison, the GWAS of the final selected simple phenotype,
as described below (section 4.5), discovered 3,434 significantly associated genetic vari-
ants. Filtering of SNPs based on LD to identify lead variants in loci was not performed
here because the aim is still phenotype exploration. Many of the genetic variants found
in the PC GWAS and final GWAS overlapped. Correlation of the effect size of SNPs
discovered in the GWAS of the PCs, and the effect size of the same SNPs in the final
GWAS, results in Pearson’s r=-0.528, P <2.2 ×10-16, figure 4.9. The correlation pattern
of the effect size on each phenotype is not linear. Whilst a subset of the SNPs appears to
be positively correlated with one another, another subset appears to be negatively cor-
related. This suggests that some of the SNPs have opposite effects on the simple inner
retinal thickness and the inner thickness derived PCs.
Considering the results of this analysis and the broader characteristics of the two
phenotypes, there are advantages and disadvantages to using both the traditional clin-
ical measures and the dimensionality transformed measures. The two phenotypes ap-
pear to identify a group of jointly associated genetic variants in addition to each identi-
fying a unique set of significantly associated SNPs. The use of the higher dimensional
phenotypes does not appear to yield more statistical power, and subsequent increased
number of overall discovered loci, than when using the simple phenotype. Following
discussion with clinical colleagues, considering that minimal statistical power is lost, it
was decided to use the simple measure of retinal layer thickness going forward. One of
the main advantages of using this phenotype is the easier interpretation of the results
and subsequent translation into the clinical space.
4.5. Final GWAS
Having pursued the use of other possible phenotypes to represent inner retinal mor-
phology from the available data within the Macula 6 grid, I decided to use a simple
representation: the mean thickness across the Macula 6 grid of the two inner retinal
layers, the RNFL and GCIPL, averaged across left and right eyes. This value is clinically
valuable, easily interpretable and as shown below provides rich results likely informed
by the size of the dataset providing large power to the statistical analysis.
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Figure 4.8: Genome-wide association study of first ten principal components of inner retinal
phenotypes. Manhattan plot of meta-analysed results of genome-wide association studies of
first ten principal components (PCs) of inner retinal phenotypes. The PCs are derived from
the thicknesses of the retinal nerve fibre layer (RNFL) and ganglion cell inner plexiform layer
(GCIPL) at the six segments of the Macula 6 grid in the left and right eyes. Variants are con-
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Figure 4.9: Comparison of effect size and direction of SNPs on simple inner retinal pheno-
types, and inner retinal principal components. A correlation plot of the effect sizes of the cross
section of SNPs significantly associatedwith the first 10 PCs of the inner retinal phenotypes, and
the final simple inner retinal phenotypes representing meta analysed mean retinal nerve fibre




Two GWAS were performed of the mean thickness across the Macula 6 grid of each of
the inner retinal layers, the RNFL and GCIPL, averaged across left and right eyes. The
GWASwere conducted using a linear additive model implemented in BGENIE [Bycroft
& al., 2018]. Eye specific covariates including technical covariates associated with scan
acquisition and refractive error were regressed out of the individual eye measurements
before a mean was taken of the thickness across the left and right eyes. The remaining
covariates were included in the model, as detailed in section 4.2. Variants were con-
sidered significantly associated if they met the genome-wide significance level (P <5
×10-8). LDSC regression was implemented using LDSCore v1.0.1 [Bulik-Sullivan & al.,
2015]. As there was a crossover of loci significantly associated with the two inner retinal
layers, meta-analysis implemented in MTAG [Turley & al., 2018] was applied, and the
associated variants are considered as a combined discovery set. Following application
of MTAG, Conditional Joint Analysis (COJO) [Yang & al., 2012] was applied to perform
conditional analysis and stepwisemodel selection to filter for independent loci. The res-
ulting 46 loci were further filtered and loci within 1.5Mb of one another were labelled as
being in the same locus, as indicated in table 4.1. These 46 variants were also manually
annotated with nearest gene, and any prior association with other phenotypes using
ENSEMBL [Cunningham & al., 2019] and the Open Targets Genetics [Carvalho-Silva
& al., 2019].
4.5.2. Results
In total, 46 loci were identified as significantly associated with one or both of the inner
retinal layers following meta-analysis of the two layers and conditional joint analysis
to filter those within LD (figure 4.10, table 4.1, table A.1). Both GWAS showed lim-
ited evidence of inflation due to residual population structure, as assessed by LD-scores
(RNFL: 𝜆 GC = 1.11, Linkage Disequilibrium Score regression (ldsc) intercept=1.01,
Ratio=0.05; GCIPL: 𝜆 GC = 1.12, ldsc intercept=1.01, Ratio=0.05, where ratio = (ldsc
intercept-1)/(mean(𝜒2)-1)).
Replication of our results was sought in two cohorts, the Rotterdam study [Hofman
& al., 2015], and the Raine study [McKnight & al., 2012]. The Rotterdam study contains
participants of comparable age to those in the UK Biobank and, despite the smaller co-
hort size, replication in this dataset saw correlationwith the effect sizes ofmeta analysed
loci associated with RNFL and GCIPL (Pearson’s r = 0.74, P = 1.25 x 10-6, table A.2).
The Raine study is a cohort of considerably younger individuals. Despite this, replica-
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Figure 4.10: Genome-wide association study of mean macular inner retinal thickness pheno-
types. Manhattan plot of p-values, resulting from meta-analysis across RNFL and GCIPL mean
macular thickness phenotype GWAS. Variants significantly associated (P <5 ×10-8) with only
RNFL are highlighted in yellow, those significantly associated with only GCIPL are highlighted




Figure 4.11: Quantile-quantile plots of inner retinal thickness GWAS. The quanitile-quantile
plot (qq-plot) for A) the GWAS of RNFL thickness prior to meta-analysis (Lambda GC = 1.11,
Intercept = 1.01, Ratio = 0.05). B) the GWAS of GCIPL thickness prior tometa analysis (Lambda
GC = 1.12, Intercept = 1.01, Ratio = 0.05).
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Table 4.1: 46 SNPs associated with one or more of the meta-analysed inner retinal layers
(GCIPL or RNFL) thicknesses. The variants have been annotated with ocular and general bio-
logy phenotypes. The p-values presented are resultant frommeta-analysis. Variants considered
to be representative of a single locus, examples of allelic heterogeneity, are highlighted in the
same colour alternating white and grey. For full results including effect size, effect allele spe-
cification and standard error please see supplementary Table A.1.
SNP Chr P-value Nearest gene Ocular Phenotypes Non-ocular Phenotypes
rs72739513 1 8.88E-09 ADORA1
rs79833181 2 1.55E-09 NBAS
rs13010692 2 6.72E-09 STON1-GTF2A1L
rs980772 2 4.62E-08 TEX41 Eosinophil count, Lymphocytes, Neutrophil count, Smoking,
White blood cell count
rs12998032 2 6.97E-10 CCDC148
rs2271758 2 1.34E-09 SLC25A12 Age completed full time education, Anthropometric traits,
Reaction time
rs13083522 3 4.51E-08 CRBN
rs17279437 3 7.81E-24 SLC6A20 Macular thickness Blood metabolite levels, BMI, Hyperglycinuria,
Iminoglycinuria, Overall health rating, Urinary metabolites
rs62252355 3 2.17E-16 FRMD4B
rs149831820 3 2.53E-08 ROBO2
rs66511946 4 2.15E-13 STOX2
rs2004187 5 1.43E-11 IRX2 Macular thickness Acute renal failure
rs17421627 5 8.09E-27 LINC00461 Retinal vascular calibre, Macular thickness Seen doctor for nerves/anxiety
rs527871768 6 3.37E-10 KIF6
rs13215351 6 1.36E-09 SNAP91 Spherical power Bronchiectasis, Menarche, Napping, Standing height
rs9398171 6 7.51E-22 FOXO3 Macular thickness Anthropometric traits, BMI, Coffee intake, Fat-free mass,
Intelligence, Lung function, Menarche, Schizophrenia
rs11762530 7 3.45E-28 IGFBP3 Body Mass
rs73348111 7 7.15E-10 IKZF1 Mean reticulocyte volume, Monocyte percentage
rs35001871 7 1.17E-09 GRB10
rs12719025 7 3.09E-10 COBL Macular thickness, Spherical power,
Strong/weak meridian
rs6989495 8 1.27E-09 RDH10
rs115520750 8 2.54E-10 ANGPT1
rs13271359 8 5.89E-26 RSPO2
rs376067714 8 1.28E-18 RSPO2
rs4871827 8 7.41E-09 DEPTOR Asthma, Height, Heel bone mineral density, Platelet count
rs118031671 9 2.53E-09 PTPRD
rs2787394 9 8.64E-09 INVS Macular thickness BMI, Body Mass, Weight
rs1947075 10 2.60E-08 ARHGAP22 Macular thickness
rs10762201 10 1.05E-26 ATOH7 Anthropometric traits
rs181211282 10 1.12E-08 MRPL43
rs2008905 11 6.81E-14 PIK3C2A Platelet count, Schizophrenia, Standing height
rs12574166 11 2.82E-08 LINC02747 Breast cancer
rs1042602 11 3.96E-22 TYR Eye colour, IOP, Macular thickness,
Oculocutaneous albinism
Depression, Hair colour, Heel bone mineral density,
Nerves, Skin pigmentation, Tanning
rs5442 12 2.36E-13 GNB3 Hypermetropia, Macular thickness,
Myopia, Spherical power
rs146652416 14 4.46E-08 FOXG1
rs17095953 14 1.76E-10 DAAM1
rs1254276 14 7.52E-14 SIX6 Age started wearing glasses,
Primary open angle glaucoma (POAG)
Anthropometric traits, Heel bone mineral density,
Menarche
rs10140252 14 1.05E-25 BBOF1 Mean corpuscular haemoglobin, Mean corpuscular volume,
Red blood cell count, Red cell distribution width
rs35337422 14 3.50E-08 TDRD9 Myopia, Spherical equivalent
rs1800407 15 3.19E-12 OCA2 Age started wearing glasses, Cataract,
Eye colour, Oculocutaneous albinism
Hair colour, Skin colour, Tanning response
rs1470108 15 7.09E-10 AEN Standing height
rs117304899 16 1.74E-09
rs117300236 17 5.57E-09 NSF Balding, Forced expiratory volume,
Haemoglobin concentration, Height, Mean corpuscular volume,
Mean sphered cell volume, Neuroticism, Neutrophil percentage,
Red blood cell count, Sensitivity
rs7503894 17 2.49E-29 TSPAN10 Age started wearing glasses, Astigmatism,
Cataract, Cylindrical power, Spherical power
Hair colour, Tanning
rs143330165 20 1.97E-08 LINC01428
rs7277632 21 1.20E-10 PCBP3
tion in the Raine dataset saw correlation of effect sizes for loci associatedwith the GCIPL
(Pearson’s r = 0.84, P = 5.95 x 10-6), however not with RNFL (Pearson’s r = -0.03, P =
0.88). It is interesting to note that the RNFL showed more discrepancy of genetic effect
between left and right eyes than the GCIPL in the analysis in section 4.3. Full replication
results are available in table A.3.
The absence of a significant replication result in the Raine cohort may be attributed to
a number of its population’s characteristics. Notably the Raine cohort comprises of con-
siderably younger individuals than the UK Biobank - whilst the mean age of our filtered
UK Biobank population is 57, participants of the Raine dataset were phenotyped at age
20. As previously mentioned the thickness of retinal layers has been shown to change
with age [Khawaja & al., 2020], so this significant age disparity may in part account
for the lack of replication. Another potential cause for the lack of replication may be
the small size of the replication cohort. The Raine cohort contained 1,014 participants
compared to the 31,434 individuals used in the UK Biobank inner retinal GWAS. The
smaller sample size of the replication dataset may have meant that many loci found in
the inner retinal GWAS would not pass genome-wide significance in these replication
cohorts. Considering these factors, and the robust replication in the Rotterdam cohort,
the lack of replication in the Raine cohort is unlikely a cause for concern.
A large portion of the significant variants lie within or near genes that have previously
been linked to eye phenotypes. Only one well-known glaucoma locus was found to
be significantly associated with inner retinal thickness near the SIX6 gene (rs1254276).
SIX6 has previously been associated with a thinner RNFL and overall development of
the inner retinal neural layers [Ulmer Carnes & al., 2014]. Other well known POAG loci
were not significantly associated including CAV1 (P= 0.92 for rs10258482), CDKN2B-
AS1 (P= 1.70 × 10-3, 1.20 × 10-2 and 1.20 × 10-2 for rs4977756, rs2157719 and rs1333037
respectively) and TMCO1 (P= 0.20 and 0.28 for rs4656461 and rs7555523 respectively)
[Liu & al., 2017]. This is not entirely unsurprising as the method of action for increased
susceptibility to the disease that CAV1 and CDKN2B-AS1 take is through protection of
the canal of Schlemm, not susceptibility of the neural cells [Elliott & al., 2016; Burdon
& al., 2011]. Furthermore, very few of the loci discovered in the inner retinal GWAS
reached genome wide significance in the IGGC GWAS of POAG (table A.4). In spite of
little crossover with previously known glaucoma genetics, several loci, including TYR,
PIK3C2A, NSF, TSPAN10 and STOX2 have previously been associated with IOP, an en-
dophenotype of glaucoma (Further exploration below).
Two loci significantly associated with the inner retinal phenotypes are in or near
genes with well-documented involvement in . These loci are TYR (rs1042602) and
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OCA2 (rs1800407). Oculocutaneous albinism (OCA) is a rare condition in which there
is lowered pigmentation in the retina, contributing to lower visual acuity [Kamaraj &
Purohit, 2014] (previously discussed in chapter 1). Individuals with OCA also display
foveal hypoplasia. Foveal hypoplasia is the underdevelopment of the foveal dip lead-
ing to a flatter fovea with unexcavated inner retinal layers, which also contributes to
visual impairment [McAllister & al., 2010]. OCA is very under-represented in the UK
Biobank, with only 19 participants identifying as having the condition. This is likely
due to under-diagnosis of the condition, in combination with its low incidence in the
population. The SNP at TYR has previously been discovered as part of a haplotype that
causes Ocular Albinism, a partial form of OCA in which the ocular traits of OCA persist
but the pigmentation traits aremuchmilder [Campbell & al., 2019]. This result suggests
a continuum between rare disease causing genetic variation, and common variation that
produces much milder non-pathological forms of the same trait. This will be explored
further in chapter 6.
Several of the discovered loci have also previously been associated with refractive
error. These included TSPAN10, GNB3, SNAP91 and COBL. This is in spite of us con-
trolling for refractive error by using it as a covariate in the model. However, the best
established refractive error locus, at LAMA2 (rs12193446) [Hysi & al., 2020], was not
significantly associatedwith either of our inner retinal phenotypes (P=0.32 in themeta-
analysis). This suggests that any association with loci previously identified as being in-
volved in refractive error is due to shared genetic process, not underlying magnification
bias. Magnification bias is understood as discrepancies in accuracy of individuals’ ret-
inal thickness measurements resulting from refractive error magnifying the OCT image
[Nowroozizadeh & al., 2014].
There were many other loci significantly associated with inner retinal thickness that
are in or near genes with well established roles in eye biology. TheATOH7 (rs10762201)
and IRX2 (rs2004187) loci have both previously been associated with eye development
[Brown & al., 2001; Zagozewski & al., 2014]. Studies have shown the particular import-
ance of ATOH7 in the development of retinal ganglion cells [Gao & al., 2014; Zhang
& al., 2018]. Additionally variants at IKZF1 (rs73348111) and RSPO2 (rs13271359 and
rs376067714) have been shown to be involved in differentiation and retinal cell defini-
tion [Mattar & Cayouette, 2015; Takata & al., 2017]. These findings highlight that retinal
thickness at the individual level is affected by a number of fundamental ocular devel-
opmental genes.
There are additional loci associated with other ocular pathologies including a SNP
nearNBAS (rs79833181)which has been previously associatedwith optic atrophy [Mak-
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simova & al., 2010]. TSPAN10 and OCA2 have also previously been associated with
cataracts. These findings illustrate the complex relationship between non-pathological
population level variation and disease biology.
In addition to the loci that had prior associations to both ocular and general pheno-
types, some of the variants found significantly associated with inner retinal thickness
had no prior associations. As an example, PCBP3 (rs7277632) encodes a protein that
binds to single stranded nucleotides. The gene has also shown an enriched expression
in the inner nuclear layer (INL) of mice [McKee & al., 2005]. For each of the SNPs with
no prior annotations, further work is needed to better understand the role they play in
retinal morphology.
4.5.3. Enrichment Analysis
To gain further insight into the underlying biological pathways and mechanisms un-
derlying the inner retinal phenotypes, enrichment analysis was conducted, implemen-
ted using GARFIELD [Iotchkova & al., 2016] (figure 4.12). This looks for associations
between a trait, in this case inner retinal thickness, and regulatory features from differ-
ent cell or tissue types. A fold enrichment of more than 10 was seen in eye tissue for loci
associated with RNFL or GCIPL thickness (P <0.05). Similar fold enrichment (>15×)
was seen in brain tissue. Additional fold enrichment was seen in the pancreas (>15×),
blood (>15×) and kidney (>10×), all consistent with broad pleiotropy of many of the
loci, which have also been associated with anthropometric, developmental, and blood
cell traits. This is likely due to their general role in development, as well as specific roles
in retinal development. Interestingly, the enrichment in kidney tissue is also supported
by prior associations between kidney disease and retinal disease [Deva & al., 2011; Bod-
aghi & al., 2014; Savige & al., 2011]. This is supported by the discovery of loci including
IRX2 (rs2004187) which has previously been associated with renal failure.
4.5.4. Mendelian Randomisation
To further interrogate the unexpected discovery of few variants associated with inner
retinal thickness that are also associated with glaucoma, or its endophenotype IOP, I
appliedMR. As detailed in the section 2.8, MR analysis allows us to look for support for
a causal relationship between two phenotypes, an exposure variable and an outcome
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Figure 4.12: Regulatory feature association using GARFIELD. Wheel plot of enrichment ana-
lysis on meta-analysed GCIPL and RNFL GWAS results across a number of cell types, as per-
formed in GARFIELD. Associations at different GWAS P-value thresholds are represented in
different colours.
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4.5.5. IOP and POAG
There is a plethora of research supporting a relationship between IOP and POAG. Clin-
ically, lowering IOP viamedication or surgery is one of themain clinical interventions to
slow the progression of, or prevent POAG [Beidoe &Mousa, 2012; Weinreb & al., 2014].
Therefore I used MR to look for support of a causal relationship between the two vari-
ables. Due to the well established relationship between these two phenotypes, MR of
the two variables acts as a positive control. IOP was used as the exposure variable, with
genetic instruments selected using genome-wide associated (P <5 ×10-8) variants from
summary statistics of Khawaja & al., 2018. Summary statistics for POAG were taken
from the IGGC [Gharahkhani & al., 2020]. Two sample MR analysis was conducted us-
ing TwoSampleMR [Hemani & al., 2018] and the in-package LD-pruning function was
applied to the exposure variable to obtain a final list of genetic instruments. POAG was
used as the outcome variable and, considering the cross-section of variants within the
two studies, a final total of 97 instruments were used within the analysis. Five methods
of meta-analysis were initially used and presented in the MR figures (inverse variance
weighted, MR Egger, simple mode, weighted median and weighted mode). Two meta-
analysis methods were used to definitively analyse the bidirectional results: MR-Egger
and Inverse Variance Weighting. The Steiger test [Hemani & al., 2017] was also used
to test for the directionality of the relationship. The results show strong support for a
causal relationship between the two variables using both meta-analysis methods (fig-
ure 4.13, table 4.2). The Steiger test confirms that IOP affects POAG. This is congruent
with current clinical practice and scientific literature. Aswell as establishing support for
this relationship, this analysis acts as an appropriate control for our further analyses of
phenotypic relationships that have been less well studied thus far. It also demonstrates
that the two datasets used are well-powered to identify causal relationships using MR.
4.5.6. Inner Retinal Thickness, POAG and IOP
I used summary statistics from my GWAS of inner retinal thickness to look for a causal
relationship between inner retinal thickness and either POAG or IOP. The null hypo-
thesis stated that there was no causal relationship between the thickness of the inner
retinal layers and either POAG or its endophenotype IOP. The genetic instruments were
selected as the cross-section between the list of conditionally filtered SNPs significantly
associated with RNFL or GCIPL thickness following meta-anlysis, and the SNPs with
available information from the appropriate consortia GWAS summary statistics. Sum-
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Figure 4.13: Mendelian randomisation analysis of relationship between IOP and POAG. A)
Scatter plot showing the relationship between the effect size of SNPs significantly associatedwith
intraocular pressure (IOP), and the effect of the same SNPs on primary open angle glaucoma
(POAG). B) Forest plot showing the effect size and direction of SNPs significantly associated
with IOP on POAG.
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Table 4.2: Results of bidirectional two-sample Mendelian randomisation analysis between
IOP and POAG, IOP and inner retinal layer thickness, and POAG and inner retinal layer
thickness. Values reported for two meta analysis methods: MR Egger and Inverse Variance
Weighted. POAG summary statistics were taken from the POAG International Glaucoma Ge-
netics Consortium (IGGC) meta analysis [Gharahkhani & al., 2020]. Summary statistics for
genetic association studies of IOP, were taken from [Khawaja & al., 2018].
Exposure Outcome MR Egger Inverse Variance Weighted
Effect size P-value SE Effect size P-value SE
IOP POAG 0.66 1.68E-14 0.07 0.55 2.80E-85 0.03
POAG GCIPL -0.53 0.02 0.22 -0.16 0.06 0.09
POAG RNFL -0.41 0.03 0.18 -0.12 0.09 0.07
POAG GCIPL and RNFL meta -0.72 3.62E-03 0.24 -0.22 0.02 0.1
IOP GCIPL -0.08 0.65 0.18 -0.06 0.4 0.07
IOP RNFL -0.12 0.38 0.13 0.05 0.3 0.05
IOP GCIPL and RNFL meta -0.25 0.19 0.19 0.01 0.91 0.75
GCIPL POAG -4.39E-03 0.92 0.05 0.01 0.5 0.02
GCIPL IOP 4.70E-03 0.94 0.07 -7.93E-03 0.73 0.02
RNFL POAG -0.01 0.91 0.09 -0.04 0.18 0.03
RNFL IOP -0.08 0.26 0.07 -7.26E-03 0.77 0.02
GCIPL and RNFL meta POAG 0.02 0.66 0.05 -0.01 0.58 0.02
GCIPL and RNFL meta IOP -0.03 0.56 0.04 0.01 0.76 0.02
& al., 2018 respectively. Initially, for the analysis using both POAG and IOP, the in-
ner retinal thickness was used as the exposure variable, and the disease phenotype
was used as the outcome variable. Following Mendelian randomisation analysis, there
was no support for a causal relationships between either RNFL or GCIPL and POAG
or IOP (figure 4.14, figure 4.15 and table 4.2). When conducted with exposure and
outcome variables reversed, meaning POAG or IOP is used as the exposure, and in-
ner retinal thickness is used as the outcome, there was only minor support for a causal
relationship between POAG and the inner retinal layers via one meta-analysis method
(table 4.2). The Steiger test was also conducted bidirectionally, and the results of the
relationships directionality were inconsistent. This provides additional evidence that
there is no causal relationship between inner retinal thickness and POAG or IOP.
These results contrast the effective use of inner retinal thickness as a biomarker for
POAG. A reasonable explanation is that clinical monitoring of POAG relies upon repeat
measurements of inner retinal thickness. It is a change in the thickness over time that is
more indicative of POAG rather than an absolute value. These results suggest that one’s
genetically determined inner retinal thickness is not a risk factor for the development
of glaucoma and clinically it is a change in inner retinal thickness that is symptomatic
of the disease. These SNPs and the resulting normal variation they cause are affecting
the inner retinal measurement, and therefore may confound its use as a biomarker of
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Figure 4.14: Mendelian randomisation analysis of the relationship between inner retinal
thickness and POAG. A) Scatter plot of the relationship between the effect size of SNPs sig-
nificantly associated with ganglion cell inner plexiform layer (GCIPL) thickness, and the effect
size of the same SNPs on POAG. B) Forest plot showing the effect size and direction of SNPs
associated with GCIPL thickness on POAG. C) Scatter plot of the relationship between the effect
size of SNPs significantly associated with retinal nerve fibre layer (RNFL) thickness, and the
effect size of the same SNPs on POAGs. D) Forest plot showing the effect size and direction of
SNPs associated with RNFL thickness on POAG. E) Scatter plot of the relationship between the
effect size of SNPs significantly associated with meta-analysed GCIPL and RNFL thicknesses,
and the effect size of the same SNPs on POAG. F) Forest plot showing the effect size and direction
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Figure 4.15: Mendelian randomisation analysis of the relationship between inner retinal
thickness and IOP. A) Scatter plot of the relationship between the effect size of SNPs signi-
ficantly associated with ganglion cell inner plexiform layer (GCIPL) thickness, and the effect
size of the same SNPs on IOP. B) Forest plot showing the effect size and direction of SNPs asso-
ciated with GCIPL thickness on IOP. C) Scatter plot of the relationship between the effect size of
SNPs significantly associated with retinal nerve fibre layer (RNFL) thickness, and the effect size
of the same SNPs on IOP. D) Forest plot showing the effect size and direction of SNPs associated
with RNFL thickness on IOP. E) Scatter plot of the relationship between the effect size of SNPs
significantly associated with meta-analysed GCIPL and RNFL thickness, and the effect size of
the same SNPs on IOP. F) Forest plot showing the effect size and direction of SNPs associated
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Figure 4.16: Mendelian randomisation analysis of the relationship between POAG and inner
retinal thickness. A) Scatter plot of the relationship between the effect size of SNPs significantly
associated with POAG, and the effect size of the same SNPs on ganglion cell inner plexiform
layer (GCIPL) thickness. B) Forest plot showing the effect size and direction of SNPs associated
with POAG on GCIPL thickness. C) Scatter plot of the relationship between the effect size of
SNPs significantly associated with POAG, and the effect size of the same SNPs on retinal nerve
fibre layer (RNFL) thickness). D) Forest plot showing the effect size and direction of SNPs
associated with POAG on RNFL thickness. E) Scatter plot of the relationship between the effect
size of SNPs significantly associated with POAG, and the effect size of the same SNPs in meta
analyses of GCIPL and RNFL thickness. F) Forest plot showing the effect size and direction of
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Figure 4.17: Mendelian randomisation analysis of the relationship between IOP and inner
retinal thickness. A) Scatter plot of the relationship between the effect size of SNPs significantly
associated with IOP, and the effect size of the same SNPs on ganglion cell inner plexiform layer
(GCIPL) thickness. B) Forest plot showing the effect size and direction of SNPs associated with
IOP on GCIPL thickness. C) Scatter plot of the relationship between the effect size of SNPs
significantly associated with IOP, and the effect size of the same SNPs on retinal nerve fibre
layer (RNFL) thickness. D) Forest plot showing the effect size and direction of SNPs associated
with IOP on RNFL thickness. E) Scatter plot of the relationship between the effect size of SNPs
significantly associatedwith IOP, and the effect size of the same SNPs inmeta analyses of GCIPL
andRNFL thickness. F) Forest plot showing the effect size and direction of SNPs associatedwith
IOP on meta-analysed GCIPL and RNFL.
99
these SNPs, using them as an approximation for the baseline genetically determined
inner retinal thickness. This may help improve the speed and accuracy of glaucoma
diagnosis.
4.6. Discussion
In this chapter I have presented the first large-scale GWAS of inner retinal layer thick-
ness. Prior to conducting the final GWAS, I applied quality control metrics to the ima-
ging data and explored the validity of these metrics. A GWAS of the status of whether
an individual passed or failed saidmetrics discovered no significantly associated genetic
variants. This suggests that the quality control is not removing a genetically interesting
group that would likely represent biological interest. Thus this quality control system
was accepted and used in the rest of the analysis.
I also explored a number of alternative phenotypes representing the morphology of
the inner retina. This included examining the left and right eyes separately. The GWAS
results of the mean thickness of both the RNFL and GCIPL were largely congruent
between left and right eyes, with a small subset of SNPs differentially affecting themeas-
ures in the two eyes. There is a possibility that this discrepancy is grounded in biological
variation, however the confounding nature of scan acquisition - where order of the left
and right eye scans were not randomised - makes it impossible to disentangle any biolo-
gical and confounding signal of the order of measurement. This should be considered
when future protocols of ocular study are designed, as it would be interesting to be able
to study the biology and genetics of any asymmetry.
To consider the full scope of dimensional data available to describe the morphology
of the inner retina using the clinical segmentation grids, PCA was conducted on the
thickness of the individual retinal layers at each of the Macula 6 segments and consid-
ering the left and right eyes separately. A GWAS was conducted for each of the first 10
resultant PCs and the results of the ten GWASweremeta-analysed. A comparable num-
ber of genetic variants were found significantly associated with both the dimensionality
transformed phenotypes, and the simpler clinical phenotypes used in the final GWAS.
This similarity in discovery power is likely due to the large size of the dataset, meaning
the increased power usually afforded by using dimensionally transformed phenotypes
is unnecessary. As the magnitude of the results is similar, the simpler phenotype was
selected, enabling easier interpretation of results and translation into the clinical space.
The dimensionality of the data available to describe retinal morphology is further ex-
plored in chapter 6.
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The final GWAS of mean RNFL and GCIPL thickness across the macular field were
meta-analysed due to the overlap of discovered genetic variants associated with each
phenotype. In total, 46 loci were found to be significantly associated with one or both
of the inner retinal layers. These loci included several that have previously been as-
sociated with ocular disease such as OCA and optic atrophy as well as with general
ocular development and function. Many of the loci identified by this GWAS highlight
the link between common population level variation, optical disease and ocular biology.
There were also several genetic variants associated with inner retinal thickness that had
no prior annotations. These loci may require further investigation to better understand
their role in ocular biology.
There was only a single SNP found to be significantly associated with the thickness of
one or both of the inner retinal layerswith prior associations to glaucoma. This is in spite
of the use of inner retinal thickness as a biomarker of glaucoma. Using MR analysis, no
support was found for a causal relationship between the inner retinal phenotypes and
glaucoma, or its endophenotype IOP. From this, it can be concluded that baseline thick-
ness of the inner retinal layers is not indicative of glaucoma development. It is rather the
change in inner retinal thickness that is symptomatic of glaucoma. Considering this, it
is possible that the normal variation caused by the SNPs discovered in the GWAS is con-
founding the measure of inner retinal thickness when it is used to diagnose glaucoma.
Therefore, it may be possible to utilise the genetic markers of inner retinal thickness
during diagnosis to help control for baseline inner retinal thickness. This may increase
accuracy and efficiency of POAG diagnosis. Unfortunately an appropriate dataset in
which to test this theory does not currently exist, as the glaucoma incidence within the
UK Biobank is too low at this time. If an appropriate dataset becomes available, this
would be an interesting avenue of research, providing further translational utility to the
GWAS results.
OCT is fairly unique in its ability to image live tissue, in particular a component of
the central nervous system, in an easy and non-invasive manner. Here we have demon-
strated the potential of OCT derived quantitative measures to explore eye biology and
the impacts of common variation on specific eye pathologies. This endorses OCT de-
rived quantitative measures as an exciting path of exploration to identify novel biolo-
gical findings and candidate disease biomarkers.
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5. Genome-wide Association Study of Outer
Retinal Morphology
The outer retina is found furthest from the front of the eye, and is responsible for re-
ceiving light stimulus and the initial stages of conversion to neural signal (figure 5.1A).
Compared to the inner retina which is made up of neural cells, the outer retinal layers
are made up of photoreceptor cells (PRC) and epithelial cells. This cell type difference
leads to the inner and outer retina being affected by a set of different diseases, in ad-
dition to being differentially affected by diseases common to both areas [Müller & al.,
2019]. Here, we perform GWAS of outer retinal layer thicknesses to uncover the genetic
variation underlying outer retinal morphology.
The outermost layer of the outer retina is the RPE, the pigmented layer of cells that
plays two main roles in the retina. Firstly it is responsible for absorbing any scattered
light to improve clarity of vision. Secondly it provides nourishment to the rest of the
retinal layers and additionally aids disposal of waste [James & al., 2003]. The rest of
the outer retina is made up of photoreceptor cells, both rods and cones, responsible for
absorbing light stimulus and transmitting it through the retina. Rods are responsible for
vision in low light levels but lack colour definition. Conversely, cones are responsible for
high acuity colour vision, but only in high light levels. The cones are found at highest
number at themacula and fovea, with limited numbers of rods, and the inverse pattern is
seen at the peripheral retina. Component layers of the PRC are the outer segment (OS),
inner segment (IS) and outer nuclear layer (ONL), working inwards from the RPE (fig-
ure 5.1B). The OS contains the photopigments storedwithin stackedmembranes. The IS
contains the mitochondria of the PRC in addition to ribosomes that aid the assembly of
the photopigments. The ONL contains both the cell body of the photoreceptor, includ-
ing the nucleus and other organelles, and the synaptic terminal of the photoreceptor
[Purves & al., 2001].
There are a number of diseases associated with outer retinal layers, most notably
AMD. As previously detailed in section 1.6.2, AMD is defined by the build up of lipid
deposits known as drusen under the RPE. This accumulation of deposits leads to the






Figure 5.1: Layers of the outer retina A) A diagram of the retinal layers. The outer retina is
comprised of the photoreceptor cells (PRC) and the retinal pigment epithelium (RPE). The light
is first absorbed by the photoreceptor cells (PRC) in the PRL. The RPE absorbs scattered light
and provides nutrients and waste removal to the rest of the retina. B) A schematic of the PRC
and their component layers. The outer nuclear layer (ONL) contains the cell body of the PRC
and the synaptic terminal. The inner segment (IS) contains the mitochondria of the PRC and
the ribosomes that aid assembly of the photopigments. The outer segment (OS) contains the
photopigments stored within stacked membranes.
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vision [James & al., 2003]. It has been shown that the development of drusen cause
thinning of the photoreceptor layers, as identifiable from OCT images [Schuman & al.,
2009]. Thinning of the outer retinal layers in AMD has also been linked to reduced
visual acuity [Pappuru & al., 2011].
In this chapter, I perform the first large-scale GWAS of outer retinal layer thickness,
and analyse subsequent links to outer retinal diseases. I further explore the genetic
variation underlying morphological variation at an increased dimensionality.
5.1. Outer Retina Data
The OCT image processing software TABS outputs a number of measurements that de-
scribe the morphology of the outer retina. Information is available on the thickness of
the ONL, IS, OS and RPE (figure 5.2A).
In contrast to the inner retinal analysis in which I used the Macula 6 grid, throughout
the outer retinal analysis I used data derived from the ETDRS grid ( figure 5.2 B). The
ETDRS grid is made up of concentric rings, and also split into superior and inferior, and
nasal and temporal fields. This segmentation grid is more commonly used to look at
the outer retina clinically. Unlike the Macula 6 grid, it includes the foveal field. This is
because outer retinal layers, unlike inner retinal layers, extend into the fovea.
Therefore the available measures to describe the morphology of the outer retina in-
cludes the thickness of the ONL, IS, OS and RPE at each of the nine fields of the ETDRS
grid, as well as the thickness averaged across the ETDRS grid, for left and right eyes (fig-
ure 5.2C). In-keeping with the analysis of the inner retina, I utilised simple phenotypes,
measurements of thickness of each outer retinal layer averaged across both eyes and
across the ETDRS grid, to describe the outer retinal morphology. This led to four meas-
ures that describe the morphology of the retina being used as phenotypes in GWAS: the
mean thickness across the ETDRS grid of the ONL, IS, OS and RPE averaged across the
left and right eye. Throughout the rest of this chapter, the component layers of the PRC
(the ONL, IS andOS) are considered separately to the RPE due to the different cell type.
5.1.1. Quality Control
The quality control metrics described in chapter 3 were again applied to obtain the ana-
lysis cohort used in the outer retinal GWAS. In brief, following removal of related in-
dividuals, selection to the densest, well-mixed population, and removal of individuals
who do not pass the quality control metrics based on technical imaging variables and







Figure 5.2: Data describing the outer retinal morphology. A) An optical coherence tomo-
graphy (OCT) image that has had the Topcon Advanced Boundary Segmentation (TABS) soft-
ware applied to it. On the left half of the image the outer nuclear layer (ONL) is shaded yellow,
the inner segment (IS) is shaded blue, the outer segment (OS) is shaded pink, and the ret-
inal pigment epithelium (RPE) is shaded orange. The ONL, IS and OS are components of the
photoreceptor cell (PRC). B) An example fundus image of a retina with the Early Treatment
Diabetic Retinopathy Study (ETDRS) grid, a commonly used partition matrix, superimposed
atop in blue. The four quadrants of the grid are labelled as superior (S), temporal (T), inferior
(I), and nasal (N). C) A schematic of the available measures that describe the outer retinal mor-
phology. This includes the thickness of the ONL, IS, OS and RPE at each of the nine fields of
the ETDRS grid, as well as the thickness averaged across the ETDRS grid, for left and right eyes
separately.
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5.2. GWAS of Outer Retinal Layers
5.2.1. Methods
A total of four GWAS were performed, one for each of the ONL, IS, OS, and RPE thick-
nesses taken as amean across the ETDRS grid, and across left and right eyes. The GWAS
were conducted using a linear additive model implemented in BGENIE [Bycroft & al.,
2018]. As described in chapter 4, eye specific covariates including technical covariates
outputted during scan acquisition and refractive error were regressed out of the indi-
vidual eye measurements before a mean thickness was calculated across the left and
right eyes. The remaining covariates, as detailed in section 4.2, were included in the
model. Variants were considered significantly associated if they reached genome-wide
significance (P<5× 10-8). LD score regressionwas applied usingLDSCoreV1.01 [Bulik-
Sullivan & al., 2015]. The results of the GWAS on the component layers of the PRC,
namely the ONL, IS and OS GWAS, were meta-analysed using MTAG [Turley & al.,
2018] and combined into a single discovery list. COJO [Yang & al., 2012] was applied to
themeta-analysed PRC component layer results and the RPE results to perform stepwise
model selection and conditional analysis to select for independent loci. Further filtering
was applied and loci within 1.5Mb of one another were labelled as being in the same
locus as indicated in the results tables. The resulting genetic variants were annotated
with nearest gene, and any prior association with ocular or general phenotypes using
ENSEMBL [Cunningham & al., 2019] and Open Targets Genetics [Carvalho-Silva & al.,
2019].
5.3. Results
For the four GWAS, calculation of LDSC regression yielded the values shown in table 5.1
where ratio = (LDSC intercept-1)/(mean(𝜒2) (figure 5.3). As described in section 2.7.6,
the LDSC intercept subtracted from 1 represents the confounding bias scaled to cohort
size. Therefore an intercept close to 1 represents limited residual population structure.
Additionally the ratio represents the proportion of p-value inflation caused by factors
other than polygenicity. Considering this, the values obtained from the outer retinal
GWAS indicate limited inflation suggesting minimal effect of residual population struc-
ture on the results. The ratio value for RPE is slightly higher than expected, but consid-
ering the LDSC intercept of the RPE is low, and the same population is used throughout
the analysis, I concluded this may be due to the small number of significantly associated
SNPs and proceed with the results.
107
Table 5.1: Results from linkage disequilibrium score (LDSC) regression on the GWAS res-
ults of the outer nuclear layer, inner segment, outer segment and retinal pigment epithelium
thickness. For each GWAS 𝜆 GC is reported alongside the LDSC intercept and ratio. The LDSC
intercept subtracted from 1 represents the confounding bias scaled to the cohort size. The LDSC
ratio represents the proportion of inflation caused by factors other than polygeneicity.
GWAS trait 𝜆 GC LDSC intercept LDSC ratio
ONL 1.15 1.04 0.13
IS 1.07 1.00 <0
OS 1.09 1.02 0.15
RPE 1.03 1.01 0.41
For each of the GWAS, many of the discovered variants lie in or near genes that have
previously been associated with ocular phenotypes, including ocular development and
ocular disease. When analysing the results, I have largely considered the component
layers of the PRC and the RPE separately due to their different cell type.
5.3.1. Photoreceptor Layer
The three GWAS of the layers that comprise the PRC, the ONL, IS, and OS, yielded 74,
15 and 38 significantly associated (P <5 × 10-8) loci respectively following conditional
analysis (table A.5, table A.6, table A.7). As previously stated, due to the crossover of
loci associated with the component layers of the PRC, we meta-analysed the genome-
wide set of the three PRCGWAS summary statistics together usingMTAG [Turley & al.,
2018] (figure 5.4). Following conditional analysis, themeta-analysed discovery list con-
sists of 59 genetic variants associated with one or more of the PRC layers (table 5.2 and
table A.8).
Many of the discovered loci are in or near genes associated with other ocular phen-
otypes and conditions. A considerable number of variants have been previously as-
sociated with the age at which one starts wearing glasses or contact lenses. These
include LINC00461 (rs12653396), RORB (rs10781177), CDHR1 (rs11200922), SLC6A13
(rs2080402),RDH5 (rs3138144), FAAP100 (rs56737642) andTSPAN10 (rs62075724 and
rs9910935). LINC00461, a long non-coding RNA, has previously been associated with
AMD [Han & al., 2020] and macular telangiectasia [Scerri & al., 2017]. RORB has pre-
viously been shown to be important in rod cell development in mice [Jia & al., 2009].
CDHR1 has been associated with several retinal dystrophies, and is known to be key to
the maintenance of photoreceptor structure [Stingl & al., 2017]. RDH5 deficient mice




Figure 5.3: Quantile-quantile plots of outer retinal thickness GWAS The quanitile-quantile
plot (qq-plot) for A) the GWAS of ONL thickness (𝜆 GC = 1.15, LDSC intercept= 1.04, Ratio=
0.13); B) the GWAS of IS thickness (𝜆 GC = 1.07, LDSC intercept= 1.00, Ratio= < 0); C) the
GWAS of OS thickness (𝜆 GC = 1.09, LDSC intercept= 1.02, Ratio= 0.15); D) the GWAS of RPE
thickness (𝜆 GC = 1.03, LDSC intercept= 1.01, Ratio= 0.41).
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also known to cause fundus albipunctatus, a form of night blindness [Xie & al., 2020].
The TSPAN10 locus has been associated with a number of ocular conditions including
strabismus, the misalignment of the direction of the eyes commonly known as a squint
[Plotnikov & al., 2019], and AMD [Orozco & al., 2020]. The association of these loci to
age one started wearing glasses and the various types of photoreceptor-related ocular
phenotypes supports the general importance of outer retinal structure in visual acuity.
Many of the loci found significantly associatedwith one ormore of themeta-analysed
PRC component layers have also been previously associated with either refractive er-
ror or spherical power. However, the best established refractive error locus, at LAMA2
(rs12193446) [Hysi & al., 2020], was not significantly associatedwith themeta-analysed
PRC layers (P= 0.04). Therefore, given refractive error is also accounted for as a cov-
ariate in the GWAS model, we conclude that any associations seen with refractive error
are due to underlying shared biological pathways, and not due to residual confounding.
RORB (rs1078177),CDHR1 (rs11200922),RDH5 (rs3138144) andTSPAN10 (rs62075724
and rs9910935) are all loci associated with both the thickness of the PRC layers and re-
fractive error. Several additional loci were found to also have prior associations with
refractive error. These include MOV10 (rs2932531), a locus that has known involve-
ment in CNS development [Skariah & al., 2017], and when knocked out in Xenopus
laevis, causes reduced differentiation of retinal cells [Skariah & al., 2018]. Additionally
ZNF281 (rs6673000) has prior associations with refractive error and has been found to
be involved in neuronal differentiation in neuroblastoma cells [Pieraccioli & al., 2018].
This suggests a role of common variation in ocular function, specifically, visual acuity.
One locus,MYO7A, was found to be significantly associatedwith the PRC component
layers and has also previously been associated with Usher syndrome [Well & al., 1995;
Jacobson & al., 2011; Cheng & al., 2018]. Usher syndrome is characterised by deafness
and retinitis pigmentosa. Retinitis pigmentosa refers to a group of incurable conditions
that cause progressive loss of vision as rod cells are damaged [James & al., 2003].
TheCFHR2 locus (rs410895)whichwe found to be significantly associatedwith thick-
ness of the component PRC layers is a locus known to be involved in AMD. CFHR2 en-
codes a complement factor H (CFH)-related protein. CFH was one of two loci identified
as significantly associated with AMD in the landmark study by Klein & al., 2005. CFH
is an important part of the complement cascade, a system of immune response that pro-
motes inflammatory response [Janeway & al., 2001]. Mutations in CFH are thought to
be a factor in the formation of drusen [Hageman & al., 2005].
In total, four loci found significantly associated with the meta analysed PRC layers
reached genome-wide significance (P <5 ×10-8) in the International AMD Genomic
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Consortium (IAMDGC) GWAS of AMD [Fritsche & al., 2016]. These loci are RORB
(rs10781177, P=1.71 ×10-9), RLBP1 (rs3825991, P=3.08 ×10-8), FAAP100 (rs56737642,
P=2.15 ×10-10) and TSPAN10 (rs9910935, P=1.53 ×-10)
In addition to loci with prior associations to ocular and general phenotypes, some
of the variants found associated with thickness of the component layers of the PRC
had no prior annotations. These include KDM5B (rs11577827) which is a histone de-
methylase that helps regulate embryonic stem cell differentiation [Kidder & al., 2014].
This mirrors the involvement of some of the known ocular loci in development. DUOX1
(rs1648303) encodes Dual oxidase 1, a transmembrane protein that generates hydrogen
peroxide by transporting electrons across membranes [de Faria & Fortunato, 2020]. It is
involved in the thyroid hormone synthesis pathway, host defence and cancer. LMAN1
(rs4940460) encodes Protein ERGIC-53, a lectin that has a role in endoplasmic rect-
ticulum to Golgi apparatus transport [Zhang & al., 2003]. A more recent study has
suggested that through this function, the protein may play a role in photoreceptor gene
transport and homeostasis in mice [Hao & al., 2014]. For each of these SNPs, more
research is needed to understand their role in retinal structure.
Table 5.2: 59 SNPs significantly associated with one or more of the meta-analysed photore-
ceptor cell component layer (ONL, IS or OS) thicknesses. The variants have been annotated
with ocular and general biology phenotypes. The p-values presented are resultant from meta-
analysis. Variants considered to be representative of a single locus, examples of allelic hetero-
geneity, are highlighted in the same colour alternating white and grey. For full results including
effect sizes, effect allele specification and standard error please see supplementary Table A.8.
SNP Chr P-value Nearest Gene Ocular Phenotypes Non-ocular Phenotypes
rs11587687 1 5.02E-09 GNAT2 BMI, Frequency of tiredness/lethargy
rs2932531 1 2.79E-09 MOV10 IOP, Myopia Blood pressure, Hayfever, allergic rhinitis
or eczema, Hypertension, Platelet
distribution width
rs410895 1 8.19E-22 CFHR2 Macular degeneration
rs6673000 1 2.73E-13 ZNF281 Spherical power
rs11577827 1 2.77E-13 KDM5B
rs6665290 1 8.24E-11 COQ8A Cataract Impedance of limbs, Lymphocyte traits,
Neutrophil traits, White blood cell traits
rs2113422 2 2.89E-10 ATAD2B Anthropometric traits, Basal metabolic
rate, Forced expiratory volume, Guilt,
Intelligence, Systolic blood pressure,
White blood cell traits
rs13382582 2 5.99E-09 STK39
rs838718 2 2.05E-08 DGKD Crohn’s disease, Disorders of bilirubin
excretion, Haematocrit percentage,
Haemoglobin concentration, Ibuprofen,
Inflammatory bowel disease, Platelet
count, Urinary calculus
rs34234056 3 2.37E-08 SLC6A6
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Table 5.2: continued
rs348866 3 1.96E-13 IMPG2 Corneal hysteresis Body fat percentage, Crohn’s disease,
Eosinophill traits, Heel bone mineral
density, Inflammatory bowel disease,
Platelet traits
rs1376026 3 5.86E-09 TSC22D2 Basal metabolic rate, Body mass, High
blood pressure, Hypertension, Number of
self-reported non-cancer illnesses
rs2929724 5 4.21E-08 BASP1-AS1 Number of days per week walked >10
minutes,Open wounds on head neck
and trunk
rs12653396 5 4.67E-11 LINC00461 Age started wearing glasses ADHD, Age first had sexual intercourse,
Alcohol intake frequency, Anxiety, Basal
metabolic rate, Body mass, Educational
attainment, Frequency of travelling from
home to work place, Full cream consumption,
Hot drink temperature, Impedance of limbs,
Mean corpuscular volume, Sodium in urine
rs1109114 5 2.65E-13 AFAP1L1 BMI, Forced expiratory volume, Hearing
difficulties, High blood pressure,
Hypertension
rs1438692 5 1.32E-11 AFAP1L1 Forced expiratory volume
rs450611 5 5.82E-10 BOD1 Height at age 10
rs375435 6 3.56E-16 PRPH2 Neutrophil percentage
rs1926098 6 3.35E-08 IMPG1
rs12719025 7 6.39E-22 COBL Macular thickness, Spherical power,
Strong/weak meridian
rs2437002 8 5.77E-13 RSPO2
rs2514842 8 3.84E-16 RSPO2 Ankle spacing width, Balding pattern,
Contracture of palmar fascia, Disorders of
muscle, ligament and fascia, Fascitis,
Hair colour, Heel bone mineral density
rs10781177 9 1.49E-08 RORB Age started wearing glasses, Spherical power
rs717299 9 3.80E-13 RORB Impedance of arms
rs11200922 10 1.62E-26 CDHR1 Age started wearing glasses, Hypermetropia,
Spherical power
rs618838 11 1.79E-09 CTSF Anthropometric traits, Impedance of limbs,
Overall health rating, Red blood cell traits
rs7128814 11 4.56E-08 SMIM38 Hair colour, Platelet crit, Skin colour, Tanning
rs631695 11 1.71E-09 CCND1 Breast cancer, Leg mass
rs948962 11 4.55E-11 MYO7A Retinitis pigmentosa Deafness, Non-syndromic hearing loss
rs28620862 11 7.57E-11 TYR Hearing difficulties, Home location, Malignant
melanoma, Seen doctors for nerves, anxiety
or tension, Skin colour, Sunburn, Tanning
rs7930541 11 2.65E-09 SESN3
rs2080402 12 2.21E-12 SLC6A13 Age started wearing glasses Life time number of sexual partners,
Size at age 10
rs3138144 12 6.54E-28 RDH5 Age started wearing glasses, Myopia,
Spherical power
rs6538677 12 7.36E-10 SNRPF Mean platelet volume, Platelet count
rs9796234 13 4.69E-18 GRK1
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Table 5.2: continued
rs7151797 14 5.46E-14 ACTN1 Alternative exercises, Forced vital capacity,
Frequency of tiredness/lethargy, Mean
platelet volume, Sensitivity/hurt feelings
rs11626048 14 1.08E-45 ELMSAN1 Corpuscular traits, Mean sphered cell
volume, Red blood cell traits
rs10147158 14 9.62E-16 BBOF1 Red blood cell distribution width
rs11159058 14 1.30E-24 BBOF1
rs11159063 14 2.71E-50 LIN52 Chronotype, Mean corpuscular volume,
Red blood cell distribution width
rs1972564 14 2.93E-74 LIN52
rs28488340 14 9.02E-31 VSX2
rs888413 14 1.92E-14 YLPM1 Anthropometric traits, Depression, Mood
swings, Nervous feelings, Neuroticism,
Platelet crit
rs1648303 15 2.72E-08 DUOX1
rs10083695 15 8.00E-13 WDR72 Haematocrit, Red blood cell count
rs3825991 15 2.70E-31 RLBP1 Menarche
rs7206532 16 1.86E-09 DYNLRB2 Spherical power
rs6564059 16 1.16E-08 MEAK7 Monocyte count, White blood cell count
rs11640338 16 2.25E-08 GINS2 Monocyte traits, Neutrophil traits,
Platelet traits
rs1852269 17 1.88E-09
rs11079866 17 1.58E-08 PHOSPHO1 Spherical power Allergic disease, Asthma, Coronary
atherosclerosis, Coronary artery disease,
Eosinophill count, Forced expiratory
volume, Height, High blood pressure,
Hypercholesteromua, Impedance of limbs,
Long-standing illness, disabilities or infirmary,
Overall health rating
rs56737642 17 2.87E-11 FAAP100 Age started wearing glasses, Cataract,
Logmar, Spherical power
Ankle spacing width, Hair colour, Skin colour,
Tanning
rs62075724 17 2.91E-12 TSPAN10 Age started wearing glasses, Amblyopia,
Cylindrical power, Logmar, Myopia,
Spherical power
Hair colour, Tanning
rs9910935 17 2.75E-28 TSPAN10 Age started wearing glasses, Amblyopia,
Cataract, Spherical power
Ankle width spacing, Hair colour, Skin colour,
Tanning
rs4940460 18 2.86E-12 LMAN1
rs6077977 20 4.98E-19 JAG1 Heel bone mineral density, Height
rs8132685 21 3.58E-09 C21orf62
rs5752975 22 1.80E-09 MTMR3 Ankle spacing width, Basal metabolic rate,
Body mass, Depression, Educational attainment,
Forced vital capacity, Impedance of body,
Lymphocyte traits, Mean sphered cell volume,
Mood swings, Neutrophil percentage
rs8138196 22 2.38E-09 OSM Red blood cell count
5.3.2. Retinal Pigment Epithelium
Seven loci were found significantly associated with the thickness of the RPE (figure 5.5,
table 5.3 and table A.9). This included two well-known OCA loci, TYR (rs1126809) and
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Figure 5.4: Genome-wide association study of the mean component photoreceptor cell layer
thickness phenotypes. Manhattan plot of the p-values resulting from meta-analysis across IS,
OS and ONL mean macular thickness phenotype GWAS. These three layers are the component
PRC layers. Variants are considered significantly associated if they reach genome wide signific-
ance (P <5 ×10-8).
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OCA2 (rs1800407), which are also associatedwith inner retinal thickness. In the context
of the RPE, OCA is characterised by the underproduction of melanin in tissues such as
the skin, hair and, within the eye, the iris and RPE. OCA is well known to disrupt the
morphology of the fovea through lack of foveal excavation and subsequently less cone
maturation and lengthening [Kamaraj & Purohit, 2014]. However research has also sug-
gested that cone maturation in OCA can happen on a continuum, which is potentially
reflected in a mild form here [McAllister & al., 2010; Wilk & al., 2014]. Additionally the
SNP at the TYR locus is part of a haplotype (with one of the SNPs found associatedwith
inner retinal layer thickness) that has been shown to be associated with ocular albinism,
a partial form of OCA [Campbell & al., 2019].
One of the loci identified, CFHR1 (rs61822227), has previously been associated with
AMD. CFHR1 is a CFH-related gene. As noted above, CFH was one of two loci found
in the very first GWAS of AMD [Klein & al., 2005]. In the IAMDGC GWAS of AMD
[Fritsche & al., 2016], this SNP reached genome-wide significance (P=1.62 ×10-344).
CFHR1 encodes Complement factor H-related protein 1 which is involved in comple-
ment regulation. As stated above, the complement system is a key part of the immune
response. It involves a network of many proteins that function in a cascade to induce
inflammatory responses [Janeway & al., 2001]. It has been shown that CFHR1 acts as
a competitive antagonist to CFH, thus regulating the complement pathway[Goicoechea
De Jorge & al., 2013].
Furthermore, three of the loci discovered, GPR12 (rs77001109), NETO1 (rs56194068)
and KIF16B (rs77561053), have prior associations with neurological development.
GPR12 has been found to be expressed in areas of neuronal differentiation in the CNS
during embryonic development of mice [Ignatov & al., 2003]. NETO1, which encodes
a transmembrane protein, is known to be involved in the regulation of off-centre cone
bipolar cells of mice [Chow & al., 2004]. KIF16B has been shown to be integral to local-
isation of endosomes in mouse neurons , and is also involved in the degradation path-
way of neurons [Hoepfner & al., 2005; Farkhondeh & al., 2015] The RPE is integral in
the disposal of redundant photoreceptors and associated waste [James & al., 2003].
The link of several retinal pigment thickness associated loci to both ocular-specific, but
also general neural development, again reinforce the importance of the eye as a window
into the tissue of the CNS.
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Figure 5.5: Genome-wide association study of mean retinal pigment epithelium layer thick-
ness. Manhattan plot of mean macular retinal pigment epithelium layer thickness GWAS p-
values. Variants are considered significantly associated if they reach genome wide significance
(P <5 ×10-8).
Table 5.3: Seven SNPs associatedwith RPE layer thickness and annotations of ocular and general
biology phenotypes. For full results including effect size, effect allele specification and standard
error please see supplementary table A.9
SNP Chr P-value Nearest Gene Ocular Phenotypes Non-ocular Phenotypes
rs61822227 1 2.85E-09 CFHR1 Macular degeneration
rs1126809 11 4.47E-11 TYR Eye colour, Hypoplasia of fovea,
Oculocutaneous albinism, Optic disc size
Basal cell carcinoma, Hair colour,
Hearing difficulties, IOP, Malignant melanoma,
Skin pigmentation, Squamous cell carcinoma,
Sunburns, Tanning, Vitiligo
rs77001109 13 7.74E-09 GPR12
rs1800407 15 4.78E-14 OCA2 Age started wearing glasses, Cataract,
Central retinal arteriolar equivalent,
Cylindrical power, Eye colour, Macular
thickness, Oculocutaneous albinism
Hair colour, Relative age of first facial hair,
Skin cancer, Skin colour, Sunburn, Tanning
rs7239443 18 1.14E-08 METTL4
rs56194068 18 2.09E-08 NETO1
rs77561053 20 1.19E-09 KIF16B
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5.4. Mendelian Randomisation
Due to the known clinical relationship between AMD and the outer retinal layers, I con-
ductedMR analysis to look for support for a causal relationship between the two pheno-
types (MR is discussed in detail in section 2.8). This analysis is enabled by robust GWAS
studies of AMD within the scientific literature.
Bidirectional MR was conducted to interrogate the relationship between AMD and
the thickness of the outer retinal layers: the ONL, the IS, the OS, the meta-anlysed PRC
component layers, and the RPE. GWAS summary statistics for AMD were taken from
Fritsche & al., 2016. The MR analysis was implemented using the TwoSampleMR pack-
age [Hemani & al., 2018]. Initially, thickness of the outer retinal layers was used as the
exposure variable, and AMD was used as the outcome variable. The cross-section of
the conditionally filtered SNPs found significantly associated with each outer retinal
thickness phenotype, and the SNPs found in the AMD summary statistics were used
as the genetic instruments. The in-package LD-pruning was further applied to the list
of genetic instruments. MR analysis was also conducted in the reverse direction, with
AMD used as the exposure variable and outer retinal thickness used as the outcome
variable. In this instance, the cross-section of SNPs found to be significantly associated
with AMD in the [2016] study, defined as P <5 ×10-8, and SNPs found in the GWAS
of the thickness of each outer retinal layer were used as genetic instruments. Again the
in-package LD-pruning was applied to the list of genetic instruments. Five methods of
meta-analysis are presented in the MR figures (Inverse variance weighted, MR Egger,
simplemode, weightedmedian andweightedmode). Twometa-analysis methodswere
used to analyse the bidirectional results, MR-Egger and Inverse Variance Weighting.
Sufficient support for a causal relationship was considered significance in at least one of
two meta-analysis methods, with congruent effect size between the two meta-analysis
methods. The Steiger test for directionality was also applied.
The results of this bi-directional MR analysis were mixed (table 5.4, figure B.5, fig-
ure B.6, figure B.7, figure B.8). There was support for causal relationships between
some of the outer retinal layers and AMD (figure 5.6). However the Steiger test showed
incongruent results when applied bidirectionally for all relationships apart from the
relationship of AMD on RPE thickness. When AMD is used as the exposure variable
and RPE is used as the outcome variable, there is statistically significant evidence for a
causal relationship (Effect size = -0.19, P= 4.31 ×10-3 using Inverse Variance Weighting,
figure 5.6A and B). AMD is defined by the development of drusen, abnormal lipid de-
posits, under the RPE. It is therefore logical that AMD has a causal relationship with
117
RPE thickness.
Little support is seen for a causal relationship when the thickness of the outer retinal
layers is used as the exposure variable and AMD is used as the outcome variable (fig-
ure B.5, figure B.6). Overall, these results suggest that whilst AMD does damage the
outer retina, seen clinically as changes in the outer retinal layer thickness, one’s genet-
ically determined outer retinal thickness does not alter the risk of AMD development.
This relationship is similar to the pattern of relationship seen between the inner retina
and POAG.
Table 5.4: Results of bidirectional two-sampleMendelian randomisation analysis betweenAMD
and outer retinal layer thickness. Values are reported for two meta-analysis methods, MR Egger
and Inverse Variance Weighted. AMD summary statistics were taken from the International
AMD Genomic Consortium GWAS [Fritsche & al., 2016]. Results considered significant are
bold
Exposure Outcome MR Egger Inverse Variance Weighted
Effect size P-value SE Effect size P-value SE
ONL AMD 0.02 0.63 0.04 0.03 0.04 0.01
IS AMD 0.14 0.67 0.31 0.11 0.22 0.09
OS AMD 0.05 0.90 0.39 0.04 0.75 0.13
PRL meta AMD 0.08 0.20 0.06 0.04 0.05 0.02
RPE AMD 0.26 0.70 0.62 -0.22 0.42 0.27
AMD ONL -0.17 0.50 0.24 0.08 0.56 0.14
AMD IS 0.02 0.23 0.02 0.02 0.05 0.01
AMD OS -0.44 2.51E-03 0.14 -0.15 0.07 0.09
AMD PRL meta -0.41 0.02 0.17 -0.11 0.26 0.10
AMD RPE -0.20 0.09 0.11 -0.19 4.31E-03 0.07
5.5. Exploring the ETDRS Grid
There are a large number of individual phenotypes available using the clinical segment-
ation grids that describe the morphology of the outer retina. As outlined above, per-
forming GWAS of the thickness of outer retinal layers at each of the ETDRS grid sub-
compartments may be hard to interpret. However I was keen to explore the biological
variation occurring at a slightly higher dimensionality than that utilised in my initial
GWAS. An interesting feature of the ETDRS grid, especially compared to the Macula
6 grid used in the inner retinal analysis, is its division into concentric circles. As the
macula dip varies radially in a similar fashion to the segmentation of the ETDRS grid, I
decided to investigate whether genetic variation was affecting the foveal area, the inter-
mediate ring, and the peripheral ring differentially (figure 5.7). Therefore I calculated
the mean thickness for each of these areas for each of the outer retinal layers and per-
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Figure 5.6: Mendelian randomisation analysis of the relationship between retinal pigment
epithelium thickness and AMD. A) Scatter plot of the relationship between the effect size of
SNPs significantly associated with AMD, and the effect size of the same SNPs on RPE thick-
ness. B) Forest plot showing the effect size and direction of SNPs associated with AMD on RPE
thickness. The GWAS summary statistics for AMD come from Fritsche & al., 2016
Figure 5.7: Division of Early Treatment Diabetic Retinopathy Study grid into concentric
fields. A diagram of the Early Treatment Diabetic Retinopathy Study grid divided into con-
centric fields as denoted by shading. The foveal field is shaded purple, the intermediate field is
shaded yellow, and the peripheral field is shaded blue.
119
5.5.1. Methods
A mean thickness across the four component areas of the intermediate ring, alongside
the four component areas of the peripheral ring, was calculated. GWAS of the thickness
of the ONL, IS, OS and RPE across the foveal area, intermediate ring and peripheral
ring averaged across left and right eyes were performed, making a total of 12 GWAS.
For each quantitative phenotype, an additive linear model was used implemented in
BGENIE [Bycroft & al., 2018], with eye specific covariates regressed out prior to a mean
across left and right eyes being calculated and the remaining covariates included in the
model (as detailed above and in chapter 4).
To examine the results of the GWAS, comparisons were made between the effect sizes
obtained from the GWAS of different concentric fields across the same retinal layer.
For each SNP a z-score was calculated to compare its effect size on three areas: the
foveal field compared to the intermediate field, the foveal field compared to the peri-
pheral field, and the intermediate field compared to the peripheral field. The z-score
was defined as:
𝑍 = |𝛽0 − 𝛽1|
√𝑆𝐸20 + 𝑆𝐸21
A p-value is calculated for each z-score to identify SNPs with significantly different
effects on the retinal fields. These loci were conditionally filtered for LD using COJO
[Yang & al., 2012]. P-values were then Bonferroni adjusted and SNPs with P < 0.05
considered significant. The lists of significant SNPs were manually annotated using
ENSEMBL [Cunningham & al., 2019] and Open Targets Genetics [Carvalho-Silva & al.,
2019].
5.5.2. Results
Upon first inspection of the GWAS results across the different concentric fields, several
observations stand out (figure 5.8). Firstly, in the ONL, there is a locus on chromosome
8 that does not appear to be significantly associated with the layer’s thickness at the fo-
vea, but is increasingly significantly associated with the layer’s thickness as we move
towards the peripheral ring. The opposite effect can be seen at a locus on chromosome
6 where the significance of the association with ONL thickness is much higher at the fo-
vea than it is in the peripheral ring (figure B.1). In the IS GWAS, loci on chromosome 3,
chromosome 7, chromosome 17 and chromosome 21 are seen to be significantly associ-
ated with the layers thickness at both the fovea and in the intermediate ring, but not the
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peripheral ring (figure B.2). This pattern is seen in reverse for a locus on chromosome 13
in the OS GWAS, with the loci being significantly associated with the intermediate and
peripheral rings, but not at the fovea (figure B.3). Finally in the RPE, a locus on chro-
mosome 17 is significantly associated with the thickness of the layer at the fovea and the
intermediate ring, but not in the peripheral ring (figure B.4). These initial observations
suggest genetic variation is affecting the areas of the retina differentially, most probably













Figure 5.8: GWAS of outer thickness at concentric ETDRS fields A) ONL thickness across
foveal field, B) ONL thickness across intermediate ring, C) ONL thickness across peripheral
ring, D) IS thickness across foveal field, E) IS thickness across intermediate ring, F) IS thickness
across peripheral ring, G) OS thickness across foveal field, H) OS thickness across intermediate
ring, I)OS thickness across peripheral ring, J) RPE thickness across foveal field, K)RPE thickness
across intermediate ring, L) RPE thickness across peripheral ring. The results are also shown in
figure B.1, figure B.2, figure B.3 and figure B.4.
To further analyse the differential effect of SNPs on the sub-fields of the retina, we
looked at which SNPs had notable differences in the effect size values obtained from
their respective GWAS of the different macular fields. For each of the PRC layers there
were numerous loci that appeared to be affecting the fields differentially. The loci dis-
covered specific to each layer are detailed below.
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Outer Nuclear Layer
Many loci were found to be differentially affecting the thickness of the ONL across
the macular field (table 5.5). The ONL contains both the cell body and synaptic ter-
minal of the PRC. Some interesting loci to highlight includeMIR29B2CHG (rs6701735),
PLEKHA7 (rs10766368) and LINC00880 (rs9860481). All three loci have the strongest
effect on the thickness of the ONL at the fovea, and a reduced effect in the peripheral
field. They also all have prior association with corneal hysteresis. Corneal hysteresis is
a measure of the cornea’s resistance to deformation [Agarwal & al., 2012] and has been
shown to correlate with glaucoma progression [Medeiros & al., 2013]. As described in
chapter 4, it is the inner retina that is usually affected in glaucoma patients. This sug-
gests a possible link between the outer retina and glaucoma, however the association
with corneal hysteresis could also be through a different pathway.
Another interesting spatial effect to note is that of PLEKHA5 (rs10841116). PLEKHA5
had nearly no effect on the thickness of the ONL in the peripheral fields of the macula
(Effect size = 4.43 × 10-3), with a slight effect in the intermediate field (Effect size =
0.14) and a larger effect at the fovea (Effect size = 0.57). PLEKHA5 has previously been
associatedwith localisation ofmelanomametastasis to the brainwith an apparent role in
regulating the blood brain barrier [Jilaveanu & al., 2015]. The considerable difference in
effect size on the different macula fields of the ONL could warrant further investigation
into its role in the eye.
Table 5.5: List of SNPs differentially affecting the thickness of the ONL at the three concent-
ric fields of the macula. List of SNPs with a significant z-score (P <0.05 following Bonferroni
correction) describing the differential effect on the ONL thickness at the foveal (F), intermediate
(I) and peripheral (P) fields. The field (F1 or F2) and corresponding effect size from GWAS of
thickness in each field are listed alongside the Bonferroni adjusted p-value of the comparative
z-score. Each genetic variant is also annotated with nearest gene and any ocular and non-ocular
phenotypes previously associated with it.










Ocular phenotypes Non-ocular phenotypes
rs36052911 2 F I 0.56 0.21 0.05 CCDC88A
rs11720108 3 F I 0.71 0.12 8.37E-06 ADCY5 Birth weight, Forced
expiratory volume,
Heel bone mineral
density, Height, Type 2
diabetes
rs55914544 5 F I 0.65 0.09 1.26E-03 WWC1 Body fat percentage
rs75757892 6 F I -1.12 -0.55 2.85E-04 RREB2 Balding pattern, Heel
bone mineral density,
Height, Impedance of limbs,
Red blood cell traits,
Self reported math ability
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Table 5.5: continued
rs13263941 8 F I 0.22 0.69 1.05E-03 RSPO2 Strong/weak meridian Coffee intake, Hair colour
rs1512380 9 F I -0.51 -0.12 0.04 PTPRD
rs10841116 12 F I 0.57 0.14 1.31E-03 PLEKHA5 Time spent outside in
winter
rs1493529 13 F I -0.48 -0.08 6.18E-03 ENOX1
rs12147951 14 F I -1.57 -2.48 2.91E-04 VSX2
rs887595 14 F I 1.28 1.94 5.51E-06 VSX2 Macular thickness Red blood cell traits
rs3766775 1 F P -0.60 -0.06 1.19E-05 SLC1A7 Duration of fitness test
rs6701735 1 F P 0.67 -0.07 7.20E-05 MIR29B2CHG Corneal hysteresis Pulse rate
rs36052911 2 F P 0.56 0.10 3.86E-04 CCDC88A
rs1494836 3 F P 0.91 0.46 0.04 EOMES Macular thickness
rs73857644 3 F P -0.82 -0.18 0.04 ZBTB20
rs11720108 3 F P 0.71 -0.04 1.35E-10 ADCY5 Birth weight, Forced
expiratory volume,
Heel bone mineral
density, Height, Type 2
diabetes
rs7623382 3 F P 0.54 0.18 8.48E-03 LINC00880 Corneal hysteresis BMI, Coronary artery disease,
Height, Impedance of limbs
rs12515565 5 F P -0.07 -0.51 0.01E-03 LMNB1-DT Height, Height at age 10,
Multiple myeloma
rs55914544 5 F P 0.65 -0.04 3.54E-06 WWC1 Body fat percentage
rs258873 5 F P -0.69 -0.31 6.23E-03 BOD1
rs6875105 5 F P -0.69 -0.32 8.48E-03 BOD1
rs75757892 6 F P -1.12 -0.20 2.57E-13 RREB2 Balding pattern, Heel
bone mineral density,
Height, Impednce of limbs,
Red blood cell traits,
Self reported math ability




Trunk mass, White blood
cell count
rs4896369 6 F P 0.44 0.05 2.29E-03 HEBP2
rs4870049 6 F P 0.55 0.11 5.81E-04 LRP11 Strong/weak meridian
rs13263941 8 F P 0.22 0.93 6.81E-10 RSPO2 Strong/weak meridian
rs376067714 8 F P 0.15 0.85 3.62E-05 RSPO2
rs1512380 9 F P -0.51 0.02 1.08E-04 PTPRD
rs7893507 10 F P 0.45 0.03 1.56E-03 CUBN
rs3906617 10 F P 0.62 0.05 2.38E-06 FRMPD2 Age started wearing
glasses, Spherical
power
rs10766368 11 F P 0.56 0.14 3.27E-03 PLEKHA7 Corneal hysteresis,
Glaucoma, IOP,
Strong/weak meridian
Height, Impedance of limbs
rs1122316 11 F P 0.17 -0.45 5.98E-05 CCND1 Breast cancer, Number
of non-cancer illnesses














rs1493529 13 F P -0.48 0.07 1.47E-06 ENOX1
rs12428305 13 F P -0.68 -0.21 6.68E-04 IRS2 Peripheral nerve disorders
rs3748358 14 F P -0.60 -0.20 1.84E-03 RPGRIP1
rs12147951 14 F P -1.57 -2.35 3.71E-03 VSX2
rs887595 14 F P 1.28 1.94 1.29E-06 VSX2 Macular thickness Red blood cell traits
rs1972565 14 F P 1.27 1.94 1.20E-06 VSX2
rs7183832 15 F P 0.56 0.20 0.01 BNIP2 Myopia
rs12515565 5 I P -0.18 -0.51 0.02 LMNB1-DT Height, Height at age
10, Multiple myeloma











As a reminder, the IS contains the mitochondria and ribsomomes of the PRC. Several of
the genetic variants differentially affecting the thickness of the IS across the retinal fields
had prior associations to neurodevelopmental traits (table 5.6). This includes SLC44A4
(rs9267659) which has previously been strongly associated with multiple sclerosis and
Parkinson’s disease. SLC44A4 had a very minor effect on inner segment thickness in
the peripheral field (Effect size = 3.76 × 10-4) and a stronger effect at the fovea (Effect
size = -0.13). SLC44A4 encodes a choline transporter and mutations in the gene have
also been linked to hearing loss [Ma & al., 2017]. Additionally, TMEM106B (rs7791726
and rs1990622) has a stronger effect on IS thickness at the fovea (Effect size = -0.23)
compared to in the peripheral field (Effect size= -0.02). This locus has prior associations
to both dementia and depression. TMEM160B encodes a transmembrane protein which
a study in mice reports has an apparent effect on myelination [Zhou & al., 2020]. There
appears to be an overarching link between spatial variation in IS thickness and traits of
CNS development.
RAX2 (rs76076446) is affecting the thickness of the IS layer more at the fovea (Effect
size = 0.31) than the periphery (Effect size = -0.09). Mutations in this locus have been
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linked to both cone and rod dysfunction [Yang & al., 2015] and retinitis pigmentosa, a
rod-cone disease [Van de Sompele & al., 2019]. These two diseases have distinct and
opposing patterns in which they affect the rods and cones. As stated in the introduc-
tion to this chapter, rods and cones have a specific localisation across the macula field
with rods found most densely populated in the periphery and cones found at highest
frequency in the foveal field. There appears to be a parallel between the spatial effects
of this locus on thickness of the IS and the organisation of PRC affected by the diseases
associated with this locus.
Table 5.6: List of SNPs differentially affecting the thickness of the IS at the three concent-
ric fields of the macula. List of SNPs with a significant z-score (P <0.05 following Bonferroni
correction) describing the differential effect on the IS thickness at the foveal (F), intermediate
(I) and peripheral (P) fields. The field (F1 or F2) and corresponding effect size from GWAS of
thickness in each field are listed alongside the Bonferroni adjusted p-value of the comparative
z-score. Each genetic variant is also annotated with nearest gene and any ocular and non-ocular
phenotypes previously associated with it.










Ocular phenotypes Non-ocular phenotypes
rs4587551 1 F I -0.24 -0.10 0.05 LRRC8D
rs78878924 4 F I 0.38 0.17 0.05 RUFY3
rs10479543 5 F I -0.14 -0.05 0.03 RUFY1





rs1990622 7 F I -0.23 -0.09 2.62E-09 TMEM106B Coronary artery disease,
Depression, Differential ageing
of the frontal cortex, Height,
Irritability, Loneliness, Mood
swings
rs56280639 8 F I 0.01 0.12 0.03 PRSS51 Strong meridian Anxious feelings/worrier,
Forced expiratory volume




width, White blood cell
count
rs141629142 9 F I 0.40 0.11 0.01 RORB
rs1409396 10 F I 0.13 0.06 0.02 PIP4K2A Frequency of walking for
pleasure, Platelet disrtibution
width, Sitting height
rs11200920 10 F I 0.12 0.02 4.33E-03 CDHR1








rs76076446 19 F I 0.31 0.05 9.47E-03 RAX2 Cone-Rod Dystrophy,
Macular degerenation,
Macular thickness
rs11701177 21 F I 0.15 0.07 0.02 ZNF295-AS1





rs4587551 1 F P -0.24 -0.04 1.38E-04 LRRC8D
rs6763422 3 F P -0.26 -0.06 1.05E-16 TSC22D3 Age started wearing
glasses
rs78878924 4 F P 0.38 0.02 5.67E-07 RUFY3
rs72761109 5 F P -0.02 0.08 2.26E-04 MAP1B Age started wearing
glasses
rs10479543 5 F P -0.14 -0.03 1.72E-03 RUFY1







Red blood cell traits
rs2749938 6 F P 0.11 0.02 5.98E-03 MED23





rs4731631 7 F P -0.10 -0.02 4.34E-03 UBE2H
rs141629142 9 F P 0.40 0.06 6.59E-04 RORB




rs1409396 10 F P 0.13 0.02 5.49E-07 PIP4K2A Frequency of walking
for pleasure, Platelet disrtibution
width, Sitting height
rs11200920 10 F P 0.12 -0.04 3.69E-10 CDHR1
rs1255910 14 F P 0.10 0.03 0.04 SYNE2 Facial aging, Hair
colour
rs887595 14 F P 0.08 0.20 6.19E-04 VSX2 Macular thickness Mean corpuscular volume/
haemoglobin,Red blood cell
width
rs1201689 15 F P -0.10 -0.01 1.56E-03 MAPKBP1
rs55634267 17 F P 0.20 0.05 7.81E-10 GNGT2 Spherical power Angina, Anthopometric traits,
Asthma, Coronary artery
disease, Forced expiratory
volume, High blood pressure,
Impedance of limbs
rs35638197 17 F P -0.31 -0.12 3.51E-04 GNGT3 Spherical power
rs76076446 19 F P 0.31 -0.09 1.27E-07 RAX2 Cone-Rod Dystrophy,
Macular degerenation,
Macular thickness
rs231235 19 F P -0.09 -0.01 4.94E-03 ARHGAP33
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Table 5.6: continued
rs11701177 21 F P 0.15 0.02 1.77E-07 ZNF295-AS1
rs2282526 21 F P 0.17 0.02 2.70E-11 RRP1B Blood pressure, Hayfever,
Hypertension, Red blood
cell traits
rs1463229 3 I P -0.18 -0.06 2.60E-08 TSC22D2 Age started wearing
glasses
rs1990622 7 I P -0.09 -0.02 3.82E-04 TMEM106B Coronary artery disease,
Depression, Differential ageing
of the frontal cortex, Height,
Irritability, Loneliness, Mood
swings




rs969060 21 I P 0.11 0.02 5.44E-06 RRP1B Blood pressure, Hypertension,
Red blood cell traits
Outer Segment
Numerous loci differentially affecting the thickness of the OS layer across the concentric
retinal fields were noted to have involvement in AMD (table 5.7). This included thewell
established AMD locus CFH [Klein & al., 2005] which has an increasingly strong effect
on the thickness of the OS layer as you move inwards from the peripheral field (Effect
size = 0.24) to the fovea (Effect size =0.64). As previously mentioned, CFH encodes
complement factor H. Complement is an integral part of the innate immune response,
aiding removal of bacterial and apoptotic cell debris as well as recruiting immune cells
to sites of infection [Landowski & al., 2019]. This is of note as the OS interfaces with
the RPE whose responsibilities include the disposal of waste from outer retinal layers.
Further loci associated with AMD that were also differentially affecting OS thickness
across the macular field includeARMS2 andHTRA1. These two genes are located in the
same region on chromosome 10. The two genes have a known effect on AMD [Kortvely
& al., 2010]. Both ARMS2 and HTRA1 effect the thickness of OS most strongly at the
fovea (Effect size = -0.75 and -0.74 respectively), with less of an effect as you move out-
wards towards the peripheral field (Effect size = -0.24 and -0.24 respectively). ARMS2
has been shown to be involved in proper function of the extracellular matrix and has a
suggested protective role against drusen formation [Kortvely & al., 2010]. HTRA1 is a
heatshock protease [DeWan & al., 2006] that is involved in the processing of extracel-
lular matrix proteins. It is thought that it may help regulate inhibitors of angiogenesis
and thus the neovascularisation seen in AMD [Lin & al., 2018]. AMD affects the central
retina and spares peripheral vision [Khurana, 2007]. The spatial effect of these loci on
127
thickness of the OS appears to correlate with the spatial effect of AMD across the retina.
Another interesting locus that is differentially affecting OS thickness across themacu-
lar field is RDH5 (rs3138142). RDH5 appears to affect the foveal and intermediate fields
to the same magnitude (Effect size = 0.76 and 0.78, respectively), and the peripheral
field less (Effect size = 0.32). This genetic variant has previously been associated with
a number of ocular phenotypes including macular thickness, pigmentary retinal dys-
trophy and spherical equivalent. RDH5 has also been shown to be involved in fundus
albipunctatus. Fundus albipunctatus is a form of night blindness that affects the rods
[Skorczyk-Werner & al., 2015]. RDH5 encodes 11-cis-retinol dehydrogenase which is ex-
pressed in the RPE and is an enzyme involved in the processing of the chromophore of
mammalian visual pigments [Lidén & al., 2001]. The OS is the storage location of pho-
topigments in the retina, and thus the differential effect of this locus on OS thickness
and its association with the photopigment production pathway is of note.
MERTK has close to no effect on the thickness of the OS in the peripheral field (Effect
size = 3.98 × 10-4), but a moderate effect at the intermediate field (Effect size = 0.13),
and an increased effect at the fovea (Effect size = 0.30). MERTK encodes a receptor
localised to the RPE surface, which interfaces with the OS. Mutations in MERTK have
been found in rod-cone and cone-rod dystrophies [Audo& al., 2018]. Again, the density
of rods and cones is different across the retina, with cones being found at high density
in the foveal field, and the rods being found most densely in the peripheral field. This
distribution of photoreceptors corresponds to the spatial observations of the effect of
this locus on thickness of the OS across the macula.
Table 5.7: List of SNPs differentially affecting the thickness of the OS at the three concent-
ric fields of the macula. List of SNPs with a significant z-score (P <0.05 following Bonferroni
correction) describing the differential effect on the OS thickness at the foveal (F), intermediate
(I) and peripheral (P) fields. The field (F1 or F2) and corresponding effect size from GWAS of
thickness in each field are listed alongside the Bonferroni adjusted p-value of the comparative
z-score. Each genetic variant is also annotated with nearest gene and any ocular and non-ocular
phenotypes previously associated it.










Ocular phenotypes Non-ocular phenotypes






rs4848901 2 F I 0.30 0.13 0.04 MERTK










rs72683442 1 F P -0.57 -0.29 1.41E-03 SLC16A1 Spherical power Birth weight






rs410895 1 F P 0.58 0.25 2.36E-07 CFHR2 Macular degeneration
rs4848901 2 F P 0.30 3.98E-04 2.07E-06 MERTK
rs288282 2 F P -0.28 -0.08 0.03 DNAJC10
rs1864251 2 F P -0.74 -0.34 1.33E-03 MREG
rs148388367 2 F P 1.25 0.51 3.70E-05 MREG




rs3750846 10 F P -0.75 -0.24 1.10E-12 ARMS2 Advanced age related
macular degeneration
rs60401382 10 F P -0.70 -0.24 1.11E-10 HTRA1 Macular degeneration Anthropometric traits, Basal
metabolic rate, Intelligence,
Stroke







cancer, Skin colour, Tanning,
Vitiligo

























rs142963458 16 F P -1.21 -0.69 0.04 MEAK7 Macular thickness
rs62125245 19 F P 0.44 0.11 1.95E-044 NXNL1
rs72683442 1 I P -0.49 -0.29 0.02 SLC16A1 Spherical power




rs148388367 2 I P 0.98 0.51 0.01 MREG





rs60401382 10 I P -0.46 -0.24 0.00376442 HTRA1 Macaulr degeneration

























Many of the loci with significantly different effects on the thickness of the RPE layer
across the fields of themacula had prior associationswith ocular traits (table 5.8). These
include OCA2 (rs1800407) which has a similar magnitude of effect on the foveal and
intermediate fields of the retina (Effect size= -1.20), but less of an effect on the periphery
field (Effect size = -0.75). OCA2 is a locus with well-known involvement in OCA. As
mentioned previously, OCA causes decreased amounts of pigment in the RPE, leading
to impaired visual acuity. This is in addition to foveal hypoplasia, the flattening of the
macular dip that also causes impaired vision. It is interesting to note that the increased
effect of the SNP corresponds to the shape of the macula dip. A similar pattern can be
seen for TSPAN10 (rs7405453), which has similar magnitude of effect on the foveal and
intermediate fields (Effect size =0.58 and 0.57 respectively), and less of an effect on the
peripheral field (Effect size = 0.27). TSPAN10, similarly to OCA2, is a locus involved in
pigmentation. These results suggest an interesting relationship between spatial effect of
pigmentation and retinal morphology.
Another locus that affects the RPE layer thickness differentially at the fovea compared
to the peripheral field is MREG. MREG has double the effect on the RPE thickness at
the fovea (Effect size = -1.24) compared to the peripheral field (Effect size = -0.45).
130
MREG has been shown to play a role in retinal health, regulating the homoeostasis of
OS degradation [Frost & al., 2013]. One of the main roles of the RPE is the disposal of
redundant PRC components. Therefore it is interesting to see a locus with a known role
in this pathway differentially affecting the thickness of the RPE across the macula field.
Table 5.8: List of SNPs differentially affecting the thickness of the retinal pigment epithelium
at the three concentric fields of the macula. List of SNPs with a significant z-score (P <0.05
following Bonferroni correction) describing the differential effect on the RPE thickness at the
foveal (F), intermediate (I) and peripheral (P) field. The field (F1 or F2) and corresponding
effect size from GWAS of thickness in each field are listed alongside the Bonferroni adjusted p-
value of the comparative z-score. Each genetic variant is also annotated with nearest gene and
any ocular and non-ocular phenotypes previously associated it.










Ocular phenotypes Non-ocular phenotypes
rs148388367 2 F P -1.24 -0.45 0.04 MREG




IOP, Myopia, Refractive error
Ankle spacing width,
Hair colour, Impedance
of leg, Macular thickness,
Tanning, Snoring



















Here, I have conducted the first large-scale GWAS of outer retinal layer thickness. In-
keeping with our analysis of the inner retina, the main GWAS were conducted on the
simple phenotype of mean thickness across the macula of the outer retinal layers - the
ONL, IS, OS and RPE - averaged across left and right eyes. Due to shared associations
between the three component PRC layer - the ONL, IS and OS - weremeta-analysed and
considered together in a single robust discovery list. The results of the RPE thickness
GWAS were considered separately due to the different cell type found in this layer. 59
loci were found robustly associated to one or more of the PRC component layers. Many
of these loci have prior associations with ocular phenotypes including refractive error
and age one started wearing glasses, in addition to ocular pathologies such as AMD
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and retinitis pigmentosa. There were also a number of genetic variants significantly
associated with the component PRC layer thicknesses that had no prior annotations.
These loci may warrant further investigation as to their role in eye biology. Similarly,
seven loci were found to be significantly associated with RPE thickness. These loci also
had prior associations with ocular pathologies including oculocutaneous albinism and
AMD.
MR analysis revealed support for a causal relationship between AMD and the thick-
ness of the RPE. A Steiger test confirmed the directionality to be AMD affecting RPE
thickness. The RPE is the layer under which drusen develop during AMD, causing
damage to the outer retina and subsequent visual impairment. Support was not found
for a causal relationship between outer retinal thickness as an exposure variable and
AMD as an outcome variable. These results mirror the relationship seen between in-
ner retinal thickness and glaucoma. It suggests that, although AMD causes thinning of
outer retinal layers as the disease progresses, the baseline thickness of the outer retinal
layers as determined by genetics is not indicative of risk for AMD development.
Enabled by the use of the ETDRS grid, I explored spatial differences of the effect of
genetic variants on outer retinal thickness. For each of the retinal layers, there were
notable differences in discovery of loci across each macular subfield, representative of
concentric circles outwards from the fovea. Further interrogation produced a compre-
hensive list of loci with differential effect on the retinal sub-fields for each outer retinal
layer. It must be acknowledged that this is highly exploratory research. In line with the
nature of such comparative statistical analyses, there is the risk that probabilistic chance
may have influenced the discovery of variants. However the loci discovered included
those with prior associations with ocular diseases such as inherited retinal dystrophies
and AMD. Interestingly, several of the loci also had prior associations to neurodevel-
opmental diseases such as multiple sclerosis and dementia. This highlights the role of
the eye in the CNS and the potential of using ocular imaging as a biomarker for a broad
array of diseases.
These results emphasize the additional biology explained by a more granular phen-
otype, that is enabled by the use of imaging data from the clinical segmentation grids.
A finer grain understanding of the spatial genetic effect on retinal morphology may
provide further understanding of the biological pathways underpinning ocular devel-
opment and pathology. Such finer grain representations of retinal morphology are ex-
plored in the following chapter.
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6. Higher Dimensional Phenotyping
The OCT images used throughout this thesis contain rich high dimensional data de-
scribing the morphology of the retina. Thus far in this thesis I have focused on studying
simple phenotypes which are already utilised in the clinical environment and which
have the advantage of being more easily interpreted when discussing clinical aspects of
results. I now explore more of the high-dimensional data afforded by OCT images, har-
nessing the pixel-wise information to study variation in retinal morphology at a finer
grain level. In doing so I aim to capture the continuous variation across themacula field,
enabling new and interesting biological findings.
There are several examples of high dimensional phenotypes frommedical images be-
ing used in conjunction with genetics to interrogate the biology of human organs. Not-
able examples include the use ofMagnetic Resonance Imaging (MRI) derivedmeasures
in GWAS that led to novel associations of 148 clusters of SNPs with brain structure and
function [Elliott & al., 2018]. This study bears similarity to ours in that we both aim
to use complex image derived phenotypes to study both general human biology and
disease. Another example includes a study of heart morphology that provided further
evidence as to the function of heart trabeculation [Meyer & al., 2020]. In this case, ma-
chine learning segmentation of heart MRI were used to identify phenotypes for use in
GWAS. Given these contributions, this high-dimensional complex phenotype approach
appears to hold value in making new biological discoveries.
The retina, as previously discussed, has a specific and highly organised structure
which is integral to its function. As well as being organised into a number of distinct
layers, the retina has complex topographical variation. The macula dip, a valley like
structure in the centre of the retina, is important to visual acuity. The distribution of
photoreceptors also varies across themacular field. At the central area of themacula, the
fovea, only cones are present which are responsible for high acuity colour vision in high
light levels. These reduce in density moving towards the peripheral retina. Conversely,
rods increase in density in the peripheral fields of the retina. The rods are responsible
for vision in low light levels, but lack colour definition [James & al., 2003].
Considering this interesting topography, examination of themorphology of the retina
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at a higher dimensionality provides new opportunities for biological discovery. This
was initially explored by analysing the ETDRS grid in chapter 5, where even increasing
the dimensionality of the data fromone to three provided new information about spatial
biological variation and its underlying genetics.
Therefore, looking at alternative representations of the eye is an interesting path of ex-
ploration to understand the genetic variation underlying a finer-grainmeasure of retinal
morphology. In this chapter, I present the techniques used to obtain these novel repres-
entations of retinal morphology, and explore the biology and genetics that underlies
them.
6.1. Maculagrams
To aid easy clinical interpretations of results within this thesis thus far, we collapse the
data describing retinal morphology from pixel-wide magnitude to a single measure per
retinal layer. In chapter 5 we utilisedmore of the data available from the TABS output to
expand the dimensionality and compare effects of SNPs on the thickness of outer retinal
layers at the foveal, intermediate and peripheral fields.
I now look to extend this in two stages. First I aim look at the spatial morphological
variation in the individual sections of the two segmentation grids, the Macula 6 grid
and the ETDRS grid. I then will study the underlying genetics of the variations across
the segmentation grids. As a reminder, the Macula 6 grid segments the macula into six
radial segments, excluding the fovea, and is generally used to study the inner retina. The
ETDRS grid is a nine space segmentation grid that resembles a bullseye and includes
the foveal field. It is mainly used to study the outer retina.
To enable this analysis, I created a novel visualisation technique for the macular area,
coined in the research group as maculagrams. These maculagrams allow the plotting of
principal component loadings and genetic effect sizes back into the macular grid space.
This enables visualisation of variation patterning across the macula.
6.1.1. Principal Component Maculagrams
To examine how retinal layer thickness is varying across the macular field, I calculated
the principal components (PCs) of the measurements that are the composite of the
single measures used in the simple clinical GWAS. These measurements comprise the
thickness of the individual retinal layers at each segment of either of the segmentation
grids - the Macula 6 or the ETDRS grid - across left and right eyes separately. The load-
ings of these PCs were mapped back into the original space in the plots we have termed
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maculagrams. The aim of this is to identify which areas of the macula are contributing
the most to morphological variation and interrogate any distinct spatial patterns.
Methods
PCA was conducted on three sets of measures. Firstly the thickness of the GCIPL and
RNFL at each of the sections of the Macula 6 grid in both the left and right eye (24
dimensions, figure 4.2B). Secondly the thickness of the ONL, IS and OS at each of the
sections of the ETDRS grid in both the left and right eye (54 dimensions, figure 5.2C).
And finally the thickness of the RPE at each of the sections of the ETDRS grid in both the
left and right eye (18 dimensions, figure 5.2C). In each case the measures were scaled
and centredprior to PCA. The loadings of the first 10 PCs for each is returned andplotted
back to the original grid space. The grids are oriented so that, for both eyes and both
segmentation grids, the easterly segments represent the temporal segments of the eye
(those closest to the ear) and the westerly segments represent the nasal sides (those
closest to the nose).
Results
There are several patterns of variation that are common to all three of the retinal areas.
Firstly, in each of the three retinal layers, one of the PCs corresponds to variation between
the left and right eyes. This is likely evidence of confounding caused by scan acquisition
order, as the right eye was consistently scanned first [Patel & al., 2016], introducing a
batch like effect. Further analysis of the difference between the two eyes can be found
in section 4.3. In the GWAS conducted in the previous chapters of this thesis, this is
controlled for by regressing out eye specific traits such as technical measures outputted
from the OCT machine and by making a mean across the two eyes.
Across the layers, several PCs also appear to occur in pairs. A feature of PCA is that
each PC must be orthogonal to one another. In the spatial PC analysis of each of the
three retinal areas, one of the first 10 PCs has been representative of variation between
left and right eyes. The presence of a PC representing this variation forces all other PCs
to honour this asymmetry. Therefore it is possible that some of the PCs represent the
same pattern of spatial variation, split across the two eyes.
Inner Retinal Principal Component Spatial Analysis
The first ten PCs of the inner retinal layer component thicknesses account for 90% of
variation (figure 6.1).
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The first PC appears to affect all components of the inner retinal thickness equally and
in the same direction. Comparatively the second PC appears to be driven by variation
between the left and right eye, as discussed above.
The third PC appears to be driven by variation between the two inner retinal layers,
the RNFL and the GCIPL. This is represented in the GWAS results where, although
there is a large crossover of significantly associated loci between the two layers, some
loci are uniquely associated with one of the layers.
Many of the other PCs show complex patterning of loadings. The fourth and sixth
PCs have an interesting pattern in that they appear to show differential and antagonistic
effect of the superior and inferior segments of the eye. Notably, changes in inner retinal
morphology across this midline are a key feature used in clinical glaucoma diagnosis

















Figure 6.1: Principal component analysis of inner retinal thickness and spatial mapping Prin-
cipal component analysis (PCA) was conducted on the thickness of the inner retinal layers - the
retinal nerve fibre layer (RNFL) and the ganglion cell inner plexiform layer (GCIPL) - at the
6 segments of the Macula 6 grid across left (L) and right (R) eyes. The variance explained by
each of the first ten principal components is plotted in the top panel. The loadings of the first ten
principal components are plotted back to the original Macula 6 grid space using maculagrams.
The saturation of colour indicates the magnitude of the effect a segment is having on a PC, with
direction of effect (red or blue) being arbitrary. The grids are oriented so that for both left and
right eyes the easterly segments represent the temporal segments of the eye, those closest to the
ear, and the westerly segments represent the nasal sides, those closest to the nose.
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Photoreceptor Cell Principal Component Spatial Analysis
The first 10 PCs of the PRC component layer thicknesses account for 83% of variation
(figure 6.2).
The first two PCs appear to be mostly driven by an antagonistic effect on the ONL
and IS compared to the OS. Although inverse of one another, the first two PCs share a
common pattern of variation. Considering that PCs are inherently orthogonal, the bio-
logy driving this variation can be assumed to be complex. Comparatively the third PC
appears to be affected by the IS and OS, more so by the IS, in the same direction, and the
ONL in the opposite direction. The three component layers of the PRC represent differ-
ent parts of the same cell. These results may therefore indicate a complex relationship
between the different parts of the PRC and their unique functions.
The fourth PC represents variation between the left and right eyes which, as noted in
the previous section, is likely evidence of confounding by scan acquisition order.
Other interesting patterning can be seen in PC6, where in the ONL and IS, there ap-
pears to be an antagonistic relationship between the peripheral fields of the macula and
the central foveal area. This finding may reinforce the results of the spatial GWAS con-
ducted on the PRC component layers, in which several loci were shown to affect the
foveal area, intermediate ring and peripheral ring differentially (section 5.5). This also
aligns with the spatial differences in PRC density across the macula, with cones being
more densely populated at the fovea, and rods being present in higher quantities in the
periphery [Purves & al., 2001].
Retinal Pigment Epithelium Principal Component Spatial Analysis
Following a PCA of the component thicknesses of the RPE in the segments of the ETDRS
grid across left and right eyes, the first two PCs explain 89% of variation (figure 6.3).
This is a stark pattern which may be due to the relatively uniform nature of the RPE
across the macula.
Similarly to the inner retina, the first PC is being influenced by all components of the
RPE in the same direction and to roughly the same magnitude. Again, the second PC is
representative of variation between the left and right eyes.
The third PC appears to be affected differentially by the peripheral field, as compared
to the intermediate field and the foveal field. This is supportive of the spatial effects seen
in the GWAS of these concentric fields in section 5.5. This aligns with the distribution
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Figure 6.2: Principal component analysis of the component photoreceptor cell layer thick-
nesses and spatial mapping Principal component analysis was conducted on the thickness of
the photoreceptor cell component layers - the outer nuclear layer (ONL), the inner segment (IS)
and the outer segment (OS) - at the 9 segments of the ETDRS grid across the left (L) and right
(R) eyes. The variance explained by each of the first ten principal components is plotted in the
top panel. The loadings of the first ten principal components are plotted back to the original
ETDRS grid space using maculagrams. The saturation of colour indicates the magnitude of the
effect a segment is having on a PC, with direction of effect (red or blue) being arbitrary. The
grids are oriented so that for both left and right eyes the easterly segments represent the tem-
poral segments of the eye, those closest to the ear, and the westerly segments represent the nasal
sides, those closest to the nose.
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There are several obvious examples of variation patterning that appear to have been
split into left and right eyes by the orthogonality of PCA as detailed above. For example
PC5 and PC6 appear to occur in a pair that represent the same pattern of spatial vari-
ation, just separated by eye. In this instance both PC5 and 6 show an opposing influence
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Figure 6.3: Principal component analysis of retinal pigment epithelium thickness and spatial
mapping Principal component analysis was conducted on the thickness of the retinal pigment
epithelium (RPE) layer at the 9 segments of the ETDRS grid across the left (L) and right (R)
eyes. The variance explained by each of the first ten principal components is plotted in the top
panel. The loadings of the first ten principal components are plotted back to the original ETDRS
grid space using maculagrams.The saturation of colour indicates the magnitude of the effect
a segment is having on a PC, with direction of effect (red or blue) being arbitrary. The grids
are oriented so that for both left and right eyes the easterly segments represent the temporal
segments of the eye, those closest to the ear, and the westerly segments represent the nasal sides,
those closest to the nose.
6.1.2. Higher Dimensional GeneticVariation
Considering the interesting patterns of spatial variation in morphology observed using
the maculagrams in the previous section, it can be hypothesised that the genetic vari-
ation underlying retinal morphology may be operating at a similarly high dimension. I
previously explored utilising PCA derived phenotypes to represent inner retinal mor-
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phology at a higher dimension in section 4.4. In that instance there was not a notable
increase in discovery power, most probably due to the cohort size. Therefore I opted
to use a simpler clinically utilised measure which aided easier interpretation. However,
exploring a higher dimensional space is an interesting route to further understand SNPs
discovered in the GWAS of the simpler phenotypes. Therefore I next analysed the way
in which the SNPs found to be significantly associated with the three retinal areas - the
inner retina , the PRC, and the RPE - are affecting the morphology of the layers compon-
ent areas across both eyes. This is a direct extension of the work in section 5.5 where I
looked at three dimensions of data per layer of the PRC. I nowmove to study dimensions
of 24, 54 and 18 for the inner retina, PRC component layers and RPE respectively.
Methods
The three areas of the retina were considered separately: the inner retina, the PRC and
the RPE. Firstly, the thickness of the component inner retinal layers, the GCIPL and
RNFL, at each of the sections of the Macula 6 grid across the left and right eyes (24
measures) were linearly modelled as a result of each of the 46 SNPs significantly associ-
atedwith the thickness of one or both of themeta analysed inner retinal layers. Secondly,
the thickness of the component PRC layers - the ONL, IS and OS - at each of the sections
of the ETDRS grid across left and right eyes (54 measures) was linearly modelled as a
result of each of the 59 SNPs significantly associatedwith the thickness of one ormore of
the meta-analysed component PRC layers. Thirdly, the thickness of the RPE at the com-
ponent sections of the ETDRS grid across left and right eyes (18 measures) was linearly
modelled as the outcome of each of the 7 SNPs significantly associated with overall RPE
thickness. In all of these models, height, age, weight, sex, ID of the OCT machine used
in the scan and the first 20 genotype PCs were used as covariates. The effect sizes of the
SNPs were plotted back into the original grid space from which they were calculated as
maculagrams. Once again the grids are oriented so that for both eyes and both grids,
the easterly segments represent the temporal segments of the eye, those closest to the
ear, and the westerly segments represent the nasal sides, those closest to the nose.
SpatialVariation of Genetic Effect on the Inner Retina
I observed various interesting patterns of variation in genetic effect on the inner retinal
layers across themacula field (figure 6.4). For several of the SNPs, a difference was seen
in their effect on the left and right eyes. For example, KIF6 (rs527871768, figure 6.4A),
IKZF1 (rs73348111, figure 6.4B) and ANGPT1 (rs11520750, figure 6.4C) all showed no-
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ticeably different effect size and direction between left and right eyes. The genetic effect
on the two eyes was explored in section section 4.3. The variation underlying this differ-
ential genetic effect is likely due to a lack of randomisation in the order that the left and
right OCT scans were taken, with the right eye routinely being taken first [Patel & al.,
2016], as discussed in section 6.1.1.
Some of the patterning delineates the effect of loci on a specific inner retinal layer.
GNB3 (rs5442, figure 6.4G) and SLC6A20 (rs17279437, figure 6.4H) have a stronger ef-
fect on the GCIPL than the RNFL. This is reflected in their p-values from the GWAS
of the individual layer, GNB3 was found significantly associated with GCIPL (P=2.36
× 10-13) but not in the RNFL (P=0.27), and SLC6A20 was found to have a much
stronger association with GCIPL (P=7.81 × 10-24) compared to the RNFL (P=1.23 ×
10-7). LINC00461 (rs17421627, figure 6.4K) shows the inverse pattern, in that it has a
stronger effect on the RNFL than the GCIPL. This is once again reflected in the p-values
obtained from the GWAS of the individual inner retinal layer. LINC00461 had a much
stronger association with the RNFL (P = 8.09 × 10-27) than the GCIPL (P=4.87 × 10-2).
RSPO2 (rs376067714 and rs13271359, figure 6.4 N and O respectively) shows a
slightly stronger effect on the nasal side (western side of the plot) of the RNFL than
the temporal side. The nasal side of the retina is the side from which the optic nerve
exits the eye [Freddo, 2018]. RSPO2 encodes R-spondin-2 which acts as an activator of
theWnt signalling pathway [Glinka & al., 2011]. RSPO2 has previously been associated
with retinal cell differentiation and definition [Takata & al., 2017]. This suggests a po-
tential involvement of this locus in the organisation of the neural structures within the
retina.
SpatialVariation of Genetic Effect on the Photoreceptor Cell Component Layers
Somedistinct patterns of spatial genetic effect on the component PRC layers can be noted
(figure 6.5). Firstly, there are several loci that appear to have much stronger effects on
the ONL compared to the IS and OS. These include LIN52 (rs1972564 and rs11159063,
figure 6.5 A and B respectively). The ONL comprises the cell body of the PRC, and is
also the location of the synaptic terminal [James & al., 2003]. LIN52 has previously been
linked to regulation of the cell cycle [Litovchick & al., 2011]. This speaks to the complex
relationship between the different sectors of the PRC and the developmental pathways
that underlie them.
RDH5 (rs3138144, figure 6.5C) shows an interesting pattern of effect on the ONL and
OS. In these layers the SNP appears to be affecting the foveal and intermediate ringmore






































Figure 6.4: Spatial variation of genetic effect on the inner retina across the Macula 6 grid,
illustrated as a maculagram The thickness of each inner retinal layer, both the retinal nerve
fibre layer (RNFL) and the ganglion cell inner plexiform layer (GCIPL), in each segment of the
Macula 6 grid across both left and right eyes was modelled as the outcome of each of the genetic
variants found significantly associated with mean inner retinal thickness. The effect sizes from
each of these models is plotted back into the Macula 6 grid space using maculagrams. 15 of the
46 SNPs are plotted here, selected based on interesting patterning. For each plot, the RNFL is
pictured at the top, and the GCIPL is pictured below. The grids are oriented so that for both left
and right eyes the easterly segments represent the temporal segments of the eye, those closest to
the ear, and the westerly segments represent the nasal sides, those closest to the nose.
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the genetic effect of RDH5 on the foveal, intermediate and peripheral areas separately.
RDH5 encodes a protein involved in the production of the human chromofore of visual
pigments[Lidén & al., 2001]. Also RDH5 is a gene known to be involved in fundus
albipunctatus, a form of macular dystrophy [Yamamoto & al., 2003; Xie & al., 2020].
Fundus albipunctatus is characterised by white lesions across the retina, excluding the
fovea [Skorczyk-Werner & al., 2015]. This differential spatial pathology aligns with the
spatial genetic effect we see in these results.
VSX2 (rs28488340, figure 6.5D), OSM (rs8138196, figure 6.5E), CCND1 (rs631695,
figure 6.5F) and FAAP100 (rs56737642, figure 6.5G) all show a similar pattern of genetic
effect across the macula. Each of the four loci have a stronger genetic effect on the ONL
compared to the IS and OS. Conversely, TSPAN10 (rs9910935, figure 6.5M) shows a
much stronger effect on the OS compared to the ONL and IS. Although part of the same
cell, the ONL, IS and OS each have different roles within the PRC. These patterns of
genetic effect are in keeping with layer specific roles within the PRC.
CCND1 also shows a pattern of effect on the ONL whereby it has a stronger effect
on the intermediate and peripheral fields of the macula compared to the fovea. This
genetic variant has previously been strongly associated with breast cancer. CCND1 en-
codes cyclin D1, a regulator of cyclin-dependent kinase that is involved in the control of
the cell cycle [Motokura & al., 1991]. This highlights the complex relationship between
development and disease and the potential insights that the eyes, as direct windows to
tissue of the CNS, could provide.
Additionaly TSC22D2 (rs1376026, figure 6.5O) shows an opposing effect on the thick-
ness of the ONL in the foveal field compared to the intermediate and peripheral fields.
This locus has previously been associated with the presence of tumours using linkage
analysis and has since been suggested to have roles in cellular metabolism and cell-cycle
regulation [Li & al., 2016]. The variant at this locus has also been previously associated
with basal metabolic rate, body mass and high blood pressure. Further investigation is
needed to fully elucidate the role of this genetic variant in retinal morphology.
ZNF281 (rs6673000, figure 6.5K) appears to affect the thickness of the intermediate
ring of the ONL more than the fovea and peripheral ring. ZNF281 encodes a zinc finger
transcriptional regulator which has been shown to be required for embryonic stem cell
development [Pieraccioli & al., 2016]. The locus has also previously been associated
with spherical power. This suggests spatial patterns of development that have effects
on retinal function.
AFAP1L1 (rs1109114 and rs1438692, figure 6.5I and J respectively) has a notably
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Figure 6.5: Spatial variation of genetic effect on the component photoreceptor cell layers
across the ETDRS grid, illustrated as a maculagram The thickness of each component photore-
ceptor layer, the outer nuclear layer, the inner segment and the outer segment, in each segment
of the ETDRS grid across both left and right eyes was modelled as the outcome of each of the
genetic variants significantly associated with mean inner retinal thickness. The effect sizes from
each of these models is plotted back into the ETDRS grid space using maculagrams. 15 of the
59 SNPs are plotted here, selected based on interesting patterning. For each plot, the layers are
organised from top to bottom as follows: the outer nuclear layer, the inner segment, then the
outer segment. The grids are oriented so that for both left and right eyes the easterly segments
represent the temporal segments of the eye, those closest to the ear, and the westerly segments
represent the nasal sides, those closest to the nose.
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areas of that layer, and this effect is antagonistic to the effect exerted on the other two
layers. COBL (rs12719025, figure 6.5L) also shows a milder form of this nasally local-
ised genetic effect. As previouslymentioned, the optic nerve exits the retina via the nasal
side of the retina [Freddo, 2018]. COBL has prior associations with spherical power and
total macular thickness. AFAP1L1 has previous associations with BMI, hearing diffi-
culties, hypertension and lung-related traits. The association with hearing difficulties
suggests a role of this locus in fine neuronal structure and development that provides
an interesting avenue for future research.
SpatialVariation of Genetic Effect on the Retinal Pigment Epithelium
The majority of SNPs associated with RPE layer thickness have a uniform effect across
the macular field and the two eyes (figure 6.6). There are two SNPs, METTL4
(rs7239443, figure 6.6B) and KIF16B (rs77561053, figure 6.6C), that show a distinction
between the left and right eyes, but once again this is likely an example of confound-
ing due to lack of randomisation in which eyes was scanned first. The simplicity of the
topographical genetic effect may be due to the fact that the RPE layer is comprised of
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Figure 6.6: Spatial variation of genetic effect on the retinal pigment epithelium across the ET-
DRS grid, illustrates as a maculagram The thickness of the retinal pigment epithelium in each
segment of the ETDRS grid across both left and right eyes was modelled as the outcome of the
genetic variants significantly associated with mean retinal pigment epithelium layer thickness.
The effect sizes from each of these models is plotted back into the ETDRS grid space using mac-
ulagrams. Three of the seven SNPs are plotted here, selected based on interesting patterning.
The grids are oriented so that for both left and right eyes the easterly segments represent the
temporal segments of the eye, those closest to the ear, and the westerly segments represent the
nasal sides, those closest to the nose.
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6.2. Extracting Higher Dimensional Phenotypes
Utilising more of the data extracted using the segmentation grids enabled novel discov-
eries about genetic effect on spatial morphology variation. However, even by analysing
the subsections of the TABS segmented grids, much of the rich data available in the OCT
images is ignored. Therefore, I developed image analysismethods to extract phenotypes
representing higher dimensional variation in retinal morphology from OCT images. I
aim to extract severalmeasures of retinalmorphology,mainly quantified as retinal thick-
ness, from rawOCT images fully utilising the pixel level information available. Studying
a finer grain phenotype enables analysis of the genetic effect on a more continuous and
detailed representation of retinal morphology.
6.2.1. Image Analysis Methods
To extract higher dimensional phenotypes, I segmented the two limiting membranes
of the retina, and from this calculated the overall retinal thickness. I also extracted an
additional phenotype measuring the total retinal thickness at the central fovea.
Input Images
RawOCT images were available for each of the ophthalmologically imaged participants
of the UK Biobank. Whereas the TABS derived phenotypes collapsed the available data
into a number of discrete values, information is available in the raw images at a pixel-
wise level. Each three-dimensional (3D) image is comprised of 128 B-scans, along the z-
dimension (figure 6.7). Each B-scan is comprised of 512A-scans, along the x-dimension.
Each A-scan has 650 values in the y dimension. In total, there are >40million pixel-wise
values per OCT image.
Segmentation of Retinal Limiting Membranes
To generate an initial phenotype, I segmented the limiting retinal membranes from the
raw OCT images. First a running median, with window size of three, is applied to the
intensity values for each A-scan per B-scan. The median intensity of the A-scan is sub-
tracted from this vector, and the absolute value calculated, resulting in a normalised
intensity vector per A-scan. A threshold is set as the median of this normalised in-
tensity vector plus two times the standard deviation of the vector. The maximum and
minimum indices of the values that pass the threshold are considered the preliminary
limiting membrane positions (figure 6.8 A).
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Figure 6.7: Dimensions of raw OCT image data A single slice of an OCT image, or B-scan, has
512 pixel values in the x dimension, and 650 pixel values in the y dimension. y × z dimension
are known a the A scans. There are 128 B-scans per OCT image.
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Having identified the preliminary position of the limiting retinalmembranes for every
A-scan in a B-scan, the vector of the segmented surface for the outer and inner limiting
membranes are considered separately. For each surface vector across a B-scan, a run-
ningmedian is calculated with a median window of 51. The derivative log spread of the
membrane vector was calculated as a measure of the noise between consecutive data
measurements. Where the preliminary value of the limiting membrane was outside of
a confidence interval - defined as the running median value ±three times the derivative
log spread - the original value was replaced with the interpolated value (figure 6.8 B).
This two step process was performed to minimise noise and attempt to model a more
consistent gradual change in thickness across the macula. The result of this process is
two vectors, representing the inner and outer limiting membrane of the macular retina
for a B-scan. This process was repeated for every B-scan. This creates a 3D segmen-
ted representation of the retinal limiting membranes (figure 6.8 C). For each limiting
membrane, we have 65,536 values describing their locations.
A B C
Figure 6.8: Segmentation of retinal boundaries The main stages of identifying the limiting
membranes of the retina from raw OCT images. A) A running median of intensity is calculated
along each A-scan for every B-scan, and the median intensity across the overall A-scan subtrac-
ted, the absolute values of which are plotted as the black line. A threshold is set as themedian of
this vector plus two times the standard deviation, plotted as the dotted line. The maximum and
minimum values that pass this threshold are considered the limiting membranes of the retina,
the positions of which are plotted as yellow lines. B) Having selected the limiting membrane for
eachA-scan across a B-scan, the data outside of band specific noise confidence intervals are inter-
polated to smooth the line. C) This smoothed line is used as the segmented limiting membranes
of the macular retina.
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New High Dimensional Measures
As an initial high dimensional phenotype, the total retinal thickness across the macula
was calculated for every pixel dimension. This was done by calculating the difference
between the two segmented retinal limiting membranes. This resulted in 65,536 meas-
ures of total retinal thickness per 3D image.
To look at the genetic effect on this high-dimensional phenotype, participants were
stratified by genotype into three groups at each locus of interest: homozygous refer-
ence, heterozygous and homozygous alternative (labeled as 0, 1 and 2 respectively).
The mean total retinal thickness at each pixel-wise location of the macular area was cal-
culated across each genotype group. I next compared the phenotype between the gen-
otype groups using the homozygous reference as the baseline. It should be noted that
the assignment of reference and alternative allele is arbitrary and the alternative allele
does not necessarily refer to the derived allele. For each SNP, two phenotype matrices
were calculated. The difference between themean retinal thicknessmatrix of the hetero-
zygous genotype groupwas subtracted from that of the homozygous reference, labelled
as ”0 to 1”. The homozygous alternative mean retinal thickness matrix was subtracted
from the homozygous reference, labelled as ”0 to 2”. The resulting matrices are plotted
as heatmaps.
Results
On initial examination of the resulting heatmaps, several spatial patterns of morpho-
logical variation were notably different between the genotype groups. I observed that
for several of the SNPs, there is noise within the heatmap visualisation. This is seen as
vertical stripes in the heatmaps. This is likely an artefact of scan acquisition and im-
age processing, which in both cases is done in a slice-wise manner through the retina.
Another observation was that, for multiple SNPs, changes in the morphology between
genotype groups was localised to the fovea. This suggested that these genetic variants
were affecting the overall thickness of the retina at the fovea differentially to the rest
of the retina. Several SNPs also appeared to have an effect on overall retinal thickness
localised to a ring enclosing the fovea. These results are explored in more detail below.
Central Foveal Thickness Phenotype
Following observation of a foveal localised genetic effect upon visualisation using the
heatmaps, I looked to explore the differential genetic effect on total retinal thickness at
the fovea as compared to the rest of the macula. To do so a measure of retinal thickness
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at the centre of the fovea was calculated. The vectors representing the thickness at the
central cross-section of the macula in both the x and z dimensions in the left eye were
identified. A spline was applied to each of these vectors. Two values of total retinal
thickness at the central fovea were defined as the value at the midpoint of both these
vectors. These values were modelled as the outcome of each of the SNPs found to be
associated with the three retinal areas - the inner retina, the PRC and the RPE. The
first 20 genotype PCs were included as covariates in the models. Loci were considered
significantly associatedwith the central foveal thickness phenotype if P>0.05 formodels
of both the x and z dimension value following Bonferroni correction formultiple testing.
6.2.2. Higher Dimensional Analysis of the Inner Retina
Each of the SNPs found significantly associated with the meta-analysed inner retinal
layers were used as input into the above stratification analysis. Three loci were found
to be significantly associated with the central foveal thickness phenotype. These were
OCA2 (rs1800407)TYR (rs1042602), andTSPAN10 (rs7503894). Comparing their effect
on retinal thickness against a control genetic variant - the SNP with the lowest p-value
in the inner retinal thickness GWAS which was not significantly associated with central
foveal thickness - using visualisation by heatmaps highlights the fovea localised effect
(figure 6.9).
To better visualise the spatial effect of these SNPs on overall retinal thickness,
the cross-section through the central macula was plotted stratified by genotype (fig-
ure 6.10). As compared to a control (IGFBP3, figure 6.10 A), in which there is no notice-
able separation between the genotype groups in terms of overall retinal thickness, the
three loci significantly associated with the retinal thickness at the fovea show a notice-
ably different pattern. The majority of differentiation in total retinal thickness between
genotype states appears to occur at the fovea, with smaller or no differences at the mac-
ula shoulders and peripheral areas.
This foveal localised pattern of effect noted using the central foveal thickness bears
similarity to the rare clinical condition of foveal hypoplasia. Foveal hypoplasia clin-
ically refers to a shallower foveal dip, and a consequently thicker retinal thickness at
the fovea. Foveal hypoplasia is the result of underdevelopment of the foveal dip, due to
lack of excavation of the inner retinal layers. Foveal hypoplasia is commonly seen in sev-
eral conditions including OCA [McAllister & al., 2010]. Both TYR and OCA2 are well-
studied OCA genes. The SNPs associated with retinal thickness are not those found
previously mutated in oculocutaneous albinism but are common variants. As previ-













Figure 6.9: Difference in overall retinal thickness of groups stratified by genotype at loci asso-
ciatedwith inner retinal thickness The overall retinal thickness is calculated across themacular
field for each participant in the left eye. The participants are stratified by genotype, homozygous
reference, heterozygous or homozygous alternative (encoded 0, 1, and 2 respectively) at each of
the loci found to be significantly associated with inner retinal thickness. The mean retinal thick-
ness of each of these groups is calculated. The difference in thickness between the homozygous
reference and heterozygous (0 to 1), and homozygous reference and homozygous alternative (0
to 2) are calculated and plotted as heatmaps. IGFBP3 (rs11762530), the control, was not signific-
antly associated with total retinal thickness at the foveola. TYR (rs1042602),OCA2 (rs1800407)
and TSPAN10 (rs7503894) were all found to be significantly associated with total retinal thick-
ness at the central fovea.
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Figure 6.10: Cross-section of mean total retinal thickness stratified by genotype state. The
mean total retinal thickness at the central cross-section of the retina in the z-dimension across
groups stratified by the genotype state. The three genotype states are homozygous reference (0),
heterozygous (1) and homozygous alternative (2). Stratified by genotype state at: A) IGFBP3
(rs11762530), the variantwith the lowest p-value aside fromTSPAN10 in the inner retinal GWAS,
used as a control. B) TYR (rs1042602), C) OCA2 (rs1800407) D) TSPAN10 (rs7503894). The
y-axis represents the overall retinal thickness.
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ocular albinism [Campbell & al., 2019]. Ocular albinism displays the same ocular phen-
otypes as OCA, including foveal hypoplasia, but not the pigmentation phenotypes. In
spite of this, both TYR and OCA2, in addition to TSPAN10 share prior associations to
pigmentation.
To test this association between pigmentation and the central foveal thickness trait,
the hair colour by percentage of the population stratified by genotype at these three loci
was plotted (figure 6.11). To confirm the link of these loci to pigmentation, a model of
SNP effect on hair colour was built. Self-reported hair colour within the UK Biobank,
excluding red hair, was numerically encoded from light (blonde) to dark (black) and
the effect of the three SNPs determined by linearly modelling their effect with the first
20 genotype PCs as covariates. All three loci were significantly associated with hair
colour. Interestingly, the direction of effect was not consistent across the three loci. For
bothTYR andTSPAN10, the allele associatedwith increased central foveal thicknesswas
associatedwith lighter hair colour. The genetic variant at TSPAN10 in particular appears
to follow a classic dominant recessive model. Conversely, in the case ofOCA2, the allele
associated with increased central foveal thickness was associated with darker hair. This
result hints at the complex relationship between foveal morphology and pigmentation.
TYR OCA2 TSPAN10




















Figure 6.11: Hair colour proportions within the population stratified by allele state. Percent-
age of self-reported hair colour within each group, defined by their stratification based on gen-
otype state at loci significantly associated with central foveal thickness. From left to right: TYR
(rs1042602), OCA2 (rs1800407), TSPAN10 (rs7503894).
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The clinical condition of foveal hypoplasia which shows acute thickening of the cent-
ral fovea is often associatedwith poor visual acuity. Therefore I proceeded to explore the
functional impact of this milder central foveal thickness phenotype seen above. There-
fore the 46 SNPs significantly associated with inner retinal thickness were checked for
association with visual acuity. To do this, the effect of each of the 46 SNPs on the log-
MAR score was linearly modelled with the first 20 genotype PCs included as covariates.
Three of the loci were found to be significantly associated with visual acuity following
Bonferroni correction for multiple testing. These three loci were the same loci that were
significantly associatedwith the central foveal thickness phenotype. It is of great interest
that only the three loci that significantly display the foveal localised effect on thickness
appear to also affect a change in function.These results show that common variants in
disease loci show milder versions of the disease phenotype, both structurally and func-
tionally.
It should be noted that other patterns of high dimensional spatial variation may also
be affected by genetic variants. For example, in addition to the effect of the TSPAN10
locus localised to the fovea, there appears to be an effect on the intermediate concentric
field, presenting as a dark ring around the fovea (figure 6.9). Future research would be
needed to find a quantitativemeasure of this effect and thus test for significant examples
of this pattern.
6.2.3. Higher Dimensional Analysis of the Photoreceptor Cell Layer
Visualisation of the spatial genetic effect again led to the observation that several SNPs
appear to have a differential effect on total retinal thickness at the fovea compared to the
rest of the macula. Therefore, the genetic variants found significantly associated with
the thickness of the component PRC layers were each used to model the total retinal
thickness at the central fovea. Of the 59 SNPs tested, four were found to be associated
with this measure. The effect of these SNPs on the total retinal thickness across the
macula is visualised in heatmaps (figure 6.12). A distinct difference in pattern can be
seen between SNPswith no association (LIN52, rs1972564, the locuswith the smallest p-
value in the PRL GWAS), and those significantly associated with total retinal thickness
at the foveola, TYR (rs28620862), FAAP100 (rs56737642) and TSPAN10 (rs62075724
and rs9910935).
TYR and FAAP100, are both known pigmentation loci, with previous associations to
hair and skin colour. FAAP100 is also in LD with the two SNPs associated with cent-
ral macula thickness at TSPAN10. The three SNPs at this locus are likely an example















































Figure 6.12: Difference in overall retinal thickness of groups stratified by genotype at loci
associated with photoreceptor cell layer thickness. The overall retinal thickness is calculated
across themacular field for each participant in the left eye. The participants are stratified by gen-
otype, homozygous reference, heterozygous and homozygous alternative (encoded 0, 1, and 2
respectively) at each of the 59 loci found to be significantly associated with photoreceptor layer
thickness. The mean retinal thickness of each of these groups is calculated. The difference in
mean thickness between the homozygous reference and heterozygous (0 to 1), and homozygous
reference and homozygous alternative (0 to 2) are calculated and plotted. LIN52 (rs1972584),
the control, was not significantly associated with total retinal thickness at the foveola. TYR
(rs28620862), FAAP100 (rs56737642) and TSPAN10 (rs62075724 and rs9910935) were all found
to be significantly associated with total retinal thickness at the central fovea.
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Similarly to the analysis of the SNPs associated with inner retinal thickness, these res-
ults highlight the complex relationship between retinal structure in particular central
foveal thickness, and pigmentation.
Once again, an additional pattern of effect is localised to a ring surrounding the fovea
for the TSPAN10 variants. This effect requires further investigation in the future.
6.2.4. Higher Dimensional Analysis of the Retinal Pigment Epithelium
Visualisation of the effect of genetic variants associated with RPE thickness on total ret-
inal thickness across macula highlighted a differential effect at the fovea as compared to
the rest of the macula. Three of the loci associated with RPE layer thickness were found
to be significantly associated with total retinal thickness at the central fovea. The fovea
specific changes are starkly noticeable when comparing to those not significantly asso-
ciated (KIF16B, rs77561053) (figure 6.13).These include the TYR (rs1126809) andOCA2
(rs1800407), well-characterised oculocutaneous albinism genes recurrently discovered
across the retinal areas. Additionally, a variant at the CFHR1 (rs61822227) locus was
also found to be significantly associated with differential total retinal thickness at the
central fovea. CFHR1 is known to play a role in AMD, a condition that causes progress-
ive loss of vision. As AMD mainly affects central areas of the macula, this spatial effect
aligns with genetic effect on the thickness of the retinal epithelium seen here. This again
highlights an interesting relationship between common variation causing mild spatial
effects and disease phenotypes.
6.3. Discussion
In this chapter, I explored the biological variation in retinal morphology at a higher di-
mensionality, and looked at the genetics underlying these more granular phenotypes.
To do this, I developed a technique, termed maculagrams, for visualising and assess-
ing the morphological variation across the macula field and the genetics underlying it.
I then developed image analysis techniques that can extract high dimensional pheno-
types from the raw OCT images, taking further advantage of the higher dimensionality
available within the data. The combined application of both of these analyses enabled
novel findings about retinal morphology and genetics.
Themaculagrams allowed for identification of several interesting patterns ofmorpho-
logical variation in retinal layer morphology across the macular field. Common to all
of the layers, a considerable source of variation in layer thickness appears to be differ-
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Figure 6.13: Difference in overall retinal thickness of groups stratified by genotype at loci
associated with retinal pigment epithelium layer thickness. The overall retinal thickness is
calculated across the macular field for each participant in the left eye. The participants are strat-
ified by genotype, homozygous reference, heterozygous and homozygous alternative (encoded
0, 1, and 2 respectively) at each of the 7 loci found to be significantly associated with retinal
pigment epithelium layer thickness. The mean retinal thickness of each of these groups is calcu-
lated. The difference inmean thickness between the homozygous reference and heterozygous (0
to 1), and homozygous reference and homozygous alternative (0 to 2) are calculated andplotted.
KIF16B (rs77561053), the control, was not significantly associated with total retinal thickness at
the foveola. TYR (rs1126809), OCA2 (rs1800407), and CFHR1 (rs61822227) were all found to
be significantly associated with total retinal thickness at the central fovea.
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variation results from the lack of randomisation of order of eye scans. The protocol was
designed so that the right eye was consistently scanned first, and the left eye second. It
is likely that this has produced a batch-like effect, caused by differential light exposure,
eye dryness, blinking behaviour and other eye-specific scanning responses. There may
be biological variation underlying these differences, as suggested blinking response or
adaptation to reduced light levels. However in this instance, this is not the variation we
wish to investigate, so the best option was to control for it. In an ideal situation, the or-
der in which the left and right eyes were scanned would have been randomised, which
would allow for us to identify if the left-right eye variation had a biological basis or was
a result of measurement order.
Some of the PCs representing variation in retinal thickness across the macula field
appeared to cluster into pairs representative of the same spatial patterning, but split by
eye. This is due to the nature of PCA in which all resulting PCs must be orthogonal to
one another [Pearson, 1901]. Considering that for each retinal area, one of the first PCs
represented between eye variation, this forces all other PCs to respect this asymmetry.
Therefore it can be assumed that several of the PCs occur in pairs that represent the
same pattern of variation, but across the two eyes separately. This makes interpretation
of the visualisation technique less intuitive. Therefore in the future it would be inter-
esting to explore other methods of dimensionality transformation that do not assume
orthogonality of the resulting dimensions.
The use of maculagrams also allowed for interesting observations on the spatial ge-
netic effects on retinal layer thickness. Some patterns of note include a differential effect
of SNPs on the thickness of both the inner retinal layers and the component PRC layers
at the fovea compared to the peripheral macula. The structure of the macula dip var-
ies radially. Additionally the distribution of the two forms of PRC, the rods and cones,
varies in a concentric pattern from the fovea outwards. Some diseases affect only one
type of PRC and loci associated with such diseases - including fundus albipunctatus
and AMD - were found to exhibit this distinctive genetic effect across the macula field.
The alignment of the pattern of genetic effect of these SNPs on retinal layer thickness
with the shape of the macular dip and PRC distribution suggest a relationship between
retinal disease, common variants at disease loci, and retinal structure.
Moving to an even higher dimensional representation of the macular space that util-
ised the pixel-wise information available in OCT images revealed new insights into the
complexities of retinal morphology. This is highlighted by the results showing the dif-
ferential effect of multiple SNPs at the fovea as compared to other areas of the macula.
Several of the loci associated with total retinal thickness at the central macula were also
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associated with visual acuity. Some of these loci are known to be involved in optical
pathologies including OCA or its milder form, ocular albinism [Campbell & al., 2019].
In these conditions, foveal hypoplasia, the underdevelopment of the foveal dip and sub-
sequent thicker centralmacula, occurs. The foveal localised thickness represented by the
central foveal thickness phenotype may exist on a spectrum that also includes the rare
and more acute condition of foveal hypoplasia. This analysis appears to have identi-
fied common variants at loci associated with rare disease that present with phenotypes
related to the disease phenotype. This highlights the continuum between rare and com-
mon variation. It is probable that the milder phenotypes are often not recognised due
to the lower impact, but that they are still affecting retinal function.
Further, the discovery of central foveal thickness being affected by genetic variants
that also affect retinal layer thickness - with links to pigmentation and visual acuity -
suggests that the thickness of the central fovea may be confounding measures of retinal
thickness. This is of importance in several instanceswhere retinal layer thickness is used
as a biomarker of disease. In the future, the genetic variants could be controlled for to
gain more accurate retinal layer thickness measures. Alternatively, the way in which
the scans are conducted could be altered or the macula field better modelled to exclude
more of the central foveal field, minimising the effect of the central foveal thickness on




In this thesis, I have conducted the first large-scale GWAS of individual retinal layer
thicknesses. This has elucidated a number of genetic variants significantly associated
with retinal morphology. A portion of these genetic variants are novel, with many oth-
ers having prior associations to ocular and general biology. By employing MR on the
outcome of my GWAS, I have been able to interrogate commonly observed correlations
between clinical traits. I have also demonstrated the discovery power enabled by util-
ising high-dimensional phenotypes derived from medical imaging.
7.1. Summary of the main findings
The key results of this thesis are:
• I explored the range of available phenotypes extracted from OCT images to de-
scribe retinal morphology. I showed that a simple measure of mean thickness
across the macula and across both eyes provides comparable genetic discovery
power to measures derived from higher dimensional morphological measures.
This is likely owing to the large size of the UK Biobank dataset. The use of the
simple measure is also beneficial in terms of ease of interpretation as it is a meas-
ure more closely aligned with that used in routine clinical examinations.
• In chapter 4 I conducted the largest GWAS of inner retinal thickness as extrac-
ted from OCT images. As a result I found 46 genetic variants associated with
the thickness of one or both of the inner retinal layers, the RNFL and the GCIPL.
Many of these loci had prior associations to ocular phenotypes. There were also
loci discovered with prior associations to anthropometric and blood related-traits,
asthma and neurodevelopmental conditions. Additionally a number of the SNPs
were novel, with no prior associations to ocular or general biological phenotypes.
• Later in chapter 4, usingMR, I found evidence for a causative relationship between
POAG and IOP, consistent with the treatment of POAG through the lowering of
IOP via medication or surgery. In contrast, MR did not provide evidence for a
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causal relationship between inner retinal thickness and POAG, suggesting they
do not share the same underlying genetic pathway. This is in contrast to the use
of inner retinal thickness as a diagnostic biomarker of POAG. These results indic-
ate that a genetically determined thinner inner retina does not predispose one to
glaucoma, rather it is the thinning of the inner retina over time that is symptomatic
of glaucoma.
• In chapter 5 I conducted the largest GWAS of outer retinal layer thicknesses to
date, including the thickness of the ONL, IS, OS and RPE layer. In total this led
to the discovery of more than 100 loci associated with one or more of these layers.
The ONL, IS and OS were jointly meta-analysed as they constitute subsections of
the PRC. This resulted in 59 loci significantly associated with one or more of the
layers of the PRC. Seven loci were discovered to be significantly associated with
RPE thickness. In both cases, discovered loci included those previously associ-
ated with ocular phenotypes and general biology. Each GWAS also found novel
genetic variants with no prior associations. Using MR, support was shown for a
causal relationship between AMD and RPE thickness but not between AMD and
the other outer retinal layers.
• In the latter half of chapter 5, I explored expanding the dimensionality of the data
we use to describe outer retinal morphology from one measure to three. Moving
from the mean thickness across a retinal layer, to the thickness in the peripheral,
intermediate and foveal fields of the retina, provided novel discoveries about ge-
netic variation driving both intra and inter-layermorphological variation. Numer-
ous loci were discovered to be differentially affecting the retinal fields of the PRC
component layers and the RPE layer. These included loci associated with retinal
disease such as cone-rod dystrophy, already known to have a disease process with
spatial variation.
• In chapter 6 I developed a visualisation technique, maculagrams, that allow for
visualisation and identification of variation patterns across the macula field as
defined by clinical segmentation grids. Thesemaculagrams enabledme to explore
variation at two levels. First, the variation in retinal morphology across the mac-
ula field. Second, the differential effect of genetic variants on retinal morphology
across the macula field. These maculagrams enabled visualisation of the complex
patterns in which morphology of the retinal layers was varying. There were also
several notable patterns of spatial genetic effect on the thickness of the retinal lay-
ers across the macular field. This includes a differential effect of several loci on
162
the thickness of retinal layers at the fovea compared to the peripheral macula. The
macula dip varies radially, as does the distribution of rods and cones across the
macula. Some of the loci found to affect retinal thickness in this pattern had prior
associations with ocular diseases that affected a particular type of photoreceptor
cell.
• Later in chapter 6, I further developed image analysis techniques that extracted
phenotypes from OCT images, taking advantage of the pixel-wise data to gener-
ate more granular representations of retinal variation. These phenotypes describe
overall retinal thickness across the macula. I explored how this measure was in-
fluenced by the genetic variants I found associated with individual retinal layers.
I discovered a novel population level trait, a fovea-localised change in total retinal
thickness that bears resemblance to foveal hypoplasia, a clinical trait previously as-
sociated withMendelian disease. Several loci that affected individual layer retinal
thicknesses were associated with the central foveal thickness trait, and the same
loci were associated with pigmentation and visual acuity. However interestingly
the direction of the effect of hair colour relative to direction of effect of the central
foveal thickness was not consistent across loci. Meanwhile the direction of effect
of visual acuity and the effect of the central foveal thickness remained consistent
across SNPs. Some of these loci are known to be involved in ocular pathologies
including, OCA which causes severe foveal hypoplasia, and ocular albinism, a
partial form of OCA.
7.2. Conclusions
7.2.1. Implications in understanding of ocular disease
Despite the use of inner retinal thickness as a biomarker for glaucoma, MR analysis did
not find evidence to support a causal relationship between the measure and the disease.
This does not diminish the value of inner retinal thickness as a biomarker of glaucoma,
but rather informs us of the mechanism underlying disease progression. These results
suggest that whilst thinning of the inner retina is indicative of glaucoma, a genetically
determined thinner retina does not increase susceptibility to the disease. It is a change
in thickness over time that is of diagnostic importance. This findingmay help efficiently
direct therapeutic research and diagnosis (discussed further in section 7.4).
A similar relationship is seen between AMD and the thickness of the outer retinal lay-
ers excluding the RPE. Despite the thinning of the PRL during the progression of AMD,
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MR found no evidence for them being on the same genetic causal pathway. This sug-
gests that whilst PRC thinning is seen as a result of AMD, genetically determined PRC
thickness does not alter the risk of developing the disease. There was however evidence
of a causal relationship between RPE thickness and AMD, when AMD is used as the
exposure variable and RPE as the outcome. This is in-keeping with the development of
drusen, lipid deposits characteristic of AMD, occurring under the RPE.
The analysis presented in this thesis has identified common variants at loci associated
with rare disease that present with phenotypes that appear to be on the same spectrum
as the disease phenotypes. Specifically, the loci with prior associations toOCA, a disease
marked by foveal hypoplasia, were found associated with a mild localised change in
thickness at the centre of the fovea in our population. This discovery suggests there is
a continuum between rare and common variation. This is coupled with the effect of
the same loci on visual function as measured by visual acuity. It is likely that milder
phenotypes often go unrecognised due to their lower impact, but that they maintain an
effect on retinal function.
Beyond this, variants were found to be associated with both mean thickness of indi-
vidual retinal layers and the central foveal thickness trait at the loci that cause clinical
foveal hypoplasia. This suggests mild central foveal thickening may be affecting the
measurement of individual layer thicknesses. This is particularly pertinent in the in-
ner retina, where this mild central foveal thickening may be confounding inner retinal
thickness measures that are used as a biomarker for glaucoma. There are several ways
in which this could be accounted for; either through controlling for the genetic variants
associated with the central foveal thickness trait when using inner retinal thickness to
diagnose glaucoma. Alternatively, by excluding a larger field surrounding the fovea,
or modelling the macula differently, it may be possible to minimise the effect of this
phenotype on inner retinal thickness measures. Both of these theories require further
exploration but offer interesting avenues of research to improve the diagnostic efficiency
of glaucoma.
7.2.2. Strengths of high-resolution biomedical imaging
The analysis within this thesis discovered loci associated with the thickness of each of
the retinal layers. Of these, numerous loci had prior associations to visual function.
This highlights the role of morphology in function, the specificity of ocular structure,
and the potential for using non-invasive methodologies that can monitor morphology
to diagnose and manage disease. In particular the association of several of the SNPs
with both inner retinal thickness and neurodevelopmental traits reiterates the eyes’ role
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within the CNS and its potential role as a source of biomarkers for complex neurological
conditions.
Equally the exploration of genetic effect on themorphology of the retinal layers across
the macula field has provided evidence that there is both inter- and intra-layer variation
that is affected by genetic variation. The ability ofOCT to visualise the 3D space provides
a rich source of data that allows formodelling of the continuous topographical variation.
Further investigation may help us better understand development of the eye, and the
intricacies of disease that have spatial effects (discussed further in section 7.4).
Further, analysis of the three layers constituting the PRC has offered a unique op-
portunity. Although OCT imaging does not offer single cell resolution, the measures
extracted from the images are describing the sub-structures of cells. This allowed me
to study the micro-structures of the retina. The genetic variation we see underlying the
specific sub-structures of this cell type speaks to the incredible specificity of retinal struc-
ture and function. This analysis highlights the discoveries enabled by high-resolution
biomedical imaging in progressing our understanding of developmental processes, cell
biology and function.
7.3. Limitations of the analysis and potential improvements
The scope of this research allowed us to look at the effect of genetic variation on the
retinal morphology in a population with large statistical power. This was largely en-
abled by the richness and size of the UK Biobank dataset. However, the dataset and
thus the analysis was not without limitations. One limitation to studying the morpho-
logy of the human retina using this dataset is the ability to comprehensively interrogate
any asymmetry between left and right eyes. When exploring potential phenotypes that
could be used to represent inner retinal morphology, the thickness of the left and right
eyes were used as separate input into GWAS (section 4.3). Although the results were
largely congruent between the two eyes, there was some discrepancy. This discrepancy
was also seenwhen looking at the high dimensional data describing retinalmorphology
in chapter 6. However the data acquisition protocol consistently scanned the right eye
first, introducing a scan acquisition confounder. Therefore any variation grounded in
biology is inseparable from that due to scan acquisition confounding. It would be inter-
esting to be able to interrogate any asymmetry further and investigate if there are some
biological groundings to the differences that can be observed in left and right eye mor-
phology. For this to be possible, a dataset would be necessary in which scanning of the
left and right eye has been randomised so that the confounding due to scan acquisition
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can be minimised.
A strength of the UK Biobank cohort in the analysis presented was that the popu-
lation was not selected on the basis of having a disease, meaning that we were able to
look at the natural variation in morphology of the human retina. However several of
the hypotheses that this analysis generated require cohorts of individuals with rare dis-
ease, preferably of similar scale and phenotype depth. Unfortunately such cohorts are
rare which has limited follow up on some findings including the potential role of these
morphological measures as biomarkers (discussed further in section 7.4) . As the UK
Biobank population ages, some may present with these currently rare diseases making
the proposed hypotheses testable.
7.4. Outlook and future research
The research presented in this thesis has been enabled by the increasing number of
biobanks that contain coupled human phenotypic and genotypic information. Amongst
this phenotypic information, image data provides a non-invasive but rich method of
phenotyping humans, both in the research arena, but also in a clinical setting. OCT im-
ages of the eye are routinely collected in the clinic as well as by primary care opticians,
and have been included in the UK Biobank. This has providedmewith a novel research
opportunity to explore basic ocular biology and pathology. The analysis of data that is
routinely collected in clinical and primary care settings allows for broad translational
potential.
Of the SNPs discovered to be associatedwith retinalmorphology, several had no prior
associations to additional phenotypes, ocular or otherwise. Following further inquiry,
the genes the loci were labelled with suggested potential pathways through which their
involvement in retinal morphologymay act. Further investigation of these novel loci, for
example using animal models, may help us better understand the intricacies of retinal
morphology and function.
The use of MR to interrogate our understanding between the clinically utilised mor-
phological traits and disease has developed our understanding of them as biomarkers.
In the case of POAG, no evidence was found to support a causal genetic relationship
between glaucoma and one of its clinical biomarkers, inner retinal thickness. This sug-
gests it is a change in thickness over time that is indicative of the disease, and a genetic-
ally determined thinner inner retina does not predispose one to glaucoma. This suggests
that the variants discovered within this thesis are unlikely to be viable therapeutic tar-
gets of the disease. However one opportunity would be to utilise the genetic variants
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associated with non-pathological inner retina thickness to help estimate genetically de-
termined inner retinal thickness and thus improve efficiency of glaucoma diagnosis.
Exploration of this idea would require a dataset with higher glaucoma incidence. How-
ever this finding highlights the importance of reporting negative results and their value
in research.
Conversely, evidence was found in support of a causal genetic relationship between
AMD and RPE thickness, with RPE thickness being downstream of AMD. This suggests
that those with a genetically determined thinner RPE may have a predisposition for
AMD. It would be of great interest to further this work by testing the predictive power
of RPE thickness for AMD. Unfortunately at this time, the incidence of AMD within
the UK Biobank is insufficient to carry out such analysis. This is partly owing to the
age of the participants being younger than is common for the development of AMD.
Therefore an alternative dataset would be required for this analysis to be completed, or
as the population within the UK Biobank ages and follow up measures are collected,
this analysis may become feasible.
The work also highlighted the intersection between common and rare variation, and
the spectrum of clinical and sub-clinical phenotypes this can affect. In particular the
effects of common variants at TYR andOCA2, loci known to be associated with the rare
clinical condition OCA is of particular interest. SNPs at these loci were consistently
found associated with the thickness of all retinal layers. This consistency emphasises
the importance of this finding and the need for additional exploration of the biological
underpinnings of this observation. Additionally the presence of a phenotype associated
with these common variants (central foveal thickness) that appears to be on the same
spectrum as a clinical phenotype associatedwith OCA (foveal hypoplasia) is suggestive
of a phenotype continuum with complex genetic causation. Previous work has looked
at how some of these common variants interact with rare variants to produce the clin-
ical phenotype. It would be of great interest to further expand this work in light of other
common variants that may exhibit similar effect. The recent release of exome sequen-
cing data for participants in the UK Biobank may offer one opportunity, however the
incidence of OCA is very low, so an alternative clinical dataset may be better suited.
At an overarching level, care must be taken into how the results from this thesis are
extrapolated to the general population. The analysis in this thesis was consistently done
on the densest well-mixed population within the UK Biobank. This largely aligns with
a self-reported white population. Selection of a single well-mixed population was a
necessary measure to avoid confounding by population structure. However, the results
are not automatically scalable to the entire population. The consistent bias of biomedical
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research to focus on white populations influences subsequent medical decisions and
can widen the healthcare inequality gap that runs along axes of ethnicity. This signals a
requirement for me and the broader biomedical community to consciously evaluate the
data we are using.
The work within this thesis demonstrates the utility and value of biomedical imaging
derived phenotypes. This has already been establishedwith application to other human
organs such as the use of MRI in cardiology [Meyer & al., 2020] and neurology [Elliott
& al., 2018]. Image derived phenotyping is advantageous in its non-invasive nature
and density of data collected, and the work here provides further evidence for applying
similar analysis to other organs. In the future similar work could be expanded to the
skeleton using x-ray images and the reproductive organs using ultrasound.
Looking at the broader scope of the work in this thesis, the importance of studying
phenotypes at a high dimensionality and the additional discoveries it can enable is clear.
The clinical segmentation grids usedwithin this research aremedically useful, easily in-
terpretable and have shown to provide interesting insight. However their segmentation
boundaries may not best align with biological variation as morphological variation is a
continuous trait. Initial expansion of dimensionality to look at intra layer variation in
chapter 5 suggested that spatial variation of individual layers is occurring, with under-
lying causative genetics. Further expansion of phenotype dimensionality in chapter 6
to a more granular space allowed for additional biological discoveries. Considering the
evidence for both inter- and intra-layer variation, further discoveries could result from
expansion to a higher dimensional space applied to the individual layers. To facilitate
this higher dimensional phenotype extraction, employment of cutting edge image ana-
lysis techniques, particularly machine learning methods, and collaboration with those
with such expertise would be required. High level segmentation of retinal structure
from OCT has already been conducted and proven to provide rich information that has
diagnostic capabilities [De Fauw & al., 2018]. Harnessing similar technologies to in-
terrogate non-pathological retinal morphology may help us better understand ocular
biology.
In summary, this work provides a detailed approach to study the morphology of the
human retina using biomedical imaging. It has demonstrated the insights into underly-
ing genetics and function that can be discovered whenwe harness the high dimensional
data available. This work has identified genetic variation underlying morphological
variation of the human retina, opening new avenues of research in the fields of clinical
ophthalmology and biological development. It also provides support for the power of
this type of analysis in application to other areas of human physiology. This will help us
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obtain a better understanding of general human biology, whilst giving clinical insights




A.1. Genome-wide Association Study of Inner Retinal Morphology
TableA.1: Full summary statistics forGWASof RNFL andGCIPL thickness. Full GWAS sum-
mary statistics for 46 significant variants, including effect size, p-value and standard error (SE)
for the individual phenotypes, GCIPL and RNFL (labelled accordingly) after meta-analysis, as
well as the values selected within the meta analysis (labelled ”MTAG”). A1 is the effect allele.






MTAG p-value RNFL p-value GCIPL p-value MTAG SE RNFL SE GCIPL SE
rs72739513 1 203080149 A G 0.04 0.72 0.37 0.72 8.88E-09 1.05E-04 8.88E-09 0.13 0.10 0.13
rs12998032 2 159095496 C T 0.44 0.30 0.08 0.30 6.97E-10 2.12E-02 6.97E-10 0.05 0.04 0.05
rs13010692 2 48800667 C T 0.32 0.22 0.22 0.09 6.72E-09 6.72E-09 0.09 0.04 0.04 0.05
rs2271758 2 172701157 G T 0.59 -0.22 -0.22 -0.20 1.34E-09 1.34E-09 3.63E-05 0.04 0.04 0.05
rs79833181 2 15666802 C T 0.02 0.86 0.86 0.57 1.55E-09 1.55E-09 2.43E-03 0.14 0.14 0.19
rs980772 2 145442190 T G 0.67 -0.21 -0.21 0.03 4.62E-08 4.62E-08 0.60 0.04 0.04 0.05
rs13083522 3 3270368 G A 0.78 0.31 0.08 0.31 4.51E-08 0.08 4.51E-08 0.06 0.04 0.06
rs149831820 3 77192591 C T 0.06 -0.42 -0.42 -0.31 2.53E-08 2.53E-08 1.48E-03 0.07 0.07 0.10
rs17279437 3 45814094 A G 0.11 -0.77 -0.31 -0.77 7.81E-24 1.23E-07 7.81E-24 0.08 0.06 0.08
rs62252355 3 69572006 C T 0.20 -0.37 -0.37 -0.15 2.17E-16 2.17E-16 1.22E-02 0.05 0.05 0.06
rs66511946 4 184932935 G A 0.40 -0.36 -0.11 -0.36 2.15E-13 4.36E-03 2.15E-13 0.05 0.04 0.05
rs17421627 5 87847586 G T 0.07 0.97 -0.14 0.97 8.09E-27 4.87E-02 8.09E-27 0.09 0.07 0.09
rs2004187 5 2612747 C A 0.60 0.25 0.25 0.29 1.43E-11 1.43E-11 2.77E-09 0.04 0.04 0.05
rs13215351 6 84313801 T A 0.25 -0.33 -0.06 -0.33 1.36E-09 0.12 1.36E-09 0.05 0.04 0.05
rs527871768 6 39419992 A G 0.01 1.16 1.16 0.71 3.37E-10 3.37E-10 3.43E-03 0.19 0.19 0.24
rs9398171 6 108983527 T C 0.71 0.50 0.23 0.50 7.51E-22 1.45E-08 7.51E-22 0.05 0.04 0.05
rs11762530 7 46630602 C G 0.59 0.53 0.07 0.53 3.45E-28 4.77E-02 3.45E-28 0.05 0.04 0.05
rs12719025 7 51100190 G A 0.46 0.30 0.04 0.30 3.09E-10 0.29 3.09E-10 0.05 0.04 0.05
rs35001871 7 50975439 C G 0.29 0.32 0.19 0.32 1.17E-09 2.98E-06 1.17E-09 0.05 0.04 0.05
rs73348111 7 50364291 C T 0.01 1.12 1.12 0.66 7.15E-10 7.15E-10 5.70E-03 0.18 0.18 0.24
rs115520750 8 108739734 T G 0.01 1.12 1.12 0.82 2.54E-10 2.54E-10 4.51E-04 0.18 0.18 0.23
rs13271359 8 109114426 T C 0.26 -0.44 -0.44 -0.02 5.89E-26 5.89E-26 0.75 0.04 0.04 0.05
rs376067714 8 109141863 G A 0.18 -0.48 -0.48 -0.11 1.28E-18 1.28E-18 0.13 0.05 0.05 0.07
rs4871827 8 121061879 A G 0.33 -0.29 -0.12 -0.29 7.41E-09 2.00E-03 7.41E-09 0.05 0.04 0.05
rs6989495 8 74230223 T G 0.33 0.23 0.23 0.14 1.27E-09 1.27E-09 4.33E-03 0.04 0.04 0.05
rs118031671 9 10521068 G T 0.01 0.93 0.93 0.76 2.53E-09 2.53E-09 2.21E-04 0.16 0.16 0.21
rs2787394 9 103007414 T C 0.41 -0.28 -0.06 -0.28 8.64E-09 0.09 8.64E-09 0.05 0.04 0.05
rs10762201 10 70040111 G A 0.76 0.46 0.46 0.15 1.05E-26 1.05E-26 6.72E-03 0.04 0.04 0.06
rs181211282 10 102746829 A G 0.03 0.67 0.67 0.24 1.12E-08 1.12E-08 0.11 0.12 0.12 0.15
rs1947075 10 49741135 T C 0.64 -0.21 -0.21 -0.19 2.60E-08 2.60E-08 1.14E-04 0.04 0.04 0.05
rs1042602 11 88911696 A C 0.37 -0.36 -0.36 -0.33 3.96E-22 3.96E-22 2.10E-11 0.04 0.04 0.05
rs12574166 11 69291285 T C 0.15 0.28 0.28 0.24 2.82E-08 2.82E-08 3.92E-04 0.05 0.05 0.07
rs2008905 11 17184623 T C 0.42 -0.36 -0.16 -0.36 6.81E-14 1.92E-05 6.81E-14 0.05 0.04 0.05
rs5442 12 6954864 A G 0.07 -0.69 -0.08 -0.69 2.36E-13 0.27 2.36E-13 0.09 0.07 0.09
rs10140252 14 74528023 T G 0.16 0.53 0.53 0.49 1.05E-25 1.05E-25 1.39E-13 0.05 0.05 0.07
rs1254276 14 60847001 T C 0.39 -0.28 -0.28 -0.10 7.52E-14 7.52E-14 3.24E-02 0.04 0.04 0.05
rs146652416 14 29907103 G A 0.03 0.62 0.62 0.45 4.46E-08 4.46E-08 2.44E-03 0.11 0.11 0.15
rs17095953 14 59719393 A G 0.24 -0.28 -0.28 -0.08 1.76E-10 1.76E-10 0.14 0.04 0.04 0.06
rs35337422 14 104407243 C A 0.15 0.37 -0.20 0.37 3.50E-08 1.28E-04 3.50E-08 0.07 0.05 0.07
rs1470108 15 89153744 A C 0.34 0.24 0.24 0.21 7.09E-10 7.09E-10 3.77E-05 0.04 0.04 0.05
rs1800407 15 28230318 T C 0.08 -0.60 -0.36 -0.60 3.19E-12 4.08E-08 3.19E-12 0.09 0.07 0.09
rs117304899 16 15055042 G C 0.02 0.92 0.92 0.75 1.74E-09 1.74E-09 1.82E-04 0.15 0.15 0.20
rs117300236 17 44753350 G A 0.72 -0.25 -0.25 -0.30 5.57E-09 5.57E-09 1.24E-07 0.04 0.04 0.06
rs7503894 17 79583473 C T 0.65 0.56 0.37 0.56 2.49E-29 3.58E-22 2.49E-29 0.05 0.04 0.05
rs143330165 20 7154672 T C 0.01 1.04 1.04 0.41 1.97E-08 1.97E-08 0.09 0.19 0.19 0.24
rs7277632 21 47327542 G A 0.72 0.34 0.09 0.34 1.20E-10 3.56E-02 1.20E-10 0.05 0.04 0.05
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Table A.2: Association of UK Biobank inner retinal thickness-associated variants with gan-
glion cell complex thickness in the Rotterdam Study. Comparison between effect sizes and
p-values from meta-analysed inner retinal GWAS (labelled ”MTAG”), and GWAS of the GCC









rs1042602 -0.36 3.96E-22 -0.77 6.71E-03
rs10762201 0.46 1.05E-26 0.10 0.78
rs117300236 -0.25 5.57E-09 -0.03 0.94
rs11762530 0.53 3.45E-28 0.25 0.39
rs1254276 -0.28 7.52E-14 -0.20 0.48
rs12574166 0.28 2.82E-08 0.21 0.59
rs12719025 0.30 3.09E-10 0.99 5.89E-04
rs12998032 0.30 6.97E-10 0.22 0.44
rs13010692 0.22 6.72E-09 0.54 0.08
rs13083522 0.31 4.51E-08 0.03 0.93
rs13215351 -0.33 1.36E-09 -0.04 0.91
rs1470108 0.24 7.09E-10 0.34 0.27
rs149831820 -0.42 2.53E-08 0.27 0.69
rs17279437 -0.77 7.81E-24 -0.79 0.12
rs17421627 0.97 8.09E-27 1.62 2.21E-03
rs1800407 -0.60 3.19E-12 -1.12 0.16
rs1947075 -0.21 2.60E-08 -0.07 0.80
rs2004187 0.25 1.43E-11 0.31 0.29
rs2008905 -0.36 6.81E-14 0.07 0.81
rs2271758 -0.22 1.34E-09 -0.51 0.07
rs2787394 -0.28 8.64E-09 -0.36 0.21
rs35001871 0.32 1.17E-09 0.36 0.25
rs35337422 0.37 3.50E-08 0.24 0.55
rs4871827 -0.29 7.41E-09 -0.87 4.49E-03
rs5442 -0.69 2.36E-13 0.38 0.46
rs62252355 -0.37 2.17E-16 -0.27 0.43
rs66511946 -0.36 2.15E-13 -0.51 0.11
rs6989495 0.23 1.27E-09 1.00 9.50E-04
rs7277632 0.34 1.20E-10 1.35 2.25E-05
rs7503894 0.56 2.49E-29 0.57 0.06
rs9398171 0.50 7.51E-22 0.69 2.55E-02
rs980772 -0.21 4.62E-08 -0.23 0.43
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TableA.3: Association of UKBiobank inner retinal thickness-associated variantswith retinal
nerve fibre layer (RNFL) and ganglion cell inner plexiform layer (GCIPL) thickness in the
Raine Study. Comparison between effect sizes and p-values from meta-analysed inner retinal
GWAS (labelled ”MTAG”), and GWAS of the RNFL and GCIPL in the Raine Study (labelled













rs1042602 -0.36 3.96E-22 -0.20 0.11 - -
rs10762201 0.46 1.05E-26 0.42 2.95E-03 - -
rs115520750 1.12 2.54E-10 -0.66 0.39 - -
rs117300236 -0.25 5.57E-09 -0.15 0.28 - -
rs11762530 0.53 3.45E-28 - - 0.78 8.00E-04
rs118031671 0.93 2.53E-09 -0.26 0.66 - -
rs1254276 -0.28 7.52E-14 -0.24 0.05 - -
rs12574166 0.28 2.82E-08 0.35 3.32E-02 - -
rs12719025 0.30 3.09E-10 - - 0.57 1.66E-02
rs12998032 0.30 6.97E-10 - - 0.50 2.64E-02
rs13010692 0.22 6.72E-09 0.09 0.49 - -
rs13083522 0.31 4.51E-08 - - -0.28 0.32
rs13215351 -0.33 1.36E-09 - - -0.27 0.30
rs143330165 1.04 1.97E-08 -1.81 0.21 - -
rs146652416 0.62 4.46E-08 0.37 0.38 - -
rs1470108 0.24 7.09E-10 0.10 0.43 - -
rs149831820 -0.42 2.53E-08 -0.37 0.13 - -
rs17279437 -0.77 7.81E-24 - - -1.76 1.53E-06
rs17421627 0.97 8.09E-27 - - 0.58 0.20
rs1800407 -0.60 3.19E-12 -0.28 0.18 -0.49 0.23
rs181211282 0.67 1.12E-08 -0.19 0.65 - -
rs1947075 -0.21 2.60E-08 0.02 0.86 - -
rs2004187 0.25 1.43E-11 0.20 0.10 0.45 0.06
rs2008905 -0.36 6.81E-14 - - 0.03 0.90
rs2271758 -0.22 1.34E-09 -0.41 9.13E-04 - -
rs2787394 -0.28 8.64E-09 - - -0.69 3.71E-03
rs35337422 0.37 3.50E-08 - - 0.12 0.71
rs4871827 -0.29 7.41E-09 - - -0.34 0.16
rs5442 -0.69 2.36E-13 - - -1.04 2.18E-02
rs62252355 -0.37 2.17E-16 -0.05 0.72 - -
rs66511946 -0.36 2.15E-13 - - -0.70 1.07E-02
rs6989495 0.23 1.27E-09 -0.01 0.96 - -
rs72739513 0.72 8.88E-09 - - 0.26 0.71
rs7277632 0.34 1.20E-10 - - 0.69 6.14E-03
rs73348111 1.12 7.15E-10 0.88 0.21 - -
rs7503894 0.56 2.49E-29 - - 0.38 0.14
rs79833181 0.86 1.55E-09 -0.06 0.92 - -
rs9398171 0.50 7.51E-22 - - 0.37 0.14
rs980772 -0.21 4.62E-08 -0.35 5.36E-03 - -
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Table A.4: Association of UK Biobank inner retinal thickness-associated variants with
primary open-angle glaucoma in the International Glaucoma Genetics Consortium meta-
analysis [Gharahkhani & al., 2020] Each variant is annotated with the nearest gene and the
odds ratio (OR) for glaucoma reported alongside the p-value.
SNP Risk allele Other allele Chr Position Nearest gene OR for POAG P-value
rs1254276 T C 14 60847001 SIX6 1.18 2.03E-37
rs117300236 G A 17 44753350 NSF 0.93 1.82E-05
rs5442 A G 12 6954864 GNB3 1.11 9.97E-05
rs11762530 C G 7 46630602 IGFBP3 1.04 1.52E-03
rs2787394 T C 9 103007414 INVS 0.97 8.44E-03
rs1042602 A C 11 88911696 TYR 1.03 1.47E-02
rs2008905 T C 11 17184623 PIK3C2A 0.97 2.35E-02
rs7503894 C T 17 79583473 NPLOC4 0.97 2.56E-02
rs17279437 A G 3 45814094 SLC6A20 0.95 2.87E-02
rs10762201 G A 10 70040111 ATOH7 0.97 2.95E-02
rs9398171 T C 6 108983527 FOXO3 1.03 3.79E-02
rs17421627 G T 5 87847586 LINC00461 1.05 0.07
rs2004187 C A 5 2612747 IRX2 1.02 0.14
rs13271359 T C 8 109114426 RSPO2 1.03 0.18
rs73348111 C T 7 50364291 IKZF1 1.08 0.19
rs17095953 A G 14 59719393 DAAM1 1.03 0.24
rs35337422 C A 14 104407243 TDRD9 1.02 0.25
rs1470108 A C 15 89153744 AEN 1.02 0.27
rs115520750 T G 8 108739734 ANGPT1 1.07 0.37
rs79833181 C T 2 15666802 NBAS 1.05 0.37
rs62252355 C T 3 69572006 FRMD4B 1.01 0.39
rs12574166 T C 11 69291285 LINC02747 0.99 0.49
rs13010692 C T 2 48800667 STON1-GTF2A1L 1.01 0.55
rs143330165 T C 20 7154672 LINC01428 1.07 0.57
rs72739513 A G 1 203080149 ADORA1 0.98 0.58
rs117304899 G C 16 15055042 NA 1.05 0.62
rs12719025 G A 7 51100190 COBL 1.01 0.63
rs2271758 G T 2 172701157 SLC25A12 0.99 0.63
rs980772 T G 2 145442190 TEX41 0.99 0.64
rs181211282 A G 10 102746829 MRPL43 0.98 0.67
rs4871827 A G 8 121061879 DEPTOR 1.01 0.69
rs13083522 G A 3 3270368 CRBN 0.99 0.69
rs66511946 G A 4 184932935 STOX2 1.00 0.74
rs118031671 G T 9 10521068 PTPRD 1.01 0.77
rs10140252 T G 14 74528023 BBOF1 1.01 0.78
rs12998032 C T 2 159095496 CCDC148 1.00 0.80
rs1800407 T C 15 28230318 OCA2 0.99 0.81
rs13215351 T A 6 84313801 SNAP91 1.00 0.86
rs146652416 G A 14 29907103 FOXG1 0.99 0.86
rs6989495 T G 8 74230223 RDH10 1.00 0.87
rs7277632 G A 21 47327542 PCBP3 1.00 0.92
rs1947075 T C 10 49741135 ARHGAP22 1.00 0.99
rs149831820 C T 3 77192591 ROBO2 1.00 0.99
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TableA.5: Full summary statistics forGWASofONL thickness. FullGWAS summary statistics
for the 74 variants associated with ONL thickness, including effect size, p-value and standard
error (SE). A1 is the effect allele. Allele frequency (AF) refers to the frequency of the effect allele.
SNP Chr BP A1 A2 AF Effect size P-value SE
rs2128416 1 10700448 C T 0.15 -0.52 1.91E-12 0.07
rs6427827 1 200398387 A T 0.62 0.42 7.24E-16 0.05
rs4950952 1 202739602 G A 0.51 0.36 4.43E-13 0.05
rs919655 1 214157972 A G 0.12 0.47 1.05E-09 0.08
rs12032598 1 222148552 C A 0.21 0.38 3.05E-09 0.06
rs6426584 1 227374949 T A 0.34 0.30 1.64E-08 0.05
rs116350483 2 145338686 T C 0.02 -2.13 1.05E-26 0.20
rs80265589 2 169027979 A T 0.27 -0.42 1.40E-13 0.06
rs148388367 2 216850944 A T 0.04 -1.27 1.08E-20 0.14
rs72959706 2 218533177 G A 0.07 -0.60 1.84E-09 0.10
rs11129176 3 25049310 A G 0.28 0.31 1.66E-08 0.06
rs6775323 3 27721085 T G 0.20 0.49 3.40E-15 0.06
rs4681617 3 150122569 C T 0.10 0.47 1.94E-08 0.08
rs30373 5 55745334 G C 0.37 0.32 9.60E-10 0.05
rs63338061 5 71486228 T C 0.36 0.33 4.66E-10 0.05
rs17421627 5 87847586 G T 0.07 1.15 3.64E-33 0.10
rs62391700 5 126093395 C T 0.20 -0.43 1.08E-11 0.06
rs1109114 5 148615946 T C 0.43 0.38 6.11E-14 0.05
rs6875105 5 173054917 C T 0.38 -0.37 1.50E-12 0.05
rs12192672 6 7229619 A G 0.30 -0.33 1.23E-09 0.05
rs17507554 6 11394287 A G 0.05 0.69 3.73E-09 0.12
rs4711420 6 35495811 T G 0.80 0.36 1.08E-08 0.06
rs6910414 6 56726737 G A 0.18 0.37 1.12E-08 0.07
rs74526772 6 106515218 A T 0.04 -1.25 1.35E-19 0.14
rs9639276 7 867033 T C 0.17 0.43 1.12E-10 0.07
rs929511 7 8003017 T C 0.12 0.46 2.97E-09 0.08
rs12719025 7 51100190 G A 0.46 0.49 9.38E-22 0.05
rs34926272 7 129591807 C G 0.03 -1.07 9.77E-12 0.16
rs61675430 8 61671071 A G 0.20 -0.41 1.42E-10 0.06
rs13263941 8 109121945 C T 0.26 0.85 6.15E-50 0.06
rs376067714 8 109141863 G A 0.18 0.77 4.39E-24 0.08
rs9298817 9 21576591 C A 0.66 -0.49 2.67E-20 0.05
rs10781177 9 76593011 T C 0.42 -0.29 1.02E-08 0.05
rs717299 9 77185933 G A 0.45 0.36 1.28E-12 0.05
rs111245635 10 48389841 T C 0.02 1.29 3.56E-10 0.21
rs1947075 10 49741135 T C 0.64 -0.33 5.92E-10 0.05
rs7916697 10 69991853 G A 0.76 -0.43 3.36E-13 0.06
rs1016934 11 31720621 G A 0.30 -0.37 1.64E-11 0.06
rs116233906 11 68968271 A C 0.04 -0.93 2.74E-13 0.13
rs1485995 11 69307707 A G 0.67 -0.33 1.34E-09 0.05
rs6483429 11 95239787 T C 0.46 -0.30 4.51E-09 0.05
rs3138142 12 56115585 T C 0.24 0.93 1.64E-56 0.06
rs76629482 12 96178789 G C 0.18 -0.53 6.87E-16 0.07
rs2793783 13 100253216 G A 0.62 -0.29 3.88E-08 0.05
rs28468687 14 36026342 A G 0.18 0.38 1.30E-08 0.07
rs1956524 14 68800393 A G 0.64 0.29 3.49E-08 0.05
rs10135971 14 69517494 A G 0.34 0.41 1.11E-14 0.05
rs112145470 14 74356090 A G 0.03 1.30 2.87E-15 0.17
rs368205955 14 74497636 G T 0.02 -3.21 1.85E-46 0.22
rs12147951 14 74642451 C A 0.07 -2.36 5.13E-113 0.10
rs1972565 14 74666824 G A 0.82 1.92 8.13E-191 0.06
rs1972564 14 74666944 T C 0.48 1.03 7.10E-74 0.06
rs118186707 14 74686575 A G 0.03 1.78 9.73E-33 0.15
rs28488340 14 74693803 G C 0.40 -0.59 2.62E-30 0.05
rs888413 14 75267396 T C 0.47 0.39 7.11E-15 0.05
rs12904079 15 45483124 A G 0.34 0.30 2.64E-08 0.05
rs10083695 15 53987147 G A 0.49 -0.37 3.48E-13 0.05
rs1372613 15 101204835 T C 0.30 0.36 6.90E-11 0.05
rs7206532 16 80490131 C T 0.52 0.29 5.19E-09 0.05
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rs4782636 16 84585176 T A 0.19 0.41 2.51E-10 0.06
rs35444818 16 85718918 A C 0.29 -0.33 1.76E-09 0.06
rs111825734 17 44019107 G T 0.23 0.48 6.28E-16 0.06
rs8077430 17 79511135 G A 0.77 -0.49 2.78E-16 0.06
rs8070929 17 79530993 T G 0.35 -0.43 3.60E-16 0.05
rs57820851 18 53413566 T G 0.35 -0.30 1.58E-08 0.05
rs189921298 18 56922264 G A 0.30 0.46 1.70E-16 0.06
rs17696543 18 56971398 T C 0.18 -0.56 1.71E-17 0.07
rs76076446 19 3771586 A G 0.02 -1.23 2.68E-13 0.17
rs8132685 21 34220618 T C 0.52 -0.30 4.29E-09 0.05
rs2032576 22 27089655 T G 0.56 -0.28 4.46E-08 0.05
rs5752638 22 28188203 C T 0.22 -0.51 2.20E-16 0.06
rs5763593 22 30302238 C T 0.63 0.35 2.57E-11 0.05
rs2073946 22 30619599 A G 0.31 0.47 2.05E-17 0.06
rs75159625 22 46377008 G T 0.31 0.34 3.92E-10 0.05
Table A.6: Full summary statistics for GWAS of IS thickness. Full GWAS summary statistics
for the 15 variants associated with IS thickness, including effect size, p-value and standard error
(SE). A1 is the effect allele. Allele frequency (AF) refers to the frequency of the effect allele.
SNP Chr BP A1 A2 AF Effect size P-value SE
rs112248193 1 3718402 A G 0.13 -0.11 1.39E-09 0.02
rs6665290 1 227201106 T C 0.46 0.07 3.28E-09 0.01
rs2351248 3 47829277 T G 0.70 -0.07 2.75E-08 0.01
rs1463229 3 150167912 G A 0.76 -0.09 2.84E-11 0.01
rs72761109 5 71506529 T C 0.31 0.07 2.31E-08 0.01
rs7816990 8 10463944 C A 0.74 -0.08 7.13E-09 0.01
rs3779791 8 87676710 C T 0.76 0.10 4.46E-12 0.01
rs2808051 10 32205630 C T 0.51 0.07 2.47E-09 0.01
rs35314358 10 62647787 A T 0.22 0.09 2.56E-09 0.01
rs2292962 11 1778321 T C 0.13 0.10 2.78E-08 0.02
rs618838 11 66328719 C T 0.55 0.07 2.27E-09 0.01
rs1272131 14 60886150 C T 0.39 -0.09 1.03E-13 0.01
rs887595 14 74666641 G A 0.82 0.18 8.38E-33 0.02
rs10220961 16 71789550 G T 0.48 0.08 4.27E-12 0.01
rs35638197 17 47284735 C T 0.06 -0.14 2.12E-08 0.02
Table A.8: Full summary statistics for GWAS of PRL component layer thickness. Full GWAS
summary statistics for 59 significant variants, including effect size, p-value and standard error
(SE) for the individual phenotypes, IS, OS andONL (labelled accordingly), as well as the values
selected within the meta analysis (labelled ”MTAG”). A1 is the effect allele.




























rs11587687 1 110147801 A G 0.44 0.18 0.01 0.18 -0.08 5.02E-09 0.30 5.02E-09 0.12 0.03 0.01 0.03 0.05
rs2932531 1 113236309 A T 0.55 0.20 0.01 0.20 0.02 2.79E-09 0.43 2.79E-09 0.70 0.03 0.01 0.03 0.05
rs410895 1 196898226 C T 0.55 0.30 -0.01 0.30 0.06 8.19E-22 0.17 8.19E-22 0.23 0.03 0.01 0.03 0.05
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rs6673000 1 200451943 G A 0.56 0.37 0.04 -0.03 0.37 2.73E-13 8.15E-05 0.33 2.73E-13 0.05 0.01 0.03 0.05
rs11577827 1 202798831 T C 0.53 0.37 0.05 0.07 0.37 2.77E-13 6.56E-06 0.03 2.77E-13 0.05 0.01 0.03 0.05
rs6665290 1 227201106 T C 0.46 0.07 0.07 -0.04 0.24 8.24E-11 8.24E-11 0.15 2.12E-06 0.01 0.01 0.03 0.05
rs2113422 2 23939007 G A 0.58 0.20 0.02 0.20 0.17 2.89E-10 0.14 2.89E-10 1.08E-03 0.03 0.01 0.03 0.05
rs13382582 2 169079662 G C 0.42 0.18 0.04 0.18 0.18 5.99E-09 5.09E-04 5.99E-09 4.05E-04 0.03 0.01 0.03 0.05
rs838718 2 234296650 A G 0.48 -0.17 -2.13E-03 -0.17 -0.08 2.05E-08 0.77 2.05E-08 0.12 0.03 0.01 0.03 0.05
rs34234056 3 14418444 G A 0.51 0.17 -1.87E-03 0.17 0.01 2.37E-08 0.86 2.37E-08 0.78 0.03 0.01 0.03 0.05
rs348866 3 100992385 T C 0.49 0.22 0.01 0.22 -0.10 1.96E-13 0.19 1.96E-13 0.05 0.03 0.01 0.03 0.05
rs1376026 3 150182592 G A 0.51 0.18 -0.02 0.18 0.14 5.86E-09 0.12 5.86E-09 6.11E-03 0.03 0.01 0.03 0.05
rs2929724 5 17200427 G C 0.52 0.17 -2.71E-03 0.17 2.96E-03 4.21E-08 0.80 4.21E-08 0.95 0.03 0.01 0.0315 0.05
rs12653396 5 87847273 A T 0.57 0.34 0.05 0.06 0.34 4.67E-11 1.54E-06 0.07 4.67E-11 0.05 0.01 0.03 0.05
rs1109114 5 148615946 T C 0.43 0.37 0.07 -0.04 0.37 2.65E-13 1.28E-10 0.23 2.65E-13 0.05 0.01 0.03 0.05
rs1438692 5 148659664 A G 0.42 0.07 0.07 -0.01 0.32 1.32E-11 1.32E-11 0.75 3.59E-10 0.01 0.01 0.03 0.05
rs450611 5 173038618 C A 0.59 -0.32 -0.03 -0.05 -0.32 5.82E-10 1.37E-03 0.13 5.82E-10 0.05 0.01 0.03 0.05
rs375435 6 42661404 C T 0.57 -0.25 -0.01 -0.25 -0.06 3.56E-16 0.62 3.56E-16 0.20 0.03 0.01 0.03 0.05
rs1926098 6 76715926 A G 0.56 -0.17 0.02 -0.17 -0.06 3.35E-08 0.10 3.35E-08 0.27 0.03 0.01 0.03 0.05
rs12719025 7 51100190 G A 0.46 0.49 0.07 -3.73E-03 0.49 6.39E-22 1.33E-10 0.90 6.39E-22 0.05 0.01 0.03 0.05
rs2437002 8 109034419 T G 0.58 0.37 0.05 0.06 0.37 5.77E-13 1.06E-06 0.07 5.77E-13 0.05 0.01 0.03 0.05
rs2514842 8 109062046 G T 0.47 0.41 0.07 0.12 0.41 3.84E-16 2.59E-10 1.01E-04 3.84E-16 0.05 0.01 0.03 0.05
rs10781177 9 76593011 T C 0.42 -0.29 -0.05 -0.01 -0.29 1.49E-08 1.12E-05 0.64 1.49E-08 0.05 0.01 0.03 0.05
rs717299 9 77185933 G A 0.45 0.37 0.04 0.06 0.37 3.80E-13 9.57E-05 0.04 3.80E-13 0.05 0.01 0.03 0.05
rs11200922 10 85961758 G A 0.46 0.32 -0.03 0.33 0.08 1.62E-26 0.01 1.62E-26 0.12 0.03 0.01 0.03 0.05
rs618838 11 66328719 C T 0.55 0.06 0.06 0.03 0.19 1.79E-09 1.79E-09 0.28 1.49E-04 0.01 0.01 0.03 0.05
rs7128814 11 68953054 A G 0.58 0.28 0.04 0.07 0.28 4.56E-08 9.68E-05 0.02 4.56E-08 0.05 0.01 0.03 0.05
rs631695 11 69283303 G T 0.59 -0.31 -0.04 -0.02 -0.31 1.71E-09 9.01E-04 0.46 1.71E-09 0.05 0.01 0.03 0.05
rs948962 11 76919478 A C 0.47 -0.20 0.01 -0.20 0.01 4.55E-11 0.40 4.55E-11 0.87 0.03 0.01 0.038 0.05
rs28620862 11 88979097 C A 0.47 0.20 -0.01 0.20 -0.02 7.57E-11 0.45 7.57E-11 0.74 0.03 0.01 0.03 0.05
rs7930541 11 95238880 C A 0.42 -0.30 -0.04 -0.01 -0.30 2.65E-09 5.64E-04 0.83 2.65E-09 0.05 0.01 0.03 0.05
rs2080402 12 345175 C T 0.56 0.22 -0.03 0.22 -0.13 2.21E-12 2.18E-03 2.21E-12 0.01 0.03 0.01 0.03 0.05
rs3138144 12 56114769 C G 0.49 0.56 0.06 0.26 0.56 6.54E-28 1.89E-09 1.17E-16 6.54E-28 0.05 0.01 0.03 0.05
rs6538677 12 96254528 G A 0.60 0.32 0.04 0.01 0.32 7.36E-10 4.44E-05 0.64 7.36E-10 0.05 0.01 0.03 0.05
rs9796234 13 114323997 C T 0.52 0.27 0.03 0.27 0.19 4.69E-18 3.13E-03 4.69E-18 1.57E-04 0.03 0.01 0.03 0.05
rs7151797 14 69499509 C T 0.42 0.39 0.03 0.02 0.39 5.46E-14 2.82E-03 0.58 5.46E-14 0.05 0.01 0.03 0.05
rs11626048 14 74282511 C T 0.54 0.72 0.09 0.04 0.72 1.08E-45 1.59E-16 0.21 1.08E-45 0.05 0.01 0.03 0.05
rs10147158 14 74465741 T A 0.54 -0.41 -0.08 -0.02 -0.41 9.62E-16 8.15E-13 0.54 9.62E-16 0.05 0.01 0.03 0.05
rs11159058 14 74497642 G T 0.56 -0.56 -0.09 -0.02 -0.56 1.30E-24 9.28E-16 0.52 1.30E-24 0.05 0.01 0.03 0.05
rs11159063 14 74614566 C T 0.53 0.75 0.11 0.02 0.75 2.71E-50 9.84E-25 0.51 2.71E-50 0.05 0.01 0.03 0.05
rs1972564 14 74666944 T C 0.48 1.03 0.15 -0.04 1.03 2.93E-74 1.40E-37 0.22 2.93E-74 0.06 0.01 0.03 0.06
rs28488340 14 74693803 G C 0.40 -0.59 -0.08 -0.05 -0.59 9.02E-31 1.07E-13 0.14 9.02E-31 0.05 0.01 0.03 0.05
rs888413 14 75267396 T C 0.47 0.39 0.07 0.07 0.39 1.92E-14 3.64E-10 0.02 1.92E-14 0.05 0.01 0.03 0.05
rs1648303 15 45445692 G A 0.57 -0.28 -0.04 -0.01 -0.28 2.72E-08 8.32E-04 0.66 2.72E-08 0.05 0.01 0.03 0.05
rs10083695 15 53987147 G A 0.49 -0.36 -0.06 -0.06 -0.36 8.00E-13 5.67E-09 0.03 8.00E-13 0.05 0.01 0.03 0.05
rs3825991 15 89761664 A C 0.47 0.36 -0.04 0.36 0.05 2.70E-31 1/10E-04 2.70E-31 0.29 0.03 0.01 0.03 0.05
rs7206532 16 80490131 C T 0.52 0.30 0.03 0.02 0.30 1.86E-09 3.06E-03 0.56 1.86E-09 0.05 0.01 0.03 0.05
rs6564059 16 84587249 T G 0.43 -0.18 0.03 -0.18 0.15 1.16E-08 2.30E-03 1.16E-08 2.87E-03 0.03 0.01 0.03 0.05
rs11640338 16 85689653 G A 0.46 0.29 0.03 3.28E-03 0.29 2.25E-08 3.93E-03 0.94 2.25E-08 0.05 0.01 0.03 0.05
rs1852269 17 43655273 G A 0.45 0.38 0.05 -0.01 0.38 1.88E-09 8.63E-05 0.85 1.88E-09 0.06 0.01 0.04 0.06
rs11079866 17 47324485 C T 0.53 0.17 -0.03 0.17 0.05 1.58E-08 0.00509477 1.58E-08 0.32 0.03 0.01 0.03 0.05
rs56737642 17 79515509 G A 0.48 -0.34 -0.06 0.21 -0.34 2.87E-11 3.90E-08 4.64E-11 2.87E-11 0.05 0.01 0.03 0.05
rs62075724 17 79611410 C T 0.46 0.38 0.07 -0.21 0.38 2.91E-12 1.94E-09 1.12E-10 2.91E-12 0.05 0.01 0.03 0.05
rs9910935 17 79613949 C T 0.53 -0.34 0.05 -0.34 0.30 2.75E-28 8.88E-07 2.75E-28 3.96E-09 0.03 0.01 0.03 0.05
rs4940460 18 57045134 A G 0.50 -0.35 -0.06 0.03 -0.35 2.86E-12 1.74E-07 0.34 2.86E-12 0.05 0.01 0.03 0.05
rs6077977 20 10930708 G A 0.49 0.27 -0.01 0.27 -0.09 4.98E-19 0.28 4.98E-19 0.08 0.03 0.01 0.03 0.05
rs8132685 21 34220618 T C 0.52 -0.30 -0.04 -0.02 -0.30 3.58E-09 1.01E-04 0.54 3.58E-09 0.05 0.01 0.03 0.05
rs5752975 22 30274335 G C 0.40 0.31 0.06 4.89E-047 0.31 1.80E-09 9.13E-08 0.98 1.80E-09 0.05 0.01 0.03 0.05
rs8138196 22 30656635 G A 0.53 -0.30 -0.05 -0.07 -0.30 2.38E-09 8.70E-07 0.03 2.38E-09 0.05 0.01 0.03 0.05
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Table A.7: Full summary statistics for GWAS of OS thickness. Full GWAS summary statistics
for 38 variants associated with OS thickness, including effect size, p-value and standard error
(SE). A1 is the effect allele. Allele frequency (AF) refers to the frequency of the effect allele.
SNP Chr BP A1 A2 AF Effect size P-value SE
rs11587687 1 110147801 A G 0.44 0.19 7.53E-10 0.03
rs3790612 1 113084146 A G 0.26 -0.27 1.87E-15 0.03
rs72683442 1 113468825 C T 0.22 -0.34 9.79E-21 0.04
rs410895 1 196898226 C T 0.55 0.30 7.01E-22 0.03
rs7594221 2 24112724 A T 0.76 0.27 3.30E-14 0.04
rs6737602 2 169062731 C T 0.39 0.19 5.14E-10 0.03
rs1866665 2 198925980 G A 0.17 0.23 1.24E-08 0.04
rs148388367 2 216850944 A T 0.04 0.64 1.03E-14 0.08
rs7564805 2 234228946 G A 0.05 -0.79 1.48E-29 0.07
rs34234056 3 14418444 G A 0.51 0.17 1.53E-08 0.03
rs62282867 3 100972078 A G 0.79 0.35 9.46E-21 0.04
rs111163508 3 129235423 C G 0.16 -0.40 3.65E-22 0.04
rs7430585 3 150112041 A G 0.76 0.22 4.46E-10 0.04
rs115237855 5 17186336 A G 0.03 -0.69 8.57E-13 0.10
rs78303234 5 17218432 G C 0.12 -0.26 4.08E-08 0.05
rs2326838 6 6901663 A G 0.36 -0.23 7.21E-13 0.03
rs9470055 6 35521961 A G 0.82 0.22 1.97E-08 0.04
rs375435 6 42661404 C T 0.57 -0.25 2.36E-16 0.03
rs947340 6 76747944 C A 0.70 -0.25 1.50E-13 0.03
rs111963714 7 99948655 G T 0.21 0.27 1.27E-12 0.04
rs62490856 8 10469030 A G 0.13 0.35 3.54E-14 0.05
rs11200922 10 85961758 G A 0.46 0.32 2.68E-26 0.03
rs60401382 10 124227624 T C 0.23 -0.30 5.32E-17 0.04
rs12574286 11 76937602 C G 0.21 -0.30 2.01E-15 0.04
rs1126809 11 89017961 A G 0.30 -0.34 3.32E-24 0.03
rs2080402 12 345175 C T 0.56 0.22 2.77E-13 0.03
rs3138141 12 56115778 A C 0.25 0.43 4.00E-35 0.03
rs9796234 13 114323997 C T 0.52 0.26 1.15E-17 0.03
rs1254260 14 60835737 A G 0.29 -0.23 1.52E-11 0.03
rs1800407 15 28230318 T C 0.08 0.58 9.33E-26 0.06
rs183626410 15 55738274 T C 0.01 -0.73 1.59E-08 0.13
rs3825991 15 89761664 A C 0.47 0.36 3.52E-31 0.03
rs142963458 16 84561361 T C 0.04 -0.78 2.18E-20 0.08
rs8059590 16 84572816 G C 0.38 -0.25 2.08E-14 0.03
rs4794029 17 47280301 C T 0.68 0.24 4.22E-13 0.03
rs7405453 17 79615572 G A 0.65 -0.41 1.84E-37 0.03
rs1232603 20 10612963 T C 0.33 -0.23 2.25E-12 0.03
rs6077977 20 10930708 G A 0.49 0.28 3.03E-20 0.03
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Table A.9: Full summary statistics for GWAS of RPE thickness. Full GWAS summary statistics
for seven variants associated with RPE thickness, including effect size, p-value and standard
error (SE). A1 is the effect allele. Allele frequency (AF) refers to the frequency of the effect
allele.
SNP Chr BP A1 A2 AF Effect size P-value SE
rs61822227 1 196767705 C A 0.26 0.45 2.85E-09 0.08
rs1126809 11 89017961 A G 0.30 0.45 4.47E-11 0.07
rs77001109 13 27469579 T C 0.01 1.66 7.74E-09 0.29
rs1800407 15 28230318 T C 0.08 -0.86 4.78E-14 0.11
rs7239443 18 2460759 T C 0.01 1.78 1.14E-08 0.31
rs56194068 18 71061618 T G 0.11 0.57 2.09E-08 0.10









Figure B.1: Genome-wide association study of ONL thickness in different fields of the ET-
DRSgrid. Manhattan plots ofONL thickness averaged across theA)Fovea, B)Intermediate ring,
and C)Peripheral ring. Variants are considered significantly associated if they reach consensus





Figure B.2: Genome-wide association study of IS thickness in different fields of the ETDRS
grid. Manhattan plots of IS thickness averaged across the A)Fovea, B)Intermediate ring, and
C)Peripheral ring. Variants are considered significantly associated if they reach consensus gen-





Figure B.3: Genome-wide association study of OS thickness in different fields of the ETDRS
grid. Manhattan plots of OS thickness averaged across the A)Fovea, B)Intermediate ring, and
C)Peripheral ring. Variants are considered significantly associated if they reach consensus gen-





Figure B.4: Genome-wide association study of RPE thickness in different fields of the ET-
DRS grid. Manhattan plots of RPE thickness averages across the A)Fovea, B)Intermediate ring,
C)Peripheral ring. Variants are considered significantly associated if they reach consensus gen-
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Figure B.5: Mendelian randomisation analysis of the relationship between photoreceptor
layer thickness and AMD. A) Scatter plot of the relationship between the effect size of SNPs
significantly associated with ONL thickness, and the effect size of the same SNPs on AMD. B)
Forest plot showing the effect size and direction of SNPs associated with ONL thickness on
AMD. C) Scatter plot of the relationship between the effect size of SNPs significantly associated
with IS thickness, and the effect size of the same SNPs on AMD. D) Forest plot showing the
effect size and direction of SNPs associated with IS thickness on AMD. E) Scatter plot of the
relationship between the effect size of SNPs significantly associated with OS thickness, and the
effect size of the same SNPs onAMD. F) Forest plot showing the effect size and direction of SNPs
associated with OS thickness on AMD. G) Scatter plot of the relationship between the effect size
of SNPs significantly associated with meta-analysed PRL component layer thickness, and the
effect size of the same SNPs on AMD. H) Forest plot showing the effect size and direction of
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Figure B.6: Mendelian randomisation analysis of the relationship between retinal pigment
epithelium layer thickness and AMD. A) Scatter plot of the relationship between the effect
size of SNPs significantly associated with RPE thickness, and the effect size of the same SNPs on
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Figure B.7: Mendelian randomisation analysis of the relationship between AMD and
photoreceptor layer thickness. A) Scatter plot of the relationship between the effect size of
SNPs significantly associated with AMD, and the effect size of the same SNPs on ONL thick-
ness. B) Forest plot showing the effect size and direction of SNPs associated with AMD on ONL
thickness. C) Scatter plot of the relationship between the effect size of SNPs significantly associ-
ated with AMD, and the effect size of the same SNPs on IS thickness. D) Forest plot showing the
effect size and direction of SNPs associated with AMD on IS thickness. E) Scatter plot of the re-
lationship between the effect size of SNPs significantly associated with AMD, and the effect size
of the same SNPs on OS thickness. F) Forest plot showing the effect size and direction of SNPs
associated with AMD on OS thickness. G) Scatter plot of the relationship between the effect
size of SNPs significantly associated with AMD, and the effect size of the same SNPs on meta-
analysed PRL component layer thickness. H) Forest plot showing the effect size and direction
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Figure B.8: Mendelian randomisation analysis of the relationship between AMD and retinal
pigment epithelium layer thickness. A)Scatter plot of the relationship between the effect size of
SNPs significantly associated with AMD, and the effect size of the same SNPs on RPE thickness.
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Figure B.9: Full results of spatial variation analysis of genetic effect on the inner retina across
the Macula 6 grid, illustrated as maculagrams The thickness of the retinal nerve fibre layer
(RNFL) and ganglion cell inner plexiform layer (GCIPL) at each of the segments of the Macula
6 grid across both left and right eyes wasmodelled as the outcome of each of the genetic variants
found significantly associated with mean inner retinal thickness. The effect sizes from each of
thesemodels is plotted back into theMacula 6 grid usingmaculagrams. For each plot, the RNFL
is pictured top, and the GCIPL is pictured below. The grids are oriented so that for both the left
and right eyes, the easterly segments represent the temporal segments of the eye, those closest
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Figure B.11: Full results of spatial variation analysis of genetic effect on the photoreceptor
cells across the ETDRS grid, illustrated as maculagrams The thickness of the outer nuclear
layer (ONL), Inner segment (IS) and outer segment (OS) at each of the segments of the ETDRS
grid across both left and right eyes was modelled as the outcome of each of the genetic variants
found significantly associated with mean inner retinal thickness. The effect sizes from each of
these models is plotted back into the ETDRS grid using maculagrams. For each plot, the ONL
is pictured top, the IS in the middle and the OS is pictured below. The grids are oriented so that
for both the left and right eyes, the easterly segments represent the temporal segments of the
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Figure B.14: Full results of spatial variation analysis of genetic effect on the retinal pigment
epithelium across the ETDRS grid, illustrated as maculagrams The thickness of the retinal
pigment epithelium (RPE) at each of the segments of the ETDRS grid across both left and right
eyes was modelled as the outcome of each of the genetic variants found significantly associated
withmean inner retinal thickness. The effect sizes from each of these models is plotted back into
the ETDRS grid using maculagrams. The grids are oriented so that for both the left and right
eyes, the easterly segments represent the temporal segments of the eye, those closest tot he ear,
and the westerly represent the nasal sides, those closest to the nose.
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